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ABSTRACT 
 
THE EFFICACY OF PSYCHOSOCIAL SERVICES IN COMPREHENSIVE CANCER CARE: 
A PROGRAM EVALUATION 
Nicola B. Mucci  
 
Antioch University Seattle 
 
Seattle, WA  
 
On average, regardless of other factors, persons affected by cancer will experience some level of 
distress associated with the disease and its sequelae. Left untreated, psychosocial problems can, 
and often do, adversely affect a person’s health and healthcare treatment. As a result, national 
initiatives have been implemented to recognize and treat psychosocial stressors to optimize a 
person’s functioning and facilitate successful movement through the medical system. A program 
evaluation was conducted to examine how Providence Regional Cancer Partnership has 
addressed the psychosocial needs of its patient population. Specifically, the psychosocial 
services department, Patient Support Services, was evaluated to understand how program 
services were (a) utilized and represented across patient demographics and (b) valued or 
regarded within the larger cancer treatment center. Archival data was gathered from electronic 
health records to determine how program services were utilized and by whom. Two surveys were 
designed and distributed to understand the experiences and opinions of program services. 
Evaluation findings clarified areas of strength and identified areas of improvement. Program 
strengths provided insight into services that were well utilized and most valued and affirm the 
program’s mission to reach a broad patient population and provide services to patients in high 
need. Utilization of program services indicated two areas of underrepresentation (gender and 
cancer diversity) and one area of underutilization (support groups). Areas of program 
  
2 
dissatisfaction identified by patients and staff were categorized into three themes: education and 
outreach; program services and access; and Patient Support Services staffing. Recommendations 
were developed with input from Patient Support Services and presented to stakeholders and 
program administrators to make informed decisions about desired program changes. In general, 
evaluation findings provided efficacy of program services and support for the merit of 
psychosocial services within a cancer treatment facility. The electronic version of this 
dissertation is at AURA: Antioch University Repository and Archive, http://aura.antioch.edu/  
and OhioLINK ETD Center, https://etd.ohiolink.edu
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Chapter I: Background 
In 2015, the National Comprehensive Cancer Network ([NCCN], 2016b) estimated 
1,658,370 new cancer cases, with approximately 36%, or 589,430 , cancer-related deaths in the 
United States. Data available from the National Cancer Institute’s Surveillance Epidemiology 
and End Results (SEER) predicts that, per all incidences of cancer, men have a 42% lifetime risk 
of developing cancer while women have a 38% lifetime risk (American Cancer Society [ACS], 
2016). Thus, nearly one half of all men and one third of all women in the United States will 
develop cancer in their lifetime. 
Fortunately, despite a high prevalence of cancer among all Americans, substantial 
progress has been made in the field of oncology which has significantly extended the life 
expectancy of persons with cancer, with many people achieving remission or living with cancer 
as a chronic condition (ACS, 2016). Nevertheless, people with cancer face an array of physical, 
psychological, social, and economic hardships often as a result of a cancer diagnosis and its 
sequelae. And while advances in biomedical care have improved the early detection and 
treatment of many malignant tumors, similar recognition has not been paid to the necessity of 
high quality psychosocial care in addressing problems associated with cancer. Indeed, survivors 
of cancer and family members have reported a lack of understanding and/or failure to address 
important psychosocial needs by their cancer care providers (Institute of Medicine [IOM], 2008). 
In response to these concerns, national initiatives have been implemented over the years to 
recognize and treat psychosocial stressors to optimize the overall health of persons with cancer. 
New standards of care emphasize the inclusion of psychosocial services in delivering high 
quality cancer care because, as the sentiment of the World Health Organization expressed in 
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2001, without mental health, good health cannot exist. Left untreated, psychosocial problems 
can, and often do, adversely affect a person’s health and healthcare treatment in many ways.  
This dissertation outlines psychosocial stressors that commonly accompany a cancer 
diagnosis and the individual and systemic risks of not treating psychosocial concerns as an 
integral part of cancer care. A program evaluation was conducted to examine how one 
institution, Providence Regional Cancer Partnership, has addressed the psychosocial needs of its 
patient population. An internal behavioral health team known as Patient Support Services 
assesses distress, identifies psychosocial needs, and delivers a wide array of onsite program 
services to help patients manage distress and effectively cope with the rigors of cancer and its 
sequelae throughout all phases of the cancer continuum. A strength of the Cancer Partnership is 
its ability to provide a robust program of onsite psychosocial services that reaches far beyond 
distress screening required by governing oncology sanctions. This program evaluation sought to 
determine the overall merit of Patient Support Services and provide feedback to improve 
psychosocial program services as indicated by data on the utilization of services and patient and 
staff feedback. 
Psychosocial Distress Among Cancer Patients 
While advances in early detection and treatment of cancer have improved overall survival 
rates of patients with cancer, the effects of cancer and treatment often have long-lasting 
consequences that can interfere with a person’s ability to function optimally, contributing to 
psychological distress. Distress is an all-encompassing term chosen by the NCCN (2016b) to 
describe the subjective experience of adversity and psychological hardship likely to accompany 
cancer. The term “distress” aims to normalize psychological hardship, rather than pathologize 
persons reacting to the wide-reaching affects of cancer. In 1999, the term was selected by an 
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interdisciplinary group to reduce the potential barrier between people in need of psychosocial 
services, but reluctant to label themselves as needing help, and the clinicians who provide 
services. Distress was defined globally as  
 A multifactorial unpleasant emotional experience of a psychological (i.e, cognitive, 
behavioral, emotional), social, and/or spiritual nature that may interfere with the ability to 
cope effectively with cancer, its physical symptoms and its treatment. Distress extends 
along a continuum, ranging from common normal feelings of vulnerability, sadness, and 
fears to problems that can become disabling, such as depression, anxiety, panic, social 
isolation, and existential and spiritual crisis. (NCCN, 2016b, p. DIS-2) 
While the prevalence of psychosocial distress varies based on individual demographics 
(i.e., age, gender, race, marital status, income) as well as type and stage of cancer, research 
suggests that one third of patients newly diagnosed with first time or recurrent cancer will 
experience a significant level of distress as they adapt to their diagnosis (Zabora, 
Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Zabora and colleagues examined 
psychological distress among 4,496 patients with cancer and found the overall prevalence rate of 
distress was 35.1%. Of 14 cancer diagnoses included in the study, those cancers with poorer 
prognostic rates and/or multi-modality treatments demonstrated greater rates of distress. Lung 
cancer patients were found to have the highest prevalence of distress (43.4%) followed by 
patients with brain, liver, pancreatic, and head and neck cancers, while gynecological cancer 
patients showed lower prevalence rates (29.6%).  
On average, regardless of other factors, persons affected by cancer will experience some 
level of distress associated with their cancer diagnosis as well as the overall effects of the disease 
and/or related treatments. Indeed, symptoms of psychological distress are expected and mild 
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symptoms can be deemed an appropriate, “normal” response to enormity of the disease and 
rigors of treatment. Helgseon and Cohen (1996, as cited in IOM, 2008) defined psychological 
adjustment as an “adaption to disease without continued elevations of psychological distress (e.g, 
anxiety, depression) and loss of role function (i.e., social, sexual, vocational)” (p. 54). Even with 
the most robust resources available to a person, cancer will disrupt all aspects of a person’s daily 
life including relationships, employment, and finances (Zabora et al., 2001). The most commonly 
reported effects of cancer depict both physiological—fatigue and pain—and emotional– anxiety 
and depression—symptoms as patients confront their illness and the numerous cancer-related 
decisions that face them. Other symptoms of expected distress include feelings of uncertainty 
and fear about the future or feeling out of control; anger, irritability, and grief as one’s health and 
functioning changes; thoughts of morbidity and mortality; sleeplessness, changes in appetite and 
concentration, concerns about the illness and a preoccupation with side effects from treatment; 
and concerns about one’s identity and social roles (NCCN, 2016b). Most patients will experience 
signs of distress during pivotal moments, for instance while facing a potential diagnosis of 
cancer, throughout arduous phases of treatment, and following the completion of treatment.  
While psychosocial distress is expected even among psychologically healthy persons, 
persons with preexisting psychiatric disorders represent a more vulnerable population of cancer 
patients who may have greater difficulty coping with the disease (NCCN, 2016b). Patients bring 
with them a multitude of characteristics and psychosocial factors and, not surprisingly, those 
variables can either add to patients’ resiliency— nearly two-thirds of patients successfully adapt 
to their cancer diagnosis without clinical intervention— or hinder their ability to adapt to their 
cancer experience, the remaining one third demonstrated by Zabora et al. (2001). Research 
conducted as far back as the 1980s (Wesiman, Worden, & Sobel, 1980, as cited in Zabora et al., 
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2001), demonstrated that preexisting psychosocial factors, including social support and previous 
history of functioning, significantly contributed to a person’s initial adaption to cancer. With 
psychosocial variables in mind, providers may begin to identify persons at risk of experiencing 
greater difficulty and poor adjustment.  
It is of the utmost importance to identify and treat the subset of patients likely to 
experience clinically significant levels of distress to optimize patients’ successful movement 
through the medical system. Compared to patients with mild symptoms of distress, persons 
exhibiting symptoms of severe distress may show signs of excessive worry or fear; extreme 
sadness, feelings of despair or hopelessness; confused or unclear thinking; and severe problems 
involving their family, spirituality, or social concerns (NCCN, 2016b). Patients with a history of 
psychiatric illness, including substance abuse and cognitive disorders, are at greater risk of 
experiencing severe psychosocial distress. Other populations at risk of acute distress include 
persons with complex comorbid disorders or difficult to control symptoms and persons with an 
array of social issues such as limited social support, limited access to resources or fewer financial 
resources, conflict with family members or caregivers, communication barriers or cultural and 
spiritual/religious concerns. Patients may also be at greater risk of distress during periods of 
vulnerability throughout the course of treatment. Vulnerable periods may include initial workup 
prior to diagnosis, changes in treatment modalities, treatment resistance or failure, side effects or 
complications during treatment, treatment completion, disease progression or recurrence, and 
end of life (NCCN, 2016b). Clearly, many factors may complicate an already arduous experience 
for persons facing cancer, including a history of psychiatric illness, psychosocial issues, and 
treatment-related concerns or complications.   
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Consequences of Unmet Psychosocial Needs  
Given the high prevalence of distress among cancer patients and implications for coping 
with the disease and rigors of treatment, the importance of addressing psychosocial distress 
cannot be understated. Indeed, a failure to identify and treat clinically significant levels of 
distress can have negative effects on an individual and organizational level. Many patients 
experience significant mental health problems that can impair quality of life and the ability to 
carry out social and functional roles. Ultimately, untreated psychosocial problems and distress 
can affect the onset and progression of disease interfering with treatment compliance, 
compromising treatment outcomes, and escalating healthcare costs (IOM, 2008).  
Meta-analyses conducted by the National Comprehensive Cancer Network (2016b) and 
Institute of Medicine (2008), two of the leading international organizations responsible for 
creating oncology standards of care, have discussed the perils of unmet psychosocial needs and 
the affects on patients. In general, research has focused on three psychosocial variables proven to 
affect patient care and treatment outcomes: depression and mental health issues, inadequate 
social support, and insufficient finances or access to resources. 
Emotional distress. All persons are at risk of emotional suffering when confronted with 
a potentially life-threating disease such as cancer (NCCN, 2016b). People afflicted by depression 
or anxiety and comorbid health conditions tend to report more social and functional impairment 
than their non-depressed, non-anxious peers. Somatic symptoms that accompany emotional 
distress such as sleep issues, fatigue, and pain can exacerbate physical symptoms associated with 
cancer and treatment, leading to further functional impairment and greater difficulty engaging in 
change behaviors that promote health (IOM, 2008).   
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By and large, the most serious consequence of emotional distress on health is its 
interference with adaptive coping and adherence to treatment recommendations. Studies have 
indicated that as many as 20% of cancer patients have been noncompliant with treatment 
recommendations including oral chemotherapy, radiation, and adjuvant hormone therapy (IOM, 
2008). Psychological distress can alter patients’ perceptions and motivation to engage in healthy, 
adaptive coping skills. Self-defeating and pessimistic attitudes, for example, may contribute to 
feelings of helplessness and powerlessness that prevent patients from engaging in treatment-
related decisions. Adaptive coping skills may be averted or delayed and patients may gravitate 
towards unhealthy or avoidant behaviors—smoking, excessive alcohol use, medication misuse— 
in an effort to cope with emotional distress. Avoidant-based coping, in particular, has harmful 
consequences on treatment adherence as patients disengage from the problem-solving skills and 
decision-making (IOM, 2008).     
Depression and other psychological disorders can also impair cognition including thought 
processes, perceptions, memory, and executive functioning skills (American Psychiatric 
Association, 2013). Thus, stress, anxiety, and depression among cancer patients can affect the 
ability to adequately process complicated information necessary to understand the disease and 
treatment options. Distraught patients may struggle to work effectively with their treatment 
providers or participate in making treatment decisions leading to poorer outcomes (IOM, 2008).  
Inadequate social support. Social support plays a pivotal role in helping persons with 
cancer manage their illness and shield them from the array of stressors involved. Social support 
can improve healthcare outcomes by helping patients cope with the emotional stress of illness 
and the rigors of treatment procedures, providing informational support during instrumental 
treatment phases, and/or logistical support as a person’s functional abilities and roles change 
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throughout the course of illness and treatment. With the knowledge that social support can help 
mitigate the stressors related to the challenges of illness, it is not surprising that inadequate or 
dysfunctional support systems can negatively affect the course of illness, including worse 
treatment outcomes and higher mortality rates (IOM, 2008). Inadequate social relationships lead 
to a decreased ability to cope with illness and often increase stress rather than insolate a person 
from it. 
Insufficient financial and material resources. Persons with fewer financial resources 
are also at greater risk of developing severe distress. Limited access to resources or financial 
means can interfere with a person’s ability to fully participate in healthcare, thereby inadequately 
managing his/her illness. Indeed, a survey conducted in 2006 on households that were affected 
by cancer found that 8% of families had delayed or declined treatment because of the cost of care 
(IOM, 2008). Given the necessity of wealth and access to resources in this country, especially in 
the management of disease and health maintenance, socioeconomic status has become a strong 
predictor of illness, disability, and mortality rates (IOM, 2008).  
In general, psychosocial stressors such as those described above—depression and mental 
health problems, inadequate social support, and insufficient financial resources—are correlated 
with higher morbidity and mortality rates as well as lower functional status (IOM, 2008). In and 
of itself, psychological distress can cause emotional suffering and significantly decrease a 
person’s effectiveness in his/her social and economic roles. Furthermore, psychosocial problems 
can affect health by obstructing a person’s ability to effectively manage his/her illness, thereby 
creating suboptimal conditions for treatment. Studies have shown that psychosocial problems can 
impede access to necessary healthcare and treatment resources, interfere with treatment 
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compliance, and restrict engagement in adaptive behaviors that promote good health (IOM, 
2008). 
In summary, persons with cancer must approach their cancer treatment from two angles: 
First, they must face their illness and the risks to their physical health that are at stake. Secondly, 
they must confront the many psychosocial challenges related to the sequelae of cancer that 
threaten optimal functioning and high quality healthcare. As Zabora and colleagues indicated in 
their 2001 review of the prevalence of psychological distress among cancer patients, “Failure to 
detect and treat elevated levels of distress jeopardizes the outcomes of cancer therapies, 
decreases patients’ quality of life and increases healthcare costs” (p. 27). Thus, the detection and 
treatment of clinically significant levels of distress is critical in providing comprehensive cancer 
treatment.  
Early psychological intervention in particular, can benefit both patients and the medical 
institution. While psychological interventions may not affect cancer cure rates, evidence supports 
its efficacy helping patients adopt positive coping mechanisms that can minimize symptoms of 
physical and psychological distress and improve overall health (IOM, 2008). In general, patients 
who receive psychosocial services have better quality of living and a lower likelihood of 
developing severe emotional disorders (NCCN, 2016b). Additionally, these patients report 
greater satisfaction in their cancer care. Systemically, psychological interventions during 
appropriate treatment intervals help patients optimize their healthcare experience; psychosocial 
interventions are expected to improve treatment compliance and provider recommendations, 
reduce unnecessary office visits with physicians and emergency room resources, and increase 
communication and collaboration with providers (NCCN, 2016b). Further, psychosocial services 
within oncology aim to benefit the community by promoting better health and wellness and 
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working to improve the delivery of services and care for all persons affected by cancer 
(Association of Oncology Social Work [AOSW], 2012).   
Psychosocial Standards of Care and Distress Management 
The National Comprehensive Cancer Network (2016a), an alliance of the world’s most 
premier cancer centers, is collectively responsible for the development of standards and clinical 
practice guidelines affecting patient care, research, and education. NCCN creates resources that 
lead cancer institutions in delivering high quality cancer care, including the identification and 
treatment of psychosocial services in patients with cancer. Indeed, since 1997, NCCN (2016b) 
has sought to create provisions to advocate for and improve psychosocial care in oncology 
settings. The first clinical practice guidelines on the management and treatment of distress were 
published in 1999 by a panel of interdisciplinary specialists. Since its inception, these guidelines 
have provided a framework for understanding psychosocial distress and they continue to inform 
all future handbooks for oncology specialists and clinicians.  
In 2008, the Institute of Medicine issued the first report recommending the inclusion of 
psychosocial distress screening and appropriate treatment, creating a new standard of quality 
cancer care. IOM standards provided recommendations for the effective delivery of psychosocial 
health services within oncology settings. The proposed model of care begins with effective 
communication between patients and their providers to screen and detect psychosocial needs. 
Once needs are identified, providers are encouraged to connect patients and families to resources 
and support, which may include internal or external services. A strength in this approach is its 
reliance on the use of interdisciplinary collaboration to coordinate psychosocial and biomedical 
care. Figure 1 provides an illustration of the cyclical model proposed by IOM (2008, p. 8). 
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Effective Patient-Provider Communication  
 
Patient/Family Patient-Provider 
Partnership 
 
Provider Team 
 
 
Identification of Psychosocial Needs 
 
 
 
Development and implementation of a plan 
 
 
 
 
Links patient/family  
with needed psychosocial 
services 
Supports patients by: 
o Providing personalized information 
o Identifying strategies to address needs 
o Providing emotional support 
o Helping patients manage their illness 
and health 
 
 
 
 
 
Coordinates 
psychosocial  
& biomedical care 
  
 
Follow-up & 
re-evaluation 
 
   
 
Figure 1. Model for the delivery of psychosocial health services. Reprinted with permission from 
Cancer Care for the Whole Patient, 2008 by the National Academy of Sciences, Courtesy of the 
National Academies Press, Washington, D.C.  
Standards of practice for oncology social workers, the primary professional discipline 
responsible for providing psychosocial services in cancer settings, expands upon IOM 
recommendations to provide more detail regarding the role of clinicians delivering psychosocial 
services. The Association of Oncology Social Work (2012) recommends clinical providers 
possess knowledge of oncological disease and associated treatments to understand the 
psychosocial implications for patients and family and appropriately support them in coping with 
anticipated challenges and changes that occur. Clinicians are encouraged to explore patients’ 
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understanding of their disease, reactions, and expectations while also assessing the psychosocial 
functioning of the patient and family including strengths, coping skills, socioeconomic resources, 
and cultural and spiritual factors that may affect oncology care. Clinical providers are tasked 
with identifying patients at high risk of suboptimal psychosocial functioning during their 
treatment. Similarities can be seen in the recommendations proposed by AOSW in 2012 and the 
psychosocial factors outlined by Wesiman, Worden, and Sobel in 1980 (as cited in Zabora et al., 
2001), demonstrating the resoluteness of psychosocial variables affecting healthy adaptation to 
disease.   
Implementation of standards and guidelines. In 2012, new accreditation standards for 
cancer treatment centers were released by the Commission on Cancer of the American College of 
Surgeons (ACoS); whereas previous standards were once recommendations, new accreditation 
standards required all patients receive screening for psychosocial distress as part of routine care 
(NCCN, 2016b). These most recent standards were subsequently endorsed by the American 
Psychosocial Oncology Society (APOS), the Association of Oncology Social Work (AOSW), 
and the Oncology Nursing Society (ONS).  
NCCN (2016b) guidelines for the management of distress were intended to assist 
oncology teams in identifying cancer patients with distress and/or psychosocial needs and 
recommending appropriate treatment interventions. According to the established standards of 
care, distress should be assessed, documented, and promptly treated at all stages of a patient’s 
disease and throughout appropriate treatment intervals. The detection of distress begins with a 
brief screening tool to identify distress levels (e.g., mild, moderate, severe) and specific areas of 
distress (e.g., practical concerns, family problems, emotional difficulties, spiritual or religious 
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concerns, physical problems, etc.). The reader may refer to Appendix A to review NCCN 
(2016b) standards of care for distress management.  
Subsequently, the NCCN (2016b) created the Distress Thermometer (DT) to quickly 
identify sources of distress related to cancer. A standard, brief questionnaire format was used to 
identify distress and psychosocial needs and assist in developing a plan to manage needs. While 
screening is a critical component of psychosocial care, the DT was, more importantly, designed 
to facilitate dialogue between providers and patients and to ensure that psychosocial needs do not 
go unrecognized and untreated in busy ambulatory care settings. The oncology team is often the 
first to detect psychosocial concerns and, thus, providers must handle these conversations with 
compassion and sensitivity:  
It is important for the oncology team to acknowledge and validate that this is a difficult 
experience for the patient and that distress is normal and expected. Being able to express 
distress to the staff helps provide relief to the patient and builds trust. (NCCN, 2016b, p. 
MS-12) 
Once psychosocial needs are identified, patients need access to appropriate referral 
sources and treatment. Cancer patients are not a homogenous group with homogenous needs; 
interventions must to be selected according to where patients are on the continuum of distress 
and cancer-related needs. NCCN recommends psychological interventions that offer 
psychoeducation, resources that promote medication management and healthy lifestyle choices, 
counseling, relaxation strategies, and spiritual support. Additionally, psychosocial providers 
should be prepared to assess patients’ capacity to make treatment decisions and concerns related 
to safety. Table 1 outlines examples of psychosocial needs and corresponding services to treat 
specific areas of distress, as proposed by IOM (2008). 
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Table 1 
 
Psychosocial Needs and Formal Services to Address Them  
 
Psychosocial Need Health Services 
Information about illness, 
treatments, health, and 
services 
 
• Provision of information, e.g., on illness, treatments, effects 
on health, and psychosocial services, and help to 
patients/families in understanding and using the information  
Help coping with emotions 
and accompanying illness and 
treatment 
 
• Peer support programs 
• Counseling/psychotherapy to individuals or groups 
• Pharmacological management of mental symptoms 
Help in managing illness • Comprehensive illness self-management/self-care programs 
 
Assistance changing 
behaviors to minimize impact 
of disease 
 
• Behavioral/health promotion interventions, such as:  
- Provider assessment/monitoring of health behaviors 
(e.g., smoking, exercise) 
- Brief physician counseling 
- Patient education, e.g., in cancer-related health risks and 
risk reduction measures 
 
Material/logistical resources 
 
• Provision of resources  
Help in managing disruptions 
in work, school, and family 
life 
• Family and caregiver information  
• Assistance with activities of daily living, chores 
• Legal protections and services, e.g., under Americans with 
Disabilities Act and Family and Medical Leave Act 
• Cognitive testing and education assistance  
 
Financial advice and/or 
assistance 
• Financial planning/counseling, including management of 
day-to-day activities such as bill paying 
• Insurance (e.g., health, disability) counseling 
• Eligibility assessment/counseling for other benefits (e.g., 
Supplemental Security Income, Social Security Disability 
Income) 
• Supplemental financial grants  
  
Note. Care for the Whole Patient, 2008 by the National Academy of Sciences, Courtesy of the 
National Academies Press, Washington, D. C.  
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Providence Regional Cancer Partnership 
 In 2007, Providence Regional Cancer Partnership (PRCP), also referred to as the Cancer 
Partnership throughout, was founded in collaboration with four of the region’s leading healthcare 
organizations: Providence Everett Medical Center, The Everett Clinic, Western Washington 
Medical Group, and Northwest Washington Radiology Oncology Associates. PRCP was 
established with the intent of creating an integrative outpatient treatment center where all aspects 
of patient care could be provided in one building including: chemotherapy, radiation oncology, 
clinical research, and integrative medicine where behavioral health services reside. PRCP’s 
vision statement conveys the standard of care they have strived to provide, “[PRCP is] a 
comprehensive, regional, state-of-the-art, single destination designed exclusively for the cancer 
patient and family with integrated and seamless clinical, operational and business processes” 
(PRCP, 2009, p. 1). An illustration of PRCP’s organizational structure is found in Appendix B.  
As of 2013, the Cancer Partnership was recognized as the fourth largest cancer program 
in the region based on the number of patients served annually (PRCP, 2015a). PRCP is 
accredited by the Commission on Cancer which ensures high-quality cancer care based on data-
driven performance measures overseen by the American College of Surgeons (2014). Indeed, the 
Cancer Partnership recently achieved the Outstanding Achievement Award after attaining the 
Approval Award with Commendation for three consecutive years (PRCP, 2015a). Additionally, 
the Cancer Partnership is certified by the Quality Oncology Practice Initiative, a program 
administrated by the American Society of Clinical Oncology to ensure high practice standards of 
quality and safety through ongoing assessment (ASCO, 2016). PRCP’s adherence to these 
standards speaks to its culture of excellence and commitment to continued self-examination and 
improvement. 
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Patient population. PRCP treats a wide range of cancers and hematology disorders. The 
Cancer Partnership employs specialists in medical oncology, radiation oncology, surgical 
oncology, thoracic oncology, gynecologic oncology, and neurosurgery. The reader is encouraged 
to refer to Appendix C, which outlines the expansive list of medical and support services offered 
at PRCP during 2014.  
During the 12 months this evaluation was conducted, PRCP saw 1904 new cancer cases, 
which is consistent with the average number of patients treated in previous years. Fifty-six 
percent of all new patients were female (n = 1067), while 44% were male (n = 837). The most 
frequently diagnosed tumor sites included breast (n = 370, 19.4%), lung (n = 275, 14.4%), 
prostate (n = 105, 5.5%), lymphoma (n = 92, 4.8%), bladder (n = 92, 4.8%), and uterine cancer 
(n = 92, 4.8%). Patients with stage I cancer were most prevalent among new cancer cases  
(n = 561, 29.5%), followed by stage IV (n = 375, 19.7%). PRCP’s patient population is looked at 
more closely in the chapters that follow as this evaluation examined patient demographics and 
trends in utilization of psychosocial program services. The reader may also refer to Appendices 
D, E, and F for a comprehensive look at the patient population during the time of this evaluation, 
including the incidence of cancer site by gender, stage, and insurance type.  
Psychosocial Services. As the Cancer Partnership was being conceptualized in 2005, a 
multidisciplinary task force was concurrently planning and developing the inclusion of 
psychosocial services, which became known as the department of Patient Support Services 
(PSS). The mission and goals of PSS were established in alignment with NCCN (2016b) clinical 
practice guidelines for the management of psychosocial distress. At the time, psychosocial 
support goals were identified as follows (PRCP, 2005a):  
• To assess the psychosocial needs of each newly diagnosed patient  
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• To help patients and their families cope more effectively with the rigors of cancer 
treatment and follow-up 
• To connect patients and family members with appropriate community resources to 
meet their needs 
• To be available as a resource to help patients manage distress throughout their 
treatment  
• To ensure that all patients, family members, and caregivers receive access to 
psychosocial services to support the best possible outcomes for persons affected by 
cancer 
PSS has become an internal behavioral health team tasked with addressing the 
psychological and social distress likely to accompany cancer throughout all phases of the cancer 
continuum including diagnosis, treatment, survivorship, terminal care, and bereavement. The 
department’s strength resides in its ability to offer patients and family members a wide range of 
support options, beyond distress screening required by governing oncology sanctions. While 
distress screening measures help monitor the psychological acuity and health of the patient 
population at PRCP, the department offers a multitude of support services and interventions to 
help patients utilize the healthcare system more effectively, mitigate psychosocial distress, foster 
positive coping strategies, and optimize functioning, as suggested by AOSW (2012) guidelines. 
In-house onsite psychosocial services reflect many of the services recommended by IOM (2008) 
and may include education and advocacy, crisis intervention, individual and family counseling, 
formal and informal assessments, support groups and group therapy, case management and 
community resourcing, and financial assistance. PSS works closely with integrative medicine to 
provide holistic healthcare and psychosocial support to patients, family members, and caregivers 
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five days a week. Many services are offered at no cost to patients or family members. The reader 
may refer to Appendix G to review a copy of PRCP’s policy and procedure regarding access to 
psychosocial services. Additionally, Appendices H and I provide the full list with descriptions of 
support resources advertised at PRCP. 
PSS strives to be an integral part of the interdisciplinary oncology team, contributing to 
the overall treatment of person’s cancer. In 2015, psychosocial services were identified as an 
area of focus and growth by PRCP’s clinical and administrative leaders with the goal of 
promoting integrative medicine and Patient Support Services, inside and outside the organization 
(PRCP, 2015a).   
Distress management at PRCP. Since its inception, PRCP has been committed to 
following guidelines for distress management set forth by the NCCN (2016b) and IOM (2008). 
In compliance with standards, PRCP has implemented procedures for ascertaining cancer-related 
distress for medical and radiation oncology patients during appropriate treatment intervals. 
Psychosocial distress screening procedures are outlined as follows and a full copy of PRCP’s 
policy and procedure can viewed as Appendix J (PRCP, 2012b). 
 Distress Assessment tool. PRCP uses a standard, paper-and-pencil patient questionnaire 
modeled after the NCCN (2016b) Distress Thermometer to routinely monitor psychosocial 
distress and assess the need for services. PRCP’s Distress Assessment (DA) questionnaire asks 
patients to quantify their experience of distress during the past week. The term “distress” is 
intentionally undefined so patients may freely interpret their experience of distress, physical, 
emotional, or otherwise. Additionally, the DA inquires more specifically about several areas of 
distress including, practical concerns, emotional problems, family difficulties, and spiritual 
concerns. Patients may also request additional information about psychosocial resources (i.e., 
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Medicaid, Medicare, Social Security) and PRCP support programs (i.e., nutrition, support 
groups, hospice care). Please refer to Appendix K to review a complete version of PRCP’s DA 
questionnaire.  
Procedures. All patients who receive treatment at PRCP are screened for distress 
throughout their care, however, distress screening procedures vary based on the treatment 
patients receive. Medical oncology patients receive a DA questionnaire on days they both meet 
with their oncologist and receive infusion treatment. DA questionnaires may also be provided 
during pivotal intervals of care such as treatment completion, disease remission, or disease 
progression. By contrast, radiation oncology patients meet with their oncologist much more 
frequently and, therefore, only receive a DA questionnaire the day of their intake appointment.  
DA forms are generally screened on at least two occasions, first by a treatment provider 
so that distress can be addressed during a patient’s office visit or treatment session, and second 
by PSS staff for further follow-up. PSS staff assesses DA forms to “determine if there are any 
psychological, behavioral, social, practical, financial, or spiritual problems that might interfere 
with the patient’s ability to participate fully in their healthcare and adequately manage their 
illness” (PRPC, 2012b, p. 2). More specifically, PSS staff identifies patients needing follow up 
care based on distress levels greater than five on a scale of 0–10 or when patients request 
resources or a desire to be contacted. Ideally, staff makes contact with patients in need of follow 
up care in person at the Cancer Partnership or by telephone within 72 hours. Further assessment 
is completed at that time and an attempt is made to connect patients with appropriate resources 
and services, including interventions facilitated by PSS staff.  
The inclusion of this a brief assessment tool helps PRCP providers detect and assist in 
alleviating cancer-related distress and introducing patients to the spectrum of support services 
		
 
20 
available to them. During PRCP’s first year as a free-standing cancer treatment facility, PSS 
completed more than 4,479 DA questionnaires, with 22.6%, or 1,013 DA forms, indicating 
distress levels greater than five (PRCP, 2009). The most frequently identified concerns at that 
time were depression (n = 7.1%), fears and nervousness (n = 6.4%, n = 5.2%), and sleep (n = 
4.3%).  In 2013, a review of patient contact from three full-time PSS staff members 
demonstrated that per each 1.0 staff position, 91 points of contact were made each month and an 
average of 52 new patients were contacted each month (K. Johnson, personal communication, 
2013).  
Quality assurance. The NCCN (2016b) recommends systemic guidelines to ensure 
distress management standards are implemented and monitored thereafter. Institutions are 
encouraged to establish interdisciplinary committees to oversee distress management policies 
and evaluate quality of psychosocial care. In doing so, the NCCN recommends an audit of 
patient care records to (a) confirm a patient’s emotional wellbeing has been assessed and (b) 
determine if any action was taken to address identified psychosocial needs. Systemic quality 
improvement protocols are encouraged to provide feedback to oncology treatment centers about 
the quality of psychosocial care including patient satisfaction and quality of life.  
As a multidisciplinary center, PRCP has several committees that oversee best practices, 
strategic, business, and program developments, and compliance with ACoS standards for cancer 
treatment centers (the reader may find a full list of PRCP committees and their role in supporting 
program goals in Appendix L). Each department has measures that evaluate patient satisfaction, 
waiting times, and other indicators of quality care (PRCP, 2009). Some measures are compared 
to other cancer treatment centers throughout the nation, while others are for internal use only. 
Psychosocial programming and adherence to distress screening policy and procedures are 
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overseen by the Medical Director of Psychosocial Services and reported annually to the 
Multidisciplinary Cancer Committee Quality Assurance. In compliance with NCCN (2016b) 
standards, patients beginning treatment are identified each month and electronic health records 
are audited to see if distress screening has occurred within 30 days of treatment. Support group 
attendance is also reported to the Cancer Partnership administration monthly.  
In summary, the most current healthcare standards recognize high quality cancer care 
reaches beyond biomedical treatment to require the inclusion of psychosocial care. Psychosocial 
services are necessary to treat the complexity of physical, emotional, social, and economic 
hardships expected to accompany cancer and the rigors of treatment. Psychosocial interventions 
have demonstrated efficacy in helping patients adopt positive coping skills that can minimize 
symptoms of distress and improve overall health (IOM, 2008). Patients who receive psychosocial 
services in tandem with biomedical services tend to have better quality of living and a lower 
likelihood of developing severe emotional disorders that can interfere with functioning and 
healthcare treatment. In addition, these patients report greater satisfaction in their cancer care and 
greater treatment compliance with provider recommendations (NCCN, 2016b).  
In adherence with national initiatives, Providence Regional Cancer Partnership was 
established as a multidisciplinary outpatient cancer treatment center to meet the biomedical and 
psychosocial needs of its patients. The following chapters examine how PRCP has addressed the 
psychosocial needs of its patient population. A program evaluation was conducted to understand 
how program services delivered by Patient Support Services were (a) utilized and represented 
across patient demographics and (b) valued or regarded within the larger cancer treatment center. 
Program strengths provide insight into services that are well utilized and provide support for the 
efficacy of psychosocial services as part of a larger cancer treatment center. Program 
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recommendations are offered with input from stakeholders to improve areas of concern identified 
by patients and staff.  
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Chapter II: Methodology 
While PRCP routinely employs internal quality assurance procedures dictated by the 
American College of Surgeons (2014) and National Comprehensive Cancer Network (2016b), 
the organization had not taken an in-depth look at its behavioral health department, Patient 
Support Services, since it’s inception in 2007. In particular, to-date, no information had been 
gathered that analyzes how program services are utilized and by whom; additionally, program 
satisfaction data had not been collected since 2009. This evaluation sought to understand and 
evaluate the merit of PRCP’s psychosocial services department and to provide program 
feedback. A stakeholder meeting was held to generate areas of interest from the perspective of 
PRCP’s leadership team as well as clinical and support staff. The nature of this evaluation 
included gathering qualitative and quantitative data from patients and staff to understand how 
program services were currently utilized and regarded from the perspective of program 
recipients, clinical staff, and administrators. Evaluation findings provided informed and 
contextualized recommendations to further benefit PRCP’s staff and patient population.  
Program Evaluation  
 This study utilized program evaluation as a methodology to evaluate psychosocial 
services provided at PRCP. As a method, program evaluation evaluates questions concerning a 
program’s utilization, implementation, or efficacy of services (W. K. Kellogg Foundation, 
2004a). At its core, program evaluation seeks to determine the merit of the subject being studied; 
a judgment is rendered about the worth or value of the subject being studied. Herein lies the 
primary difference in purpose between research and evaluation methods: Research contributes 
information to a field by providing conclusions; whereas, evaluation aims to help stakeholders 
make informed decisions based on judgments (Fitzpatrick, Sanders, & Worthen, 2004). Unlike 
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research, which culminates in a discussion of how results are generalizable, program evaluation 
concludes with a report of evaluation findings and program recommendation specific to the 
organization. 
Formative program evaluation. More specifically, a formative program evaluation 
framework was used in this study based on the primary purpose and intended audience of the 
evaluation. Formative evaluations intend to provide feedback for the purpose of program 
improvement, providing information on the merit or worth of part of a program rather than the 
entirety of a program (Fitzpatrick et al., 2004). Such evaluations focus on examining program 
activities, outputs, and short-term outcomes to monitor progress and recommend midcourse 
corrections as needed (W. K. Kellogg Foundation, 2004b). Questions typically asked throughout 
a formative evaluation may include: What aspects of the program are working? What elements 
need to be improved and how? 
The intended audiences who will benefit from this evaluation are the people delivering 
program services, namely Patient Support Services staff and program administration; program 
recipients will benefit secondarily from recommendations aimed to improve program services.  
Stakeholder Meeting  
 Engaging stakeholders in the evaluation process, particularly during the question 
development phase, was prudent in ensuring a useful and credible project. Because stakeholders 
are invested in the organization’s success and affected by the evaluation findings, their input was 
necessary and invaluable in determining the scope and direction of this evaluation. As noted by 
Preskill and Jones (2009), evaluation findings are more likely to be relevant, accepted, and 
implemented by the organization when research questions reflect the interests and needs of 
vested members.  
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Members of the PRCP Psychosocial Steering Committee were invited to participate as 
stakeholders. The Psychosocial Steering Committee is a multidisciplinary team responsible for 
“planning and implementing program and service development to meet the psychosocial needs of 
cancer patients” (PRCP, 2012a, p. 2). Because the committee oversees psychosocial program 
development, the quarterly meeting was chosen as the forum to invite members to participate as 
stakeholders in shaping the proposal of this project and brainstorming possible areas of 
evaluation. In total, 10 members participated in the first stakeholder meeting including members 
of the management team as well as supporting specialists and clinical staff. Although program 
recipients may also be considered stakeholders as the beneficiaries of program services, patients 
were not invited to stakeholder meetings because the primary audience of this evaluation was 
persons delivering program services rather than its consumers.   
Members present at the stakeholder meeting expressed support and enthusiasm for the 
evaluation. Several areas of interest were generated and later categorized by the evaluator based 
themes and areas of focus defined by Fitzpatrick et al. (2004): needs assessment or context, 
process and monitoring, or outcomes. What follows are areas of evaluation proposed during the 
stakeholder meeting (the reader may refer to Appendix M to review notes from the first 
stakeholder meeting). 
Needs assessment or context. This area of evaluation explores program aspects 
perceived of being in need and attempts to mitigate problems through program 
recommendations: 
• What is the purpose and value of Patient Support Services? 
• How does PRCP compare to other cancer treatment centers or Providence campuses 
throughout the region? 
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Process and monitoring. These questions seek to understand how program services are 
delivered: 
• Is the current model of training and delivery of psychosocial program services 
sustainable over time? 
• Is the mission of Patient Support Services still appropriate? Is the program doing 
what we said it would and is it doing it well? 
• How are program services utilized by patients? Are there groups of patients not being 
served by PSS? 
Outcomes. Outcome questions explore how program recipients are changed through their 
participation in a program: 
• What is the patient and/or staff experience of PSS? 
• What is the cost and savings benefit of the larger Cancer Partnership because of the 
inclusion of psychosocial services in cancer treatment? 
• What is the impact of having PSS within the larger cancer treatment program and how 
does if affect the role of other staff members?  
Stakeholders continued to be involved throughout the development of this evaluation. A 
second stakeholder meeting took place prior to data collection to discuss design considerations, 
sources of available data, and data collection methods. The Medical Director of Psychosocial 
Services was closely involved in all phases of this evaluation, ensuring program support and 
interest throughout the entirety of the evaluation. Stakeholders were again included at the 
conclusion of data analysis to participate in generating proposed program recommendations 
based on evaluation findings.  
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Outcomes Approach Logic Model  
 Following the initial stakeholder meeting, a logic model was developed to provide 
clarity in understanding the presumed relationship between program services, program goals 
defined by the department’s mission, and the desired outcome of program services. Logic models 
visually depict the relationship between a program’s theory and assumptions about how the 
program works (W. K. Kellogg Foundation, 2004b). More specifically, logic models are helpful 
in illustrating the sequence of activities necessary to facilitate desired changes and bring about 
anticipated results. In this way, logic models can serve as a roadmap to guide stakeholders and 
the evaluator in understanding the relationship between the program’s goals and the results the 
program expects to achieve.  
For this evaluation, an outcomes approach logic model was chosen to illustrate the 
assumed causal relationships between PSS program services and the program’s anticipated 
outcome, to mitigate the psychosocial distress of cancer patients and their family members. 
Appendices N and O illustrate the outcomes approach logic model used in this evaluation to 
better understand the relationship between program services and desired outcomes.  
Evaluation Questions  
Evaluation questions were formulated with input from PRCP stakeholders and refined 
using program evaluation theory and methodology. Formative program evaluation methods 
provided the scope for this project, while an outcomes approach logic model provided clarity in 
understanding the relationship between program activities or services (i.e., input) and desired 
outcomes or expected results participating in services (i.e., output). Finally, project feasibility 
was also considered when identifying evaluation questions. Congruent with formative evaluation 
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practices, this evaluation aimed to provide feedback about particular aspects of PSS, rather than 
the program as a whole.  
The predominant purpose of this formative evaluation was to provide PRCP feedback 
about the merit or worth of Patient Support Services. To this effect, the evaluator examined both 
utilization and satisfaction of Patient Support Services to better understand how program services 
were (a) utilized and represented across patient demographics and (b) valued or regarded within 
PRCP, as defined by patient and staff satisfaction. A mixed method approach was used to collect 
and analyze data. Archival data was gathered from electronic health records to determine how 
program services were utilized and by whom. Two surveys were designed and distributed to 
understand the experiences and opinions of program services.  
Participants   
Demographic information was collected from electronic health records to identify a 
representative sample of patients who utilize program services. Additionally, program feedback 
was collected from patients and staff members including program administrators, clinical 
providers, and support staff persons.  
 Patient chart reviews. Four hundred chart audits were decidedly selected from an 
overall sampling of patients who received cancer treatment at PRCP. Electronic health records 
were chosen for review based on patient participation or interaction with PSS staff within twelve 
months of this evaluation being conducted. Participants were selected from charting records 
based on documentation of daily patient interactions provided by three PSS staff members. 
Patient information was then located using PRCP’s data information system which manages 
electronic health records. Participants were excluded if patient names were unable to be located 
in the electronic health record. These names likely accounted for patients with misspelled names, 
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family members calling on behalf of patients, or persons receiving treatment elsewhere but 
calling PSS for information or resources. Additionally, participants were excluded if a cancer 
diagnosis was unsubstantiated based on documentation (i.e., benign masses or tumors). On 
occasion, hematology patients were included if they received treatment from an 
oncologist/hematologist and participated in program services.  
 Patient surveys. Patients were also selected to receive surveys. This selection process 
occurred a number of ways to account for patients who were currently receiving treatment as 
well as patients who had completed treatment in recent months. Patients were offered satisfaction 
surveys if they were receiving treatment onsite during a four month period while this evaluation 
was being conducted. Patients attending a support group during this evaluation were also invited 
to participate in surveys. Lastly, patients were selected to receive a survey by mail if they had 
attended an initial oncology office visit in the year prior to this evaluation being conducted. 
Known deceased patients were excluded from the mailing list.  
 Staff surveys. PRCP staff was invited to participate in an online survey to gather 
feedback about Patient Support Services. Staff who had direct or indirect interaction with 
patients and/or PSS staff were eligible to participate in the survey. Staff members included 
program administrators, clinical providers, and support staff persons. Members of Patient 
Support Services were excluded.  
Materials and Measures  
 Chart reviews. Demographic information was collected from electronic health records 
to better understand how program services were currently represented and utilized by patients. 
Patient demographics were defined and described as follows:  
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Age. Age was determined at the time of data collection according to date of birth. Age 
was then collapsed into groupings by age range as follows: 18–25, 26–34, 35–44, 45–54, 55–64, 
65–75, 75 and older.  
Gender. A binary gender classification was used to categorize patients as either male or 
female based on documentation gathered from electronic health records. 
Insurance. Primary health insurance information was collected and then collapsed into 
three categories: private or commercial, Medicare, and Medicaid or state-sponsored insurance. 
Insurance information was used to generate inferences about socioeconomic status and access to 
resources.  
Cancer type. Type of cancer, or primary cancer site, was determined by the oncology 
team. Diagnoses were identified according to an initial oncology appointment and confirmed 
based on the most recent office visit to account for any diagnostic changes that may have 
occurred based on later imaging and pathology findings. In 2015, PRCP treated the following 
primary cancers:  
• Bladder cancer 
• Brain tumors 
• Breast cancer 
• Cervical cancer 
• Colorectal cancer 
• Endometrial cancer 
• Esophageal cancer 
• Gallbladder cancer 
• Gastrointestinal tumors 
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• Head and neck cancer 
• Kidney cancer 
• Leukemia 
• Liver cancer 
• Lung cancer 
• Lymphomas  
• Ovarian cancer 
• Pancreatic cancer 
• Skin cancer 
• Soft tissue sarcoma  
• Uterine cancer 
Several oncologists at PRCP also treat a variety of hematologic malignancies or blood diseases, 
including problems affecting blood cells, platelets, blood vessels, bone marrow, lymph nodes, 
and proteins that affect bleeding and clotting (American Society of Hematology, 2015). 
Hematology patients also had access to Patient Support Services and, therefore, were included in 
this evaluation on the rare occasion that they participated in program services. 
In general, International Classification of Diseases (ICD-9CM) (WHO, 2015) coding 
system was used to classify cancers based on primary site. For analysis, less commonly 
occurring cancers and malignant disorders were grouped together by their relationship as 
follows:  
• hematologic diseases: anemia, coagulation disorder, thrombocytosis and 
thrombocytopenia, and myelodysplastic syndrome;  
• blood cancers: lymphomas, leukemias, multiple myeloma; 
		
 
32 
• female reproductive cancers: vaginal and vulvar, cervical, uterine and endometrial, 
ovarian, and urethral cancer; 
• male reproductive cancers: penile, prostate, and testicular cancer; 
• head and neck cancers: oral cavity, pharynx, larynx, paranasal sinuses and nasal 
cavity, salivary glands, and thyroid cancer;  
• skin cancers: basal and squamous cell, melanoma, merkel, and Kaposi;  
• colon, rectal, and intestinal cancer;  
• liver and hepatocellular cancer and bile duct cancer; and 
• squamous cell carcinoma of unknown primary site 
Cancer staging.  Clinical stage was determined at diagnosis by the oncology team, prior 
to starting treatment. Staging describes the progression and severity of cancer based on the size 
of the tumor and the extent cancer has spread beyond the original tumor into nearby tissues and 
organs or into the bloodstream or lymphatic systems (ACS, 2015b). Staging provides inferences 
about treatment options as well as prognosis, including chance of survival and the likelihood of 
cancer recurring. Most cancers are classified as one of five stages, with higher stages indicating 
more extensive disease progression (National Cancer Institute at the National Institutes of Health 
[NCI], 2015): 
• Stage 0: Abnormal cells are present, but have not spread to nearby tissue. At this 
stage, abnormal cells are not cancerous, but may later become cancer.  
• Stage I: Cancer growth is limited to the primary organ site without evidence of 
metastases, or growth beyond the original tumor. 
• Stages II & III: Cancer has spread beyond the primary organ to nearby lymph nodes, 
tissues, and/or organs.  
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• Stage IV: Cancer has spread to distant lymph nodes, tissues, and/or organs. 
There are several exceptions to the staging classification system described above. For 
example, cancers of the blood or bone marrow rely on a different staging system that considers 
blood cell counts and may use a three-stage classification system (0–III) rather than five (ACS, 
2015a; ASCO, 2015; Leukemia and Lymphoma Society, 2015). Because a variety of factors 
determine cancer staging, including the number of staging classifications (typically three verses 
five), true comparisons between cancer stages across cancer types could not be made. However, 
during data analysis, it was assumed that higher stage numbers were indicative of more extensive 
disease progression, irrespective of cancer type or classification system.  
Medical treatment. PRCP (2014) provides a wide variety of medical treatments including 
prevention screening, diagnostic services, clinical research, medical oncology, radiation 
oncology, and psychosocial services. This evaluation identified whether patients received 
surgical oncology, chemotherapy, radiation, or a combination of medical services. Data analysis 
looked at trends in the utilization of program services according to medical oncology treatment. 
Program services. Participation in program services was recorded based on 
documentation from PSS staff. While PRCP offers a variety of support services and integrative 
medicine including acupuncture, yoga, hypnosis, meditation, and naturopathic medicine, this 
evaluation focused on services provided by PSS staff. Namely, this evaluation was interested in 
tracking patient interaction related to telephone contact, Distress Assessment questionnaires, 
supplemental financial services, counseling during infusion, office visits, support groups, and 
family involvement in services. Information was also collected about patient participation in the 
Cancer Resource Center and nutrition services because of the close involvement the patient 
navigator and dietician had with PSS. Support groups facilitated by PSS staff were included; 
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however, data was not collected from the Look Good, Feel Better class facilitated by the 
American Cancer Society, the prostate cancer support group facilitated by a cancer survivor, or 
gentle yoga led by yoga instructors unaffiliated with PSS.  
The number of interactions with PSS was determined based on staff documentation; any 
interaction with PSS staff, the patient navigator, or dietician was included for data analysis and 
not limited to a specific timeframe. While patient participation in support groups was included, 
the number of times a patient attended a support group was not calculated  
 Surveys. Two surveys were designed to gather information from the perspective of 
patients, or program recipients, and staff members. Surveys were developed with input from PSS 
staff and designed to elicit respondents’ experiences and opinions about program services and 
staffing, drawing out program strengths and weaknesses. Respondents’ attitudes were measured 
using fixed-choice Likert scales intended to increase the likelihood and ease of participating in 
surveys.  
Patients were asked about their familiarity with the department and program services, 
utilization of services, satisfaction regarding the quality and variety of program services as well 
as staffing, opinions about the impact program services had as part of their cancer care treatment, 
and perceived strengths and areas for improvement. Similarly, PRCP staff were surveyed about 
their familiarity with the department and program services, the referral process (how often, 
which services, and under what circumstances program services were recommended by staff), 
perceived strengths and areas for improvement, and opinions about the importance or value of 
including behavioral health services in a cancer treatment program. Copies patient and staff 
satisfaction surveys are included as Appendices P and Q. 
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Procedures 
 Patient chart reviews. Four hundred electronic health records were reviewed to gather 
information on patient demographics, general treatment information including cancer origin and 
stage, treatment modalities, and participation in Patient Support Services. Information was 
gathered from electronic health records, particularly physician treatment notes, PSS staff 
documentation, and patient demographic information.  
Patient surveys. Patient surveys were distributed both in person and by mail to capture a 
large pool of participants and to mitigate low return rates typical of surveys. Surveys were 
initially offered to patients by reception staff upon checking in for chemotherapy or radiation 
treatment. A secure box was provided to anonymously return completed surveys in common 
waiting areas. However, due to a low volume of surveys returned in person, surveys were mailed 
to patients’ homes. Preaddressed envelopes with prepaid postage were included for easily return 
completed surveys to PRCP. Four hundred and forty surveys were mailed to patients who began 
treatment between July 1 and October 1, 2014. This treatment timeframe was selected to avoid 
sending surveys to patients who were currently receiving treatment onsite, minimizing the 
possibility of surveying people on more than one occasion.  
In addition, American Cancer Society volunteers offered surveys to patients during 
chemotherapy infusion.  It was conceived that patients would be more likely to complete surveys 
during treatment, which often lasts several hours, rather than during an office visit with their 
oncologist. Presumably, patients would be more receptive to complete surveys hand-delivered by 
volunteers during treatment than by reception who routinely distribute patient paperwork upon 
checking in. Lastly, PSS staff distributed surveys during support group meetings between 
August–September 2015. In total, 590 surveys were made available for distribution in person and 
		
 
36 
by mail. Patient surveys were printed on colored paper to monitor how surveys were returned 
and by whom.  
Staff surveys. One hundred and ten eligible staff were invited to anonymously 
participate in a survey via Survey Monkey. An initial email invitation read, “Please consider 
participating in the following survey to provide feedback about Patient Support Services. Your 
input is extremely valuable in shaping ongoing and future services. Your participation is 
voluntary and anonymous. It should take no longer than ten minutes to complete. Thank you for 
your feedback.” A second email invitation was sent by the evaluator 2–4 weeks later with the 
following request, “Patient Support Services needs your feedback. If you have not already 
responded, please complete the survey using the link below. We are very interested in hearing 
from you so we can strengthen and improve services we provide to our patients each year. It is a 
quick anonymous survey, but your feedback is invaluable. Thank you.”  
Data Analysis 
 Data from electronic health records and surveys were analyzed to (a) identify trends in 
the utilization of program services and the patients who use them, and (b) draw out themes 
regarding the quality, variety, and efficacy of program services and staffing. Data analysis 
decisions were informed by the goals of this evaluation with the intention of providing feedback 
to staff delivering program services and administrators. Additionally, data analysis was informed 
by the characteristics and statistical assumptions of the data set (Salkind, 2007).  
Chart reviews. Data collected from electronic health records was recorded into Excel for 
tracking, coding, and analysis. Utilization of services data relied heavily on the use of descriptive 
statistics to describe the characteristics of program participants and services used. A majority of 
the data collected was categorized as a nominal level of measurement including gender, 
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insurance information, cancer diagnosis, and program services. Ordinal (cancer stage) and ratio 
levels of measurement (age, number of PSS visits) were less likely to characterize the data set. 
Participants were categorized into three groups based on their level of participation in program 
services, as described in the following chapter on evaluation results. Descriptive statistics were 
used to describe the characteristics of each participant group and make comparisons between 
groups to understand how services were used. Frequency charts were used to visually depict the 
occurrence of demographics and to illustrate the majority and minority characteristics of program 
users. Percentage rates and frequencies were often reported together to describe the 
characteristics of data; percentage rates demonstrated frequencies in relation to the sample 
population. Measures of central tendency described the average age range, the mean cancer 
stage, and average number of program services used.  
Inferential statistics were used to compare data to other points of reference. 
Nonparametric statistics allowed the data to be examined based on rules of distribution and the 
relationship between variables (Salkind, 2007). This data set relied on one-sample chi-square 
analyses to make inferences about demographic information compared to PRCP’s patient 
population at-large. When appropriate, chi-square analyses were also conducted to compare the 
distribution of demographics between program participants and corresponding national data.  
Surveys. All survey data was entered in SurveyMonkey for analysis. Similar to chart 
reviews, survey data heavily relied on descriptive statistics to explain findings. Demographic 
information was collected to describe the representative patient and staff sample. Frequency 
charts and pie charts were used to visually represent results; while frequency charts illustrated 
the overall tally of a variable, pie charts demonstrated values in proportion to the sum of the data.  
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The majority of survey questions measured respondents’ attitudes towards a statement 
using fixed-choice Liket-scales. Data from Likert-scales was represented using percentage rates 
and frequencies to quantify responses. Other questions contained multiple choices and 
respondents were free to select as many that applied. Again, percentage rates and frequencies 
depicted how often a response was endorsed and how it compared to the overall sample. Lastly, 
one open-ended question solicited feedback about suggested program areas for improvement. 
Responses were synthesized into shared categorizes based on observed themes and reported 
using respondents’ language. 
Risks and Ethical Considerations 
 Patients. The presumed risks of participating in surveys was deemed minimal, though 
worthy of consideration. First, cancer patients may be perceived as a vulnerable population given 
the acuity and/or chronicity of their disease and their dependence on medical providers for 
appropriate treatment (Managed Care and Healthcare Communications, 2006). The vulnerability 
of participants is further realized as additional factors are taken into account such as race, gender, 
socioeconomic status, education, and level of psychosocial distress or mental illness. As a 
vulnerable population, patients may have felt uncomfortable participating or unable to decline 
participating. Patients may have felt pressure to participate in this evaluation given the difference 
in power and status between patients and their providers. Although participation was voluntary 
and feedback was anonymous, patients may have felt uncomfortable or guilty providing critical 
feedback because of their reliance on the institution for life-prolonging treatments. Critical 
feedback may have been inhibited for fear of repercussions if patients expressed criticism of an 
organization they depend on for care.  
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Staff. PRCP staff faced similar risks participating in this evaluation. Most notably, PRCP 
staff may have been reticent to participate for fear of being identified and experiencing 
retaliation. While the staff survey was designed to be anonymous, staff were asked to identify 
their position and number of years employed, which threatened their anonymity. For example, 
some staff positions, such as advanced care practitioners, represented a very small portion of 
overall staff and, thus, such identifiers significantly reduced the anonymity of staff. A second 
consideration was the dual relationships this evaluator had with several staff members which is 
discussed further in the next section. Dual relationships may have compromised respondents’ 
objectivity or ability to provide critical feedback.  
Disclosure of roles and relationships. From 2013–2014, I was a full-time predoctoral 
psychology intern in Patient Support Services at PRCP. Following the completion of my 
internship, I obtained employment with The Everett Clinic, one of the organizations that 
comprise the partnership of PRCP. I have maintained personal and professional relationships 
with many of the people I worked with at PRCP, including current PSS staff and the Medical 
Director of Psychosocial Services, Dr. Kathryn Johnson who helped facilitate this evaluation and 
served as a committee member for my dissertation defense.  
My involvement in PSS created advantages and disadvantages as an internal evaluator. 
Foremost, the decision to evaluate the efficacy of PSS grew out of my personal involvement with 
the organization and my affection for the program’s mission to mitigate the psychosocial distress 
of persons affected by cancer. As a former intern, my relationships with the staff at-large 
facilitated a trusting and collaborative atmosphere; relationships that were cultivated years prior 
helped foster the necessary involvement of staff as vested stakeholders who shaped the 
development, execution, and utility of this evaluation. My intentions to evaluate the program 
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were also assumed to be benevolent and beneficial. I was regarded as an expert of psychosocial 
services based on my intimate knowledge and experience of the department’s workings including 
program development and services, the history, mission, and goals of the program, the patient 
population, and PSS’s position within PRCP. Further, my understanding of the organization’s 
systemic and political values helped design an evaluation that was of interest to PRCP and in 
alignment with their goals and mission.   
Conversely, my role as an internal evaluator could also be viewed unfavorably. While my 
history with the program helped facilitate the execution of this evaluation, it also contained a 
biased perspective. Whereas an external evaluator may have brought a more objective and 
arguably more credible perspective to the evaluation process, my relationship with the 
organization likely influenced the interpretation of the results. Indeed, my affinity for the 
program and its success likely influenced how feedback was interpreted and later integrated into 
recommendations. It is likely I analyzed program feedback with an “opportunistic bias,” 
unconsciously searching for feedback that confirmed own ideas about the program’s strengths 
and weaknesses (De Coster, Sparks, Sparks, Sparks, & Sparks, 2015). To account for evaluator 
bias, participants were invited to offer explicit feedback about their perception of program 
strengths and weaknesses, openly encouraging critical feedback. Additionally, stakeholders 
participated in interpreting findings and formulating recommendations, which helped provide a 
more pluralistic understanding of feedback and challenge the evaluator’s preconceived notions 
about expected findings.  
As an internal evaluator, I had little insulation when it came to scrutinizing data and 
presenting results to the organization. Critical feedback needed to be presented accurately and 
thoughtfully without fear of jeopardizing my relationships within the organization. Additionally, 
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dual relationships with staff as both participants and colleagues or friends blurred the boundaries 
of the evaluation at times, especially as the design and scope of this evaluation were considered. 
Limitations of this evaluation had to be identified and clearly negotiated early on to establish the 
parameters of this project and shield the evaluator from potential repercussions. Again, the close 
involvement of stakeholders proved essential in conducting an evaluation that was fair and 
mutually agreed upon. Further, the involvement of stakeholders throughout the entirety of this 
evaluation reduced elements of surprise or confusion and prepared stakeholders for constructive 
findings at the conclusion of the evaluation.  
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Chapter III: Results 
Results of this evaluation provided Providence Regional Cancer Partnership feedback 
about the merit or worth of Patient Support Services. To this effect, the evaluator examined both 
utilization and satisfaction of PSS to better understand how program services were (a) utilized 
and represented across patient demographics and (b) valued or regarded within the cancer 
treatment center. Results provided a snapshot of program services as they were currently utilized 
and valued from which informed recommendations were generated based on perceived program 
strengths and areas for improvement.  
Utilization of Services 
Demographic information was collected from PRCP patients to better understand how 
program services were currently represented and utilized. Information was gathered from the 
electronic health record of 400 patients who participated in a least one program service during 
the 12 months prior to this evaluation. Information was collected on patient demographics (age, 
gender, insurance information), general diagnostic information (cancer origin and stage), 
treatment modalities (surgery, chemotherapy, radiation), and participation in program services 
(telephone contact, distress assessment, Cancer Resource Center, nutrition services, financial 
services, support during infusion, office visit, support groups, family services). 
Demographics of patients who participated in program services were compared to 
demographics of all new patients at PRPC during the same timeframe. Program recipients were 
categorized into three groups for analysis based on their level of participation in program 
services, defined as follows: (a) single-use participants: patients who participated in program 
services once (n = 89), (b) multiuse participants: patients who participated in program services 
on more than one occasion (n = 212), and (c) group participants: patients who participated in one 
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or more support groups (n = 99). Demographic information was analyzed to understand how 
utilization of program services compared and contrasted among the three groups. Data was then 
aggregated again to further compare program services between groups.  
All new cancer cases. According to the American Cancer Society (ACS, 2014a), there 
were 38,230 new cancer cases in Washington State in 2014. During the time of this evaluation, 
PRCP saw 1,904 new cancer cases. Of those, 44% were male and 56% were female. Patients 
were most likely to be between the ages 60–69 (n = 30%). Patients between the ages 70–79 were 
also highly represented, constituting 25% of all new patients. Patients under the age of 49 
represented 13% of all new cases.  
Table 2 
Percentage Rates and Frequency of Demographics: New Cancer Cases  
 
 
 
Percentage 
 
Frequency  
Gender   
Male 44.0% 837 
Female 56.0% 1,067 
 
Participants Age  
  
0 to 29 2.1% 40 
30 to 39 3.0% 58 
40 to 49 8.0% 153 
50 to 59 19.0% 360 
60 to 69 30.2% 575 
70 to 79 24.6% 469 
80 to 89 11.1% 211 
90 or older 2.0% 38 
 
According to national statistics on gender and cancer incidences reported by ACS 
(2014b), the number of all new cancer cases per men was 855, 220 (n = 51.3%), while new 
cancer cases per women was 810, 320 (n = 48.7%). A chi-square analysis was conducted to 
determine if the distribution of men and women constituting new cancer cases at PRPC was 
meaningful or likely due to chance based on ACS (2014b) national gender and incidence rates. 
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Results from the chi-square analysis suggested the distribution of men and women was 
meaningful (X2(1) = 41.06, p < 0.05). Indeed, PRCP observed lower frequencies of men  
(n = 44%) and higher frequencies of women (n = 56%) than expected according to national 
averages.  
The age range of new patients seen at PRCP was roughly compared to national estimates 
of all cancer cases based on ACS (2014b) data. An exact comparison was not possible due to the 
different intervals used to calculate age ranges. Even so, differences between PRCP cancer cases 
and national data could be inferred. While national data estimated persons older than 65 
represent the majority of new cancer cases (n = 54.3%), PRPC’s greatest range of new cancer 
cases was represented by patients age 50–69 (n = 49.1%). Presumably, PRCP saw a higher 
incidence of new cancer cases among persons age 50–69 than estimated according to ACS 
statistics (n = 37.2%) and fewer incidences of new cancer cases among persons older than 70.  
 
 
Figure 2. National statistics and observed frequencies: gender and age. Estimated new cancer 
cases by gender and age, American Cancer Society (2014b). 
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Table 3 
Chi-square Analysis: New Cancer Cases by Gender  
 (O) Observed 
Frequency 
(E) Expected 
Frequency* 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Men  837 977 140 19,531 20.00 
Women   1,067 927 -140 19,531 21.06 
Note. Expected frequencies were based on American Cancer Society (2014b) statistics of new 
cancer cases by gender.  
 
 Among all new cases of cancer seen at PRCP, more than fifty percent of patients had 
Medicare insurance as their primary payer (n = 1002). High incidences of Medicare coverage 
coincided with the average age range of patients seen at PRCP, the majority being older than 60 
(n = 1293). Because most people age 65 and older qualify for Medicare coverage (Centers for 
Medicare & Medicaid Services, 2014), and 68% of all new cancer patients at PRCP were over 
the age of 60, it was not surprising that 54% of all new cancer patients possessed Medicare 
insurance.  Of all new cancer cases, 38% of PRCP patients possessed commercial coverage while 
7.5% had Medicaid (see Appendix F for a full report, PRCP Incidence of Cancer by Site and 
Primary Payer Report). 
In general, patients’ health insurance coverage differed from the distribution of health 
insurance across the general population. According to the U. S. Census Bureau, 55.4% of the 
general population possesses private health insurance, 16% receive Medicare, and 19.5% receive 
Medicaid (Smith & Medalia, 2015). Comparatively, PRCP’s sample was represented by 38.1% 
commercial insurance users, 53.6% Medicare, and 7.5% Medicaid recipients. While the large 
variance of Medicare users could be attributed to the high volume of persons diagnosed with 
cancer later in life, commercial and Medicaid users still appeared to be underrepresented, even 
when patients over the age of 60 were excluded from the sample (n = 611). In particular, based 
on U. S. Census Bureau estimates, Medicaid users appeared to be especially underrepresented 
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among new cancer cases at PRCP. This discrepancy may reflect the organization’s decision to 
restrict the number of persons accepted for treatment with Medicaid coverage.   
 
Figure 3. Distribution of primary insurance: all new cancer cases. 
 
 In 2014, the most commonly occurring cancers at PRCP were breast (n = 370) and lung 
(n = 275). Female reproductive (n = 178), blood cancers (n = 163), and colorectal cancer  
(n = 151) were also well represented among new cancer cases. Pancreatic (n = 36), brain  
(n = 33), and liver cancers (n = 25) were less common among new cancer cases.  
The National Cancer Institute (NCI, 2016) projects breast, lung, prostate, colorectal, 
bladder, melanoma, renal, leukemia and lymphoma, endometrial, and pancreatic cancers to be 
the most common cancers among new cancer cases diagnosed in 2016. A chi-square analysis 
was conducted to compare all new cancer cases at PRCP to expected prevalence rates across the 
United States. Specifically, a chi-square analysis was used to determine if the distribution of 
observed cancer cases at PRCP was representative of national cancer prevalence rates predicted 
by NCI. Results from the chi-square analysis suggested the distribution of cancer among all new 
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cases was not due to chance alone, indicating discrepancies between expected and observed 
prevalence rates (X2(11) = 245.87, p < 0.05). Indeed, compared to national estimates, PRCP saw a 
greater number of breast, lung, and female reproductive cancers than was expected. Conversely, 
PRCP saw fewer male reproductive cancer patients than expected. The remaining cancer types— 
brain, head and neck, liver, pancreatic, bladder, colorectal, blood, and skin cancers —appeared to 
be representative of expected prevalence rates. 
  
Figure 4. Distribution of cancer type: all new cancer cases.  
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Table 4 
Chi-Square Analysis: Cancer Type Among All New Cancer Cases  
 (O) Observed 
Frequency 
(E) Expected 
Frequency* 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Brain 33 23 -10 102 4.48 
Head & Neck 119 137 18 333 2.43 
Lung 275 217 -58 3,327 15.30 
Breast 370 229 -141 19,949 87.20 
Liver 25 36 11 120 3.33 
Pancreas 36 49 13 170 3.46 
Bladder 92 74 -18 341 4.64 
Colorectal  151 141 -10 110 0.78 
Female 
Reproductive 
178 93 -85 7,202 77.32 
Male 
Reproductive 
123 225 102 10,505 46.59 
Blood 163 160 -3 8 0.05 
Skin  69 74 5 21 0.28 
Note. Expected frequencies were based on the occurrence of cancer subtype as compared to all 
new cancer cases estimated in 2015, as indicated by the National Cancer Institute (2016). 
 
The distribution of cancer stage was difficult to predict as cancer staging varies based on 
cancer type (i.e., breast verses lung cancer) and available cancer screening or detection methods 
(Canadian Partnership Against Cancer, 2016); therefore no comparison data were available to 
determine differences in the distribution of cancer staging between all new cancer cases at PRCP 
and expected values.  
The majority of all new cancer cases were represented by stage I cancer (n = 29.5%). 
Stage II and stage IV cancer were similarly represented among new cancer cases as 17.1% and 
19.7%, respectively. Stage III cancer was less likely to be represented among new cancer cases, 
second to stage 0 cancer.   
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Figure 5. Distribution of cancer stage: all new cancer cases.  
Single-use program participants. Eighty-nine participants used services on one 
occasion with no additional follow up. Forty-two percent of single-use participants were male, 
while 58% were female. The majority of single-use participants were between the ages 65–74  
(n = 36%) and the mean age was 66.9 (median = 68, mode = 68). An additional 26% of single-
use participants were 75 or older while 24% were between the ages 55–64. Single-use 
participants were less likely to be under the age of 54 (n = 15%).   
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Table 5 
Percentage Rates and Frequency of Demographics: Single-Use Participants 
 
 
 
Percentage 
 
Frequency  
Gender   
Male 41.6% 37 
Female 58.4% 52 
 
Participants Age  
  
26 to 34 1.1% 1 
35 to 44 3.4% 3 
45 to 54 10.1% 9 
55 to 64 23.6% 21 
65 to 74 36.0% 32 
75 or older 25.8% 23 
 
Not surprisingly, because of its prevalence among all new cancer cases at PRCP, breast 
cancer was well represented among single-use participants. The majority of single-use 
participants were diagnosed with breast cancer (n = 25), while lung (n =12) and colorectal 
cancer (n =11) represented the second and third most prevalent cancer types among single-use 
participants. The remaining 64 participants represented a variety of cancer diagnoses. 
Because all patients receive screening for psychosocial distress based on NCCN (2016b) 
standards, single-use participants were expected to broadly represent cancer types relative to the 
demographics of all cancer cases treated at PRCP. A chi-square analysis was conducted to 
determine if the distribution of cancer diagnoses among single-use participants was 
representative of new cancer cases at PRCP. Results from the chi-square analysis, did in fact, 
suggest the distribution of cancer among single-use participants was equal to what was expected 
compared to PRCP data on all cancer cases (X2(10) = 15.20), although breast cancer was 
significantly represented more frequently than expected.    
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Figure 6. Distribution of cancer type: single-use participants.   
Table 6 
Chi-Square Analysis: Cancer Type Among Single-Use Participants  
 (O) Observed 
Frequency 
(E) Expected 
Frequency* 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Head & Neck 4 5 -1 2 0.38 
Lung 12 12 0 0 0 
Breast 25 16 9 72 4.39 
Liver 3 1 2 4 3.25 
Pancreas 1 2 -1 0 0.23 
Bladder 2 4 -2 4 1.06 
Colorectal  11 7 4 18 2.73 
Female 
Reproductive 
6 8 -2 4 0.46 
Male 
Reproductive 
9 5 4 13 2.33 
Blood 8 7 1 0 0.07 
Skin  4 3 1 1 0.29 
Note. Expected frequencies were calculated based on observed frequencies of cancer type among 
all new cancer cases at PRCP at the time this evaluation was conducted (see Appendix F for a 
full report, PRCP Incidence of Cancer by Site and Primary Payer Report). 
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For single-use participants, the mean stage was 2.56 (median = 3, mode = 4) with stage 
IV occurring most frequently. Similar to cancer type, because all patients receive psychosocial 
screening at PRPC and, therefore, presumably interact with PSS staff on at least one occasion, 
cancer stage was expected to be evenly distributed relative to PRCP patient demographics. 
A chi-square analysis was conducted to determine if the distribution of cancer stage 
among single-use participants was meaningful compared to demographics of all new cancer 
cases. Results from the chi-square analysis suggested the distribution of single-use participants 
based on cancer stage was not due to chance alone (X2(3) = 17.89, p < 0.05). Indeed, single-use 
participants with stage IV cancer were represented far more frequently than statistically 
expected, while stages I–III were represented as expected compared to PRCP statistics.  
 
Figure 7. Distribution of cancer stage: single-use participants.   
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Table 7 
Chi-Square Analysis: Cancer Stage Among Single-Use Participants  
 (O) Observed 
Frequency 
(E) Expected 
Frequency 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Stage I 22 24 -2 3 0.11 
Stage II 13 14 -1 0 0.03 
Stage III 13 10 3 10 1.01 
Stage IV  32 16 16 264 16.73 
 
The majority of single-use participants engaged in program services for the purpose of 
distress assessment (n = 70), which was extremely likely because all patients receive 
psychosocial distress screening as mandated by NCCN guidelines (2016b). Of note, 17% of 
single-use participants involved family members (n = 15). Minimal single-use or first time 
interactions with PSS occurred during infusion treatments (n = 3) or during office visits (n = 7), 
which likely reflected the way patient referrals were made to PSS and, thus, how patients were 
first introduced to program services.  
  
 
 
 
 
 
 
 
Figure 8. Distribution of program services: single-use participants.   
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Multiuse program participants. Two hundred and twelve participants used program 
services on more than one occasion. Thirty-six percent of multiuse participants were male, while 
64% were female. The majority of multiuse participants were between the ages 55–64 (n = 
35%), representing a slightly younger patient demographic than single-use participants. The 
mean age was 61.4 (median = 61, mode = 62). Twenty-three percent of multiuse participants 
were ages 65–74, 20% were ages 45–53, and 16% were 75 or older. Fewer than 7% of multiuse 
participants were under the age of 45. 
Table 8  
Percentage Rates and Frequency of Demographics: Multiuse Participants 
 
 
 
Percentage 
 
Frequency  
Gender   
Male 36.3% 77 
Female 63.7% 135 
 
Participants Age  
  
18 to 25 0.5% 1 
26 to 34 1.9% 4 
35 to 44 4.2% 9 
45 to 54 19.8% 42 
55 to 64 35.4% 75 
65 to 74 22.6% 48 
75 or older 15.6% 33 
 
Breast cancer patients were highly representative of multiuse participants, representing 
the majority of users (n = 50), which mirrored high prevalence rates of breast cancer among all 
new cancer cases at PRCP, in general. Lung cancer, which was second most prevalent among all 
new cancer cases at PRCP, was also well represented among multiuse participants (n = 39), as 
were head and neck (n = 23) and blood cancers (n = 27). 
 A chi-square analysis was conducted to determine if the distribution of cancer types 
among multiuse participants was equal to what would be expected relative to statistics of all 
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cancer cases treated at PRCP. Results from the chi-square analysis suggested the distribution of 
cancer types among multiuse participants was not due to chance (X2(12) = 32.94, p < 0.05), 
indicating differences between multiusers and PRCP’s general patient population. Even when 
high prevalence rates were accounted for among all cancer cases, breast and lung cancer patients 
were still represented more frequently than expected when compared to PRCP’s patient 
population. Additionally, head and neck, pancreatic, and blood cancers were represented more 
frequently among multiuse participants than predicted. Bladder cancer, on the other hand, was 
represented less frequently than expected. The remaining cancer types—glioblastomas, liver, 
kidney, colorectal, female and male reproductive cancer, and skin cancer—appeared to mirror 
expected prevalence rates. 
 
Figure 9. Distribution of cancer type: multiuse participants.  
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Table 9 
 
Chi-Square Analysis: Cancer Type Among Multiuse Participants 
 
 (O) Observed 
Frequency 
(E) Expected 
Frequency* 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Glioblastoma 5 4 1 2 0.64 
Head & Neck 23 13 10 96 7.31 
Lung 39 30 9 87 2.94 
Breast 50 40 10 101 2.52 
Liver 2 3 -1 0 0.17 
Pancreas 8 4 4 17 4.27 
Kidney 3 6 -3 9 1.48 
Bladder 2 10 -8 62 6.29 
Colorectal  16 16 0 0 0 
Female 
Reproductive 
16 19 -3 10 0.52 
Male 
Reproductive 
11 13 -2 5 0.36 
Blood 27 18 9 86 4.87 
Skin  4 7 -3 12 1.57 
Note. Expected frequencies were calculated based on observed frequencies of cancer type among 
all new cancer cases at PRCP at the time this evaluation was conducted (see Appendix 
 
 F for a full report, PRCP Incidence of Cancer by Site and Primary Payer Report). 
 
Stage IV cancer was significantly more common among multiuse participants than earlier 
stage cancer (n = 112); the mean stage was 3.13 (median = 4, mode = 4). A chi-square analysis 
was conducted to determine if the distribution of cancer stages was meaningful or likely due 
chance compared to demographics of all new cancer cases at PRCP.  Results from the chi-square 
analysis suggested the distribution of cancer stages among multiuse participants was not due to 
chance (X2(3) = 149.90, p < 0.05). As speculated, multiuse participants with stage IV cancer were 
represented more frequently than statistically expected. Despite comprising 19.7% of PRCP’s 
entire patient population, stage IV cancer patients represented 52.8% of all multiuse participants. 
Alternately, participants with stage I cancer were significantly underrepresented. Stage I cancer 
patients comprised the majority of PRCP’s patient population (n = 29.5%), but only comprised 
11.3% of multiuse participants.  
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Figure 10. Distribution of cancer stage: multiuse participants.   
Table 10 
Chi-Square Analysis: Cancer Stage Among Multiuse Participants  
 (O) Observed 
Frequency 
(E) Expected 
Frequency 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Stage I 24 61 -37 1,352 22.25 
Stage II 38 35 3 8 0.22 
Stage III 32 25 7 44 1.75 
Stage IV  112 41 71 5,101 125.68 
 
The average number of visits or points of contact with PSS staff was 7.98 for multiuse 
participants (median = 4, mode = 2). An analysis of the frequency of contact with PSS based on 
participants’ stage cancer illustrated that participants with advanced stage cancer were 
significantly more likely to have more frequent interaction with PSS than participants with early-
stage cancer.  
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Figure 11. Distribution of cancer stage and contact with PSS: multiuse participants. 
Beyond phone contact and distress assessment, multiuse participants utilized a range of 
program services. Participants were most likely to have interaction with staff at an office visit  
(n = 82) or during infusion treatment (n = 81). Of note, 42% of the multiuse participants 
involved family members in their care (n = 88). Multiuse participants also utilized nutrition 
services (n = 69) and the Cancer Resource Center (n = 60) on a fairly consistent basis; however, 
financial services were less likely to be utilized (n = 34).   
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Figure 12. Distribution of program services: multiuse program participants.   
Group program participants.  Ninety-nine participants attended a support group on at 
least once occasion. Fifteen percent of group participants were male, while 85% were female. In 
general, group users were more likely to represent a younger patient population. The majority of 
group participants were between the ages 55–64 (n = 32%) and the mean age was 57.7  
(median = 57, mode = 52). Group users were most reflective of patients under the age of 45  
(n = 11%) compared to other participant groups and 29% of group participants were ages 45–54.   
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Table 11 
Percentage Rates and Frequency of Demographics: Group Participants 
 
 
 
Percentage 
 
Frequency  
Gender   
Male 15.2% 15 
Female 84.8% 84 
 
Participants Age  
  
26 to 34 2.0% 2 
35 to 44 9.1% 9 
45 to 54 29.3% 29 
55 to 64 32.3% 32 
65 to 74 20.2% 20 
75 or older 7.1% 7 
   
While support groups presumably had the opportunity to reach a vast and broad 
population, the majority of group participants represented women diagnosed with breast cancer 
(n = 64). The fact that women with breast cancer dominated all other group participants was 
likely a result of the current content of support groups offered at PRCP. At the time of this 
evaluation, two of the six support groups facilitated at by PSS staff were exclusive to women 
diagnosed with breast cancer, clearly affecting group membership and representation. The 
remaining 35 participants represented a diverse set of cancers, though many cancers were 
underrepresented among group users. Lung and blood cancers were especially underrepresented 
compared to their prevalence among PRCP’s general patient population. Results from a chi-
square analysis confirmed the uneven distribution of cancer types among group members when 
compared to PRCP’s patient population (X2(10) = 116.67, p < 0.05). 
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Figure 13. Distribution of cancer type: group participants.   
Table 12 
Chi-Square Analysis: Cancer Type Among Group Participants 
 (O) Observed 
Frequency 
(E) Expected 
Frequency* 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Glioblastoma 2 2 0 0 0 
Head & Neck 4 6 2 5 0.86 
Lung 6 14 8 68 4.78 
Breast 64 19 -45 2,007 104.47 
Liver 1 1 0 0 0 
Pancreas 1 2 1 1 1 
Kidney 1 3 2 4 1.22 
Colorectal  5 8 3 8 1.02 
Female 
Reproductive 
7 9 2 5 0.53 
Male 
Reproductive 
4 6 2 5 0.86 
Blood  4 9 5 20 2.39 
Note. Expected frequencies were calculated based on observed frequencies of cancer type among 
all new cancer cases at PRCP at the time this evaluation was conducted (see Appendix F for a 
full report, PRCP Incidence of Cancer by Site and Primary Payer Report). 
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Contrary to multiuse participants, stage I cancer was more common among group 
participants than later stages of cancer (n = 33). The mean stage for group users was 2.16 
(median = 2, mode = 1). A chi-square analysis was conducted to determine if the distribution of 
cancer stages was meaningful or likely due chance compared to demographics of all new cancer 
cases. Results from the chi-square analysis suggested the distribution of cancer stages among 
group participants was, in fact, equal to chance and reflective of PRCP’s general patient 
population (X2(3) = 7.84). 
 
Figure 14. Distribution of cancer stage: group participants.   
Table 13 
Chi-Square Analysis: Cancer Stage Among Group Participants 
 (O) Observed 
Frequency 
(E) Expected 
Frequency 
 
(D) Difference 
 
(O-E)2 
 
(O-E)2/E 
Stage I 33 27 6 34 1.27 
Stage II 20 16 4 18 1.58 
Stage III 19 11 8 59 5.22 
Stage IV  20 18 2 4 0.19 
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Figure 15 reflects the frequency of contact group participants had with PSS based on their 
stage cancer; contact frequency did not include the number of support groups attended by 
participants, only that a participant attended a support group and whether or not additional 
program services were used. The average number of visits or points of contact with PSS staff 
(not including number of support groups attended) was 10.37, suggesting that group participants 
use program services more frequently than other participants. Participants with early-stage 
cancer were more likely to only attend a support group and utilized fewer follow up visits than 
participants with cancer stages II–IV. Participants with later stage cancer (II–IV) appeared to 
utilize services fairly homogenously, demonstrating, again, the likelihood that the demographics 
of participants who attended groups was due to chance rather than representative of a meaningful 
difference.  
 
 
 
Figure 15. Distribution of cancer stage and contact with PSS: group participants. 
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Beyond phone contact and distress assessment, group participants were most likely to 
attend an office visit with PSS staff (n = 51). Of note, more than a third of group participants 
included family members in their care (n = 37), which may in part be attributed to support group 
options available to family members and caregivers. Group participants were more likely to 
utilize the Cancer Resource Center (n = 35), than receive support during infusion (n = 26). 
Nutrition and financial services were less likely to be utilized.  
 
Figure 16. Distribution of program services: group participants.   
Six support groups were offered to participants during the twelve months prior to this 
evaluation: general support (previously its own group, but now incorporative of the advanced 
cancer and caregiver support groups), tai chi, breast cancer, young women with breast cancer, art 
therapy, and survivorship. Figure 17 illustrates the number of new patients or family members 
that attended each support group on at least one occasion in the twelve months prior to this 
evaluation, as indicated by group sign in sheets. Aside from the survivorship group, support 
groups were similarly attended by participants, which included family members and patients of 
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other cancer facilities. The most frequently attended groups were tai chi (n = 41) and art therapy 
(n = 41). The third most frequently attended group was the general support group (n = 34). Of 
note, tai chi, art therapy, and the general support group were open to family members and 
caregivers of patients, which likely contributed to their more robust attendance numbers. The 
two breast cancer support groups were limited to patients or survivors of breast cancer. The 
survivorship support group was the only closed group offered at PRCP, requiring preregistration 
and occurring on a more limited basis, reflecting it’s smaller attendance numbers.  
 
Figure 17. Distribution of support groups: group participants. 
Comparison of program services between group categories. After reviewing patient 
demographics for single-use, multiuse, and group participants separately, data was again 
aggregated to compare how program services were utilized between the three participant groups.  
Multiuse and group participants were most likely to represent patients 55–64 years old, 
whereas single-use participants were most likely to represent patients over the age of 65. Single-
use participants were especially representative of patients older than 75, compared to multiuse 
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and group participants. Group participants were observed in high numbers among patients age 
45–54 compared to single and multiuse participants. Patients under the age of 44 were 
represented across all three groups nearly equally, with patients age 35–44 represented more 
frequently observed in groups than among single or multi-service users. 
 
Figure 18. Comparison between groups: age range. 
Figure 19 illustrates how PSS services were utilized by age range. Aside from telephone 
contact and distress assessments which should capture most of all patients based on NCCN 
(2016b) psychosocial screening guidelines, several program services stand out among 
participants, regardless of age. Infusion, office visits, support groups, and family counseling 
were well utilized by all participants to a large degree, regardless of age. Financial support, the 
Cancer Resource Center, and nutrition services appeared to be less well utilized than counseling 
services.  
 Participants 55–64 years old were most frequently and consistently represented across 
all program services, followed by participants ages 45–54. Participants under the age of 35 were 
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consistently underrepresented across all program services, which was indicative of lower cancer 
incidence rates of younger persons in general (Cancer Research UK, 2016) and PRCP’s patient 
population at-large. Participants over the age of 75 were less likely to engage in program services 
beyond distress assessment; however, elderly participants did commonly involve family 
members in their care, respective of their overall participation in program services.  
 
Figure 19. Distribution of program services: age range.  
Women were more frequently represented in higher numbers across all three groups, 
representing 68% of all participants (n = 271). Men and women were most evenly distributed 
among single-use participants, which was likely due to the fact that all patients receive at least an 
initial, one-time screening with PSS staff whereas group and multiuse participants represented 
patients seeking follow up care beyond an initial screening. It appeared that, in general, men 
were much less likely to seek services beyond an initial screening.  
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Figure 20. Comparison between groups: gender. 
Women were consistently represented in higher numbers across all program services. 
Women were least likely to utilize financial services, representing fewer than 11% of all female 
participants. Women were consistently represented among the Cancer Resource Center, infusion, 
office visits, family counseling, and support groups, with the highest percentage of women 
attending an office visit (n = 35%).  
Men appeared less likely to utilize supplemental supportive services, such as the Cancer 
Resource Center or financial support. Men were also poorly represented among support groups, 
although the current data did not include information from the men’s only support group for 
prostate cancer because PSS staff did not facilitate that group. Forty-four percent of men did, 
however, include family members in their care and 35% of men attended an office visit with 
staff. Support during infusion and nutrition services were utilized by 27–29% of male 
participants, respectively.  
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Figure 21. Distribution of program services: gender. 
Participation in program services appeared to vary based on participants’ primary health 
insurance coverage. In general, participants with Medicaid were more likely to participate in 
nearly all program services, despite comprising only 16% of all participants. Especially 
noteworthy, participants with Medicaid were three times as likely to utilize financial services  
(n = 27%) compared to Medicare (n = 9%) and commercial insurance users (n = 5%). 
Commercial and Medicare participants appeared nearly unequivocal across all program 
services, aside from distress assessment and support groups. Medicare participants were more 
likely to receive follow up on distress assessments while participants with commercial insurance 
were nearly twice as likely (36%) to participate in support groups than either Medicare  
(n = 16%) or Medicaid (n = 17%) participants.  
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Figure 22. Distribution of program services: primary insurance.  
Figure 23 illustrates how cancer diagnoses varied among service user groups. As 
previously discussed, breast cancer patients represented the majority of PRCP’s patient 
population at-large. As such, breast cancer patients were more frequently represented across all 
three groups by a significant amount, nearly one and a half times the frequency of all other single 
and multiuse participants and nearly ten times the frequency of all other group participants. 
Further, breast cancer patients were nearly three times as likely to attend a support group than to 
represent single or multi-use participants.  
 Because breast cancer patients dominated the representation of group program users, 
differences could be seen among group users and single/multiuse participants across cancer type. 
For example, lung cancer patients were three times as likely to represent multiuse participants  
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(n = 18) than group participants (n = 6). Likewise, patients with blood cancer were also three 
times as likely to represent multiuse participants (n = 13) than group participants (n = 4). Head 
and neck cancer patients were more than two times as likely to represent multiuse participants  
(n = 11) than single-use and group participants (n = 4). In a few instances, single-use 
participants outnumbered multiuse and group participants, as was the case with colorectal and 
male reproductive cancer patients. Interestingly, patients with female reproductive cancers were 
represented nearly homogenously across participant groups.   
 
Figure 23. Comparison between groups: cancer type. 
Figure 24 reflects how program services were utilized across common cancer diagnoses. 
Breast cancer was superiorly represented across all program services, which corresponds with 
high prevalence rates (N = 12.3%) observed nationally (National Cancer Institute, 2016) and 
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among PRCP’s patient population (n = 22.6%). Participants with breast cancer were most well 
represented in support groups (n = 64) in addition to office visits (n = 52). Interestingly, despite 
similarly high prevalence rates for prostate cancer (N = 14%), participants with male 
reproductive cancers were consistently represented in low numbers across program services and 
within PRCP in general. Of the male reproductive cancer patients that did utilize program 
services, participants were most likely to involve family members in their care (n = 9) and least 
likely to utilize financial services (n = 0).  
Lung cancer, which represents 13.3% of all new expected cancers nationally, was the 
second most commonly occurring cancer at PRCP and, similarly, the second most prominent 
cancer represented across program services unanimously. Participants with lung cancer were 
especially well represented among family counseling services (n = 22) and less likely to utilize 
financial services (n = 4) or support groups (n = 5).  
 Participants with head and neck, colorectal, female reproductive, and blood cancer were 
closely represented across program services. Notably, participants with head and neck cancer 
were most likely to utilize nutrition services (n = 21), which was likely due to adverse effects 
from treatment commonly associated with head and neck cancer patients (National Cancer 
Institute, 2013).  
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Figure 24. Distribution of program services: cancer type.  
As previously demonstrated in Figures 6 and 9, patients with stage IV cancer were most 
well represented among single and multiuse participants, with the highest percentage of stage IV 
patients representing multi service users (n = 53%). Alternately, stage I patients were most likely 
to represent group participants. 
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Figure 25. Comparison between groups: cancer stage.  
Patients with stage IV cancer were represented more frequently than earlier stage cancer 
across all program services, with the exception of support groups. Patients with stage IV cancer 
were nearly three times as likely to involve family members in their care and two times as likely 
to attend an office visit, receive services during infusion, and participate in nutrition services. 
Alternately, patients with stage I cancer were represented less frequently across all program 
services, with the exception of support groups in which case patients with stage I cancer were 
most commonly observed (n = 33). Patients participated in the Cancer Resource Center nearly 
equally, while financial services were most frequently utilized by patients with cancer stage II 
and later.  
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Figure 26. Distribution of program services: cancer stage.  
Patients receiving chemotherapy were represented in high numbers across most program 
services, which could be expected given the near ubiquity of chemotherapy in treating cancer 
systemically (Cancer Research UK, 2015). Interestingly, patients who received chemotherapy 
alone were most likely to attend an office visit (n = 35) and involve family members in their care 
(n = 39), even more so than patients receiving chemotherapy in addition to surgery and/or 
radiation. Patients receiving radiation alone were also more likely to involve family members 
than patients receiving multiple treatments (n = 31).  
Of note, patients receiving multiple treatments (surgery + chemotherapy, surgery + 
chemotherapy + radiation) were nearly twice as likely to attend a support group than patients 
receiving surgery, chemotherapy, or radiation alone. Patients receiving multiple treatments were 
also more likely to use the Cancer Resource Center than patients receiving single modality 
treatments. Financial services were utilized fairly evenly among participants, though patients 
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receiving radiation or surgery combined with chemotherapy were less likely to use financial 
services than others.  
Differences in how program services were utilized may be, in part, attributed to how 
program referrals were made within each department, as distinct departments govern surgery, 
chemotherapy, and radiation and referrals were likely handled differently between each 
department. Additionally, differences in program participation may have been indicative of how 
patients’ needs and their ability to utilize program services fluctuated as they moved throughout 
the treatment process.  
 S = Surgery, C = Chemotherapy, R = Radiation 
 
Figure 27. Distribution of program services: cancer treatment.  
Satisfaction of Services  
Two surveys were created and distributed to patients and PRCP staff to solicit feedback 
and opinions about their experiences using PSS program services. Patients and PRCP staff were 
asked to respond to a series of statements indicating their level of agreement or disagreement. 
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Statements inquired about patients’ familiarity with the department and program services, 
utilization of services, satisfaction with the quality and variety of program services and PSS 
staffing, opinions about the impact program services had as part of their cancer care treatment, 
and perceived strengths and areas for improvement. Similarly, PRCP staff were asked about their 
familiarity with the department and program services, the referral process (how often, which 
services, and under what circumstances program services were recommended), opinions about 
the importance or value including behavioral health services in a cancer treatment program, and 
perceived strengths and areas for improvement. Results from surveys were used to identify 
trends and inform program recommendations based on perceived strength and areas of 
improvement. 
 Patient satisfaction. In total, 590 surveys were made available for distribution to 
patients by mail (n = 440) and in person (n = 150). One hundred and fifty-two patient surveys 
were returned, accounting for a 26% return rate. Seventy-nine surveys were returned by mail, 49 
surveys were returned to reception following office visits with an oncologist, 18 surveys were 
returned to American Cancer Society volunteers during chemotherapy infusion, and six surveys 
were returned to PSS staff following a support group meeting.  
 Patient demographics. Demographic information was collected to describe the patient 
population who participated in providing program feedback. Of the 152 returned surveys, 142 
surveys were completed by patients and nine were completed by family members or caregivers. 
The majority of respondents were between the ages 65–74 (n = 56). Fewest responses were 
received from persons under the age of 45 (n = 7).  
Sixty-two percent of respondents identified as female and 38% identified as male. The 
majority of respondents identified as married or in a domestic partnership (n = 89), while 41% 
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identified as single (n = 17), separated (n = 3), divorced (n = 18), or widowed (n = 14). Ninety-
one percent of respondents identified as Caucasian or White American while 9% identified as 
persons of color.  
Table 14 
Percentage Rates and Frequency of Patient Demographics 
 
 
 
Percentage 
 
Frequency  
Gender*   
Male 38.0% 57 
Female 62.0% 93 
 
Respondents Age** 
  
26 to 34 2.0% 3 
35 to 44 2.7% 4 
45 to 54 15.4% 23 
55 to 64 21.5% 32 
65 to 74 37.6% 56 
75 or older 20.8% 31 
 
Relationship Status* 
  
Single 11.3% 17 
Married or Domestic Partner 59.3% 89 
Separated 2.0% 3 
Divorced 18.0% 27 
Widowed 9.3% 14 
   
Race/Ethnicity**   
Caucasian/White 90.7% 136 
Hispanic/Latino 2.0% 3 
African American/Black 0.7% 1 
Asian/Pacific Islander 4.7% 7 
American Indian/Alaska Native 2.0% 3 
Note. *Based on 150 responses; two blank responses. **Based on 149 responses; three blank 
responses. 
 
Cancer and treatment. Patient demographics were widely represented according to type 
and stage of cancer, the year treatment began, and types of treatment completed in the past 
twelve months. The majority of patients began treatment between 2014–2015 (n = 97); 24 
patients began treatment between 2010–2013. Two patients began treatment prior to 2007, the 
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year PRCP was established as an integrative oncology center. Twenty-eight respondents did not 
report the year treatment began.  
 
Figure 28. Patient demographics: year treatment began. 
Among survey respondents, the three most frequently reported types of cancer were 
breast cancer (n = 52), blood cancer (n = 21), and male reproductive cancer (n = 19), 
representing 62% of all respondents. Female reproductive cancers and lung cancer were equally 
represented as the 4th and 5th most commonly occurring cancers among survey respondents, 
comprising 22% of all respondents.  
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Table 15 
Percentage Rates and Frequency of Primary Cancer  
 
 
 
Percentage 
 
 Frequency 
What Type of Cancer is Being Treated?   
Bladder cancer 1.4% 2 
Blood cancer 14.2% 21 
Bone cancer 3.4% 5 
Brain tumor 3.4% 5 
Breast cancer 35.1% 52 
Colorectal cancer 7.4% 11 
Female reproductive cancer 10.8% 16 
Head and neck cancer 7.4% 11 
Kidney cancer 0.7% 1 
Liver cancer 2.7% 4 
Lung cancer 10.8% 16 
Male reproductive cancer 12.8% 19 
Myelodysplastic syndrome 0.7% 1 
Pancreatic cancer 1.4% 2 
Skin cancer 2.0% 3 
Soft tissue sarcoma 1.4% 2 
Note. Based on 148 responses; four blank responses. 
 
The demographics of survey respondents were compared to PRCP’s population at-large. 
As evidenced in Figure 29, demographics of survey respondents were generally representative of 
PRCP’s population at-large. Interestingly, the three most reported cancer types—breast, blood 
cancer, and male reproductive cancers—were overrepresented in the survey sample compared to 
PRCP’s general population. Alternately, lung and bladder cancers appeared to be 
underrepresented in the survey sample compared to PRCP’s population.  
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Figure 29. Comparison between PRCP population and survey respondents: cancer type.  
A large percentage of respondents were unable to identify their stage of cancer (n = 50). 
Of those able and willing to report their stage of cancer, 28% of respondents identified as having 
stage IV disease, while only 14% of respondents reported stage I disease. Stages II and III cancer 
accounted for 27% of all respondents.  
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Figure 30. Patient demographics: cancer stage. 
The demographics of survey respondents were compared to PRCP’s population at-large. 
While PRCP’s general population revealed predominate occurrences of patients with stage I 
cancer, survey respondents were much more likely to represent patients with stage IV cancer. 
Indeed, stage I cancer was underrepresented by survey respondents, while stage IV was 
overrepresented compared to PRCP’s general population.  
Interestingly, this trend was evident among utilization results as well, as indicated in the 
above sections. Among patients who participated in program services (i.e., utilization of services 
results) and surveys (i.e., satisfaction of services results), stage IV patients were predominately 
represented. This finding suggested patients with stage IV cancer were most likely to participate 
in program services (i.e., multiuse program participants) and most likely to respond to 
questionnaires about their satisfaction with program services. Patients with stage IV cancer may 
have been more likely to participate in the satisfaction survey based on their familiarity and use 
of program services, as previously indicated based on trends in utilization of services.  
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Figure 31. Comparison between PRCP population and survey respondents: cancer stage.  
Respondents were well represented across the most common types of cancer treatment 
including biopsy (n = 74), surgery (n = 62), chemotherapy (n = 96), and radiation therapy  
(n = 82). Less commonly occurring treatments included hormone therapy (n = 21), clinical 
research trials (n = 5), palliative care (n = 2), and hospice care (n = 1). Lastly, seven respondents 
reported being under observation but not actively receiving treatment.  
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Figure 32. Treatment modalities.  
Familiarity and use of program services. Forty-two percent of respondents indicated 
they were well informed about services available through Patient Support. An additional 40% of 
respondents indicated having knowledge of program services and being aware of where to go for 
more information as needed. Eighteen percent of respondents indicated needing more 
information (n = 13) or having no information at all (n = 13).  
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Figure 33. Familiarity of program services.  
Forty-nine percent of respondents indicated using program services at one point while 
receiving treatment at PRCP. Of those respondents, 71 indicated which services or combination 
of services they used: Thirty-nine percent attended a support group, 37% utilized social work, 
resources, or financial assistance, 30% participated in counseling with a staff member, and 27% 
received emotional support from staff directly during treatment. Patients also indicated using 
nutrition services and attending supportive services offered through the Cancer Resource Center, 
including the Look Good, Feel Better class which was hosted by the American Cancer Society.  
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Table 16 
Percentage Rates and Frequency of Patient Support Services Used  
 
 
 
Percentage 
 
 Frequency 
Have You Used Program Services?*   
Yes 48.6% 72 
No 51.4% 76 
 
Which Services Have You Used? Select All That 
Apply** 
  
Emotional support during treatment 26.8% 19 
Counseling with PSS staff 29.6% 21 
Attending a support group 39.4% 28 
Social work, resources, financial assistance 36.6% 26 
Note. * Based on 148 responses; four blank responses. ** Based on 71 responses; 81 blank 
responses. 
 
 The 71 patients who reported using services during their treatment were characterized 
as follows: Seventy-one percent were female and 56% were between the ages 55–74. Breast 
cancer was the most commonly occurring cancer by far (n = 42%), while the stage of cancer was 
nearly equally represented between stages I–IV, with stage IV cancer reported most frequently  
(n = 25%).   
Of note, the demographics of patients who reported using services on surveys were 
largely similar to the demographics of patients who used services according to results from the 
utilization of services results. Indeed, survey results appeared to corroborate the general 
characteristics of patients who participated in program services. Results from utilization of 
services and surveys suggested the most common characteristics of patients who use services 
were women, persons between the ages 55–75, patients with breast cancer, and stage IV cancer 
patients.    
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Table 17 
Percentage Rates and Frequency of Demographics of Patients Who Used Services 
 
 
 
Percentage 
 
Frequency  
Gender   
Male 29.2% 21 
Female 70.8% 51 
 
Respondents Age 
  
26 to 34 2.9% 2 
35 to 44 5.7% 4 
45 to 54 21.4% 15 
55 to 64 24.3% 17 
65 to 74 31.4% 22 
75 or older 14.3% 10 
 
What Type of Cancer is Being Treated? 
  
Bladder cancer 1.4% 1 
Blood cancer 16.9% 12 
Bone cancer 2.8% 2 
Brain tumor 4.2% 3 
Breast cancer 42.3% 30 
Colorectal cancer 5.6% 4 
Female reproductive cancer 16.9% 12 
Head and neck cancer 5.6% 4 
Kidney cancer 1.4% 1 
Liver cancer 1.4% 1 
Lung cancer 9.9% 7 
Male reproductive cancer 4.2% 3 
Skin cancer 1.4% 1 
Soft tissue sarcoma 2.8% 2 
 
What Stage of Cancer is Being Treated? 
  
Stage 0 1.5% 1 
Stage I 15.9% 11 
Stage II 14.5% 10 
Stage III 18.8% 13 
Stage IV 24.6% 17 
Unknown  24.6% 17 
 
 Satisfaction with program services. Program satisfaction results are reported separately 
based on patients’ participation in program services during their treatment. Respondents who 
reported using program services are referred to as “participants” while respondents who reported 
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not using program services are referred to as “non-participants.” Program satisfaction was 
defined by respondents’ opinions and experiences regarding the quality and variety of program 
services as well as staffing accessibility and responsiveness.  
 Quality. Sixty-seven program participants responded to the survey question about 
satisfaction regarding the quality of program services provided by PSS staff. Results 
demonstrated high satisfaction with the quality of program services. Eighty-four percent of 
participants reported being fully satisfied, while 10% reported being somewhat satisfied. Six 
percent reported neutral feelings. None of the program participants reported dissatisfaction with 
the quality of program services provided.  
 Twenty-two non-participants responded to the survey question about quality of program 
services. Interestingly, 45% reported being fully satisfied. Fifty percent felt neutral about quality 
of services, while one non-participant reported full dissatisfaction.  
 
Figure 34. Patient satisfaction: quality of program services.  
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 Variety. Sixty-eight program participants responded to the survey question about 
satisfaction regarding the variety of program services provided by PSS staff. Program variety 
also received high reviews based on participants’ responses. Seventy-eight percent of program 
participants reported full satisfaction with the variety of programs services provided by staff. 
Nine percent reported being somewhat satisfied, while 12% reported feeling neutral. One 
participant reported being somewhat dissatisfied with the variety of program services offered.  
 Twenty-four non-participants responded to the survey question about variety of 
program services. Fifty-four percent reported being fully satisfied with the variety of program 
services. Forty-two percent felt neutral, while one non-participant reported full dissatisfaction.  
 
Figure 35. Patient satisfaction: variety of program services.  
Staffing. Sixty-eight program participants responded to the survey question about their 
satisfaction with program staff. Overall, participants responded favorably regarding the 
accessibility and responsiveness of staff. Seventy-nine percent reported being fully satisfied. 
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Seven percent reported being somewhat satisfied and 13% reported neutral feelings. None of the 
program participants reported dissatisfaction regarding staff access and responsiveness.  
 Twenty-two non-participants responded to the survey question about staffing. 
Consistent with non-participants views of satisfaction with program quality and variety, 45% 
reported being fully satisfied with staff access and responsiveness. Nine percent reported being 
somewhat satisfied, while forty-one percent felt neutral. One non-participant reported full 
dissatisfaction.  
 
Figure 36. Patient satisfaction: staff access and responsiveness.  
Overall value of program services. In general, respondents indicated they considered 
PSS a valuable part of their cancer treatment at PRCP. Fifty-seven percent of all respondents 
reported strong agreement, while 20% reported agreement. Nineteen percent of all respondents 
reported neutrality, of which thirteen respondents were non-participants and seven were program 
participants. Five percent of all respondents indicated strong disagreement regarding their 
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perceived value of program services; of those respondents, four were non-participants and one 
was a program participant.  
 
Figure 37. Patient satisfaction: value of program services.  
Not surprisingly, the likelihood of respondents using program services or recommending 
program services to other patients and family members varied based on respondents participation 
in program services. Forty-one percent of all respondents reported a high likelihood of 
continuing to use program services or using them in the future. An additional 18% of all 
respondents reported being somewhat likely to participate in services, while 20% reported 
neutrality. Of the respondents who reported disagreement, 38% of non-participants reported 
being unlikely to use program services, while 9% of program participants reported being unlikely 
to continue using services.  
Program participants were highly likely to recommend services to others (n = 80%), 
reporting minimal ambivalence (n = 8%) and no dissonance. Although non-participants 
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accounted for a smaller representative sample, overall they were less likely to recommend 
services (n = 45%) and more likely to report ambivalence (n = 10%) or dissonance (n = 21%).  
 
Figure 38. Patient satisfaction: likelihood of using or continuing to use program services.  
 
Figure 39. Patient satisfaction: likelihood of recommending program services.  
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Areas of strength. Areas of perceived strength are reported in aggregate form based on 
responses from both participants (n = 60) and non-participants (n = 12). Respondents were 
offered three program service choices (emotional support, support groups, resources and 
financial support) and asked to select the program service they viewed most helpful, though 
many respondents chose more than one service. Fifty percent of all respondents reported 
emotional support was the most helpful service provided. Support groups were viewed as most 
helpful by 34% of respondents, while 32% of respondents indicated access to resources and 
financial support was most helpful. Respondents indicated three other noteworthy support 
services not listed including nutrition (n = 1), naturopathic medicine (n = 1), and American 
Cancer Society volunteers (n = 4). 
 
Figure 40. Patient satisfaction: areas of strength.   
Areas of improvement. Respondents were asked to provide open-ended feedback about 
perceived areas of improvement. Thirty-eight respondents provided feedback. Interestingly, 21 
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respondents used this question as a platform to express gratitude or their overall satisfaction with 
support services. Specific critical feedback was provided by 16 respondents and categorized into 
three themes: (a) education and outreach, (b) services and access, and (c) PSS staffing.  
Education and outreach. Several respondents recommended spending more time 
educating and informing patients and staff about PSS and support options. One respondent asked 
for greater emphasis on integrated services.  
Several respondents wanted more emphasis providing patient outreach and education 
near the beginning of treatment. One respondent recommended holding a monthly information 
session for new patients and family members to learn about support service options. Another 
respondent requested more information advertising support group options and availability or 
meeting times. A third respondent wanted medical providers to offer “stronger encouragement” 
to patients to use support services.  
Services and access. Respondents recommended several areas of interest related to 
available support service options. Areas of improvement included transportation services, 
transitioning to hospice care, and family and caregiver support opportunities. One respondent 
asked for more support services specifically for breast cancer. In addition, a request was made to 
offer support group options more frequently (i.e., weekly) as well as making weekend support 
available for patients.  
PSS staffing. Staffing concerns were less likely to be identified as an area of 
improvement; however, two respondents indicated frustration with the lack of training/education 
or consistency among support staff persons. Another respondent expressed disappointment with 
the department not being “sufficient,” though more specific information was not provided.  
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Staff satisfaction. In total, 110 staff were invited to participate in a survey including: 
medical and radiation oncologists (n = 11), advanced care practitioners (n = 4), nurses (n = 31), 
medical assistants (n = 11), other clinical staff (n = 16), nonclinical support staff (n = 15), and 
administrators (n = 22). Other clinical staff included clinical nurse specialist, palliative care, 
nutrition, pharmacy, phlebotomy, and radiation therapy technology. Nonclinical support staff 
included financial counseling, patient navigation, clinical research, radiation physics, medical 
dosimetry, nuclear medication technology and information technology. The administration team 
consisted of receptionists, schedulers, health information services, administration assistants, and 
administration management. Forty-one staff completed the survey, accounting for a higher than 
average return rate of 37%.  
Staff demographics. Of the 41 surveys returned, the nursing team provided the most 
responses with 42% of nursing staff participating. Four physicians and two medical assistants 
responded accounting for 15% of the total responses; however, physicians and medical assistants 
represented a fairly low response rate given the size of their departments (36% and 18% response 
rate, respectively). Advanced care practitioners did not participate in the survey, which may be 
related to concerns regarding anonymity given their small numbers among all staff (n = 4). 
Conversely, a high percentage of support persons participated representing 73% support staff 
persons, 31% clinical staff persons, and 22% of administrative staff persons.  
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Table 18 
Staff Demographics: Employment Position   
 Invited  Responded Response Rate 
Employment Position    
Physician  11 4 36.4% 
Advanced Care Practitioner  4 0 0% 
Nurse 31 13 41.9% 
Medical Assistant  11 2 18.2% 
Other Clinical Staff 16 5 31.3% 
Support Staff 15 11 73.3% 
Administration 22 5 22.7% 
Anonymous n/a 1 n/a 
Total 110 41  
 
Staff who responded to the survey most frequently were also those staff members 
employed at PRCP the longest, serving 7–8 years (n = 18). Staff members least likely to respond 
were those employed less than one year (n = 3) as well as those employed 3–4 years (n = 3).  
 
Figure 41. Staff demographics: number of years employed at PRCP. 	
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Familiarity with program services. Sixty-eight percent of respondents indicated they 
were familiar or very familiar with services offered by PSS. Two percent indicated they were not 
familiar with PSS at all, while 29% reported some familiarity.  
Table 19 
Percentage Rates and Frequency of Patient Support Services Familiarity  
 
 
 
Percentage 
 
 Frequency 
How Familiar Are You With Services Offered?   
(1) Very familiar 43.9% 18 
(4) Familiar  24.4% 10 
(3) Somewhat familiar  24.4% 10 
(2) A little familiar 4.9% 2 
(1) Not at all 2.4% 1 
Note. Based on a Likert-scale, where 5 is very familiar with services and 1 is not at all familiar 
with services.  
 
Referrals to program services. Despite a high percentage of respondents indicating their 
familiarity with PSS, fewer than half the respondents reported frequent referrals. Thirty-six 
percent of respondents reported referring to PSS often to very often. Ten percent of respondents 
indicated they did not refer to PSS at all, while 45% of respondents reported sometimes referring 
to PSS. It is worth noting, these findings did not account for staff positions and whether low 
referrals represented staff with minimal patient interaction or clinical providers. It is likely that 
low referrals were, in part, attributed to nonclinical staff positions rather than poor familiarity 
with program services, since PRCP indicated good familiarity with PSS in the above survey 
question. 
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Table 20 
Percentage Rates and Frequency of Patient Support Services Referrals  
 
 
 
Percentage 
 
 Frequency 
How Often Do You Refer to PSS?   
(1) Very often 24.4% 10 
(4) Often  12.2% 5 
(3) Sometimes 39.0% 16 
(2) Not very often 14.6% 6 
(1) Not at all 9.8% 4 
Note. Based on a Likert-scale, where 5 is very familiar with services and 1 is not at all familiar 
with services.  
 
PSS resources most frequently recommended to patients were social work (66%) and 
counseling (61%). The Cancer Resource Center (59%), support groups (56%), nutrition (54%), 
and financial resources (51%) were also highly recommended by staff. One respondent reported 
referring patients for cognitive testing while another respondent commented “other,” reporting 
transportation concerns as a referral reason. Six respondents noted they did not recommend PSS 
to patients given their employment position.  
 
Figure 42. Staff satisfaction: recommended Patient Support Service resources.  
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When asked about the circumstances or situations staff members typically referred 
patients to PSS, respondents identified four scenarios most frequently: patients expressing 
emotional distress (n = 70%), concern or support for family members (n = 66%), complex 
medical and/or psychosocial concerns (n = 63%), and transportation concerns (n = 63%). Three 
additional scenarios were identified with great frequency: concerns regarding risk of self-harm or 
injury (n = 59%), financial stress (n = 54%), and nutrition concerns (n = 51%).  Thirty-seven 
percent of respondents said they referred patients to services when upsetting news was received 
or delivered, while only 15% of respondents reported referring patients whose health has 
declined. Twenty-seven percent of respondents reported referring to services when a patient 
upset staff or other patients. Twenty-two percent of respondents reported referrals when concerns 
about patients’ cognitive skills or comprehension were questioned, while only 15% of 
respondents made referrals when patients had difficulty understanding their disease and 
treatment options. 
Several respondents also reported unique circumstances that preceded their referral to 
PSS including, palliative care services (n =1), high levels of distress indicated on PRCP’s 
Distress Assessment form (n =1), or when staff encountered a patient complaint or concern  
(n =1). Fourteen percent of respondents (n = 6) indicated they did not refer patients to services 
given their employment position.  
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Table 21 
Percentage Rates and Frequency of Referral Scenarios  
 
 
 
Percentage 
 
 Frequency 
What Types of Situations Do You Typically Refer 
Patients to PSS? Select All That Apply:  
  
When a patient appears upset or distraught 70.7% 29 
When a patient receives upsetting news 36.6% 15 
When family has concerns or needs support 65.9% 27 
When a patient has difficulty understanding 
diagnosis, prognosis, or treatment options 
14.6% 6 
When a patient appears cognitively impairment or 
has difficulty comprehending  
22.0% 9 
When a patient’s health begins to decline 14.6% 6 
When a patient has complex medical or psychosocial 
needs  
63.4% 26 
When a patient appears at risk of self-harm or injury 58.5% 24 
When a patient has upset staff or other patients 26.8% 11 
When a patient has financial concerns  53.7% 22 
When a patient has transportation concerns 63.4% 26 
When a patient would benefit from a nutrition 
consultation 
51.2% 21 
What a patient would benefit from additional time or 
attention  
41.5% 17 
Not applicable: I do not refer patients in my position  14.6% 6 
Other  7.3% 3 
 
Overall value of program services. Eight-five percent of respondents indicated they very 
much considered Patient Support Services a valuable part of PRCP’s cancer treatment program. 
Ten percent of respondents stated that PSS services were moderately valuable, while two 
respondents responded that services were only somewhat valuable. No respondents indicated a 
lack of value regarding PSS.  
Similarly, the majority of respondents stated PSS had a positive to very positive effect on 
treatment outcomes for patients (n = 35). Twelve percent of respondents stated that services had 
a somewhat positive effect on outcomes, while one respondent disagreed indicating that PSS had 
little positive effect on outcomes. 
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Table 22 
Percentage Rates and Frequency of Patient Support Services Value 
 
 
 
Percentage 
 
 Frequency 
Do You Consider PSS a Valuable Part of PRCP?*   
(1) Very much 85.0% 34 
(4) Moderately  10.0% 4 
(3) Somewhat 5.0% 2 
(2) A little  0% 0 
(1) Not really 0% 0 
 
Does PSS Positively Affect Treatment Outcomes?   
(1) Very much 63.4% 26 
(4) Moderately  22.0% 9 
(3) Somewhat 12.2% 5 
(2) A little  2.4% 1 
(1) Not really 0% 0 
Note. Based on a Likert-scale, where 5 is very familiar with services and 1 is not at all familiar 
with services. * Based on 40 responses; one blank response.  
 
Staff members were also asked to endorse the perceived benefits of including 
psychosocial services as an integrative program within cancer treatment. Respondents were most 
likely to agree that psychosocial services helped improve patients’ ability to cope with expected 
distress associated with cancer treatment (n = 90%) and reduced the risk of developing more 
severe emotional disorders (n = 88%). A high percentage of respondents also agreed that 
psychosocial services helped improve the satisfaction of services available for cancer treatment 
(n = 83%) and improved patient compliance with treatment and follow up care (n = 80%). Sixty-
five percent of respondents agreed that psychosocial services helped improve patients’ overall 
health and functioning. Respondents were less likely to agree that psychosocial services helped 
reduce the financial costs of the medical system (n = 50%), the use of unnecessary medical 
services (n = 55%), or the workload for treatment providers or staff (n = 48%).  
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Table 23 
Percentage Rates and Frequency of Patient Support Services Perceived Benefits 
 
 
 
Percentage 
 
 Frequency 
What Outcomes May Be Likely Because of Patient 
Involvement in PSS? Select All That Apply:  
  
Reduced risk of severe emotional disorders 87.5% 35 
Improved ability to cope with expected distress 90.0% 36 
Improved overall health and functioning 65.0% 26 
Improved satisfaction with cancer care services 82.5% 33 
Increased treatment compliance and follow up  80.0% 32 
Reduced workload for providers and staff  47.5% 19 
Lower use of unnecessary medical services  55.0% 22 
Reduced financial costs to our medical system  50.0% 20 
Note. Based on 40 responses; one blank response. 
 
Areas of strength. Eight-five percent of respondents were in agreement that the greatest 
strength of PSS was the team’s ability to provide emotional support to patients and family 
members. According to respondents, the team’s second greatest strength was its ability to 
provide crisis intervention and risk assessment (n = 66%). The third area of strength identified 
was PSS’s ability to assess psychosocial needs (n = 63%). Triaging patients with high acuity and 
facilitating support groups were less frequently reported as department strengths (n = 56%). Two 
respondents replied “other” and identified the program’s strengths as providing financial 
assistance and transportation. Two additional respondents stated they were unfamiliar with 
program strengths given their employment position.  
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Table 24 
Percentage Rates and Frequency of Patient Support Services Strengths  
 
 
 
Percentage 
 
 Frequency 
What Does the PSS Team Do Particularly Well? 
Select All That Apply:  
  
Assess psychosocial needs 63.4% 26 
Facilitate support groups  56.1% 23 
Provide emotional support to patients and family 85.4% 35 
Provide crisis intervention and risk assessment 65.9% 27 
Triage patients with high acuity or distress  56.1% 23 
Other 9.8% 4 
 
Areas of improvement. Respondents identified several areas for program improvement 
with high consistency. The two greatest areas of concern identified by respondents were 
accessibility of staff (n = 27) and responsiveness to urgent needs (n = 21). Respondents 
commented about the importance of staff responding to urgent concerns more readily and being 
available for personal referrals from staff. Of mention, respondents noted difficulty reaching staff 
by phone during regular business hours and one respondent requested faster response time 
following up with patients who report high levels of distress on Distress Assessment 
questionnaires. One respondent also suggested increasing staff access on Fridays. Two 
respondents recommended staff walk around the infusion center to make themselves more 
available to patients; additionally, two respondents wanted to ensure all patients were being 
followed by PSS staff and mentioned the importance of having an initial meeting with PSS staff 
as part of treatment orientation. Three respondents made requests for additional staff, including 
first floor reception staff to help with patient check-in for psychosocial services and more full-
time employees in PSS including a full-time nutritionist/dietician and full-time social worker.  
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The third most frequently identified area of concern was the diversity of support service 
options (n = 12). Two respondents made specific requests for more options being made available 
for caregivers or family members of patients.  
Increasing publicity or marketing to recruit patients was identified with similar frequency 
(n = 11). One respondent recommended business cards being made more readily available for 
distribution, while another respondent requested better staff education regarding program 
services, making referrals, and how to contact staff.  
Respondents were least likely to identify revenue or funding opportunities as an area in 
need of improvement (n = 5) or modifying the frequency of support group meetings (n = 7). 
Three respondents did not recommend any areas for improvement while six respondents stated 
they were unsure of areas in need of improvement.  
Table 25 
Percentage Rates and Frequency of Areas for Program Improvement  
 
 
 
Percentage 
 
 Frequency 
What Can PSS Do To Improve Its Services? Select All 
That Apply:  
  
Increase staff access during business hours 65.9% 27 
Improve staff response time for urgent needs  51.2% 21 
Offer support groups more frequently  17.1% 7 
Offer more support service options 29.3% 12 
Generate revenue or funding opportunities 12.2% 5 
Improve publicity or marketing to recruit patients 
from the community 
26.8% 11 
Nothing! Keep doing what you are doing! 7.3% 3 
I’m not sure 14.6% 6 
Other 17.1% 7 
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Chapter IV: Discussion 
This evaluation examined Patient Support Services to determine what aspects of the 
program were working well and what areas needed improvement. Evaluation findings provided 
an overview of program services as they were currently utilized and valued by patients and staff. 
The culmination of this evaluation presented stakeholders with informed recommendations to 
improve program services based on identified areas of satisfaction and dissatisfaction. Evaluation 
findings were presented to stakeholders on multiple occasions to collaboratively discuss program 
strengths and areas for improvement. Recommendations were generated with input from PSS 
staff and offered to stakeholders and program administrators to make informed decisions about 
desired future program changes. An executive report was provided outlining evaluation findings 
and recommendations for consideration (see Appendix R).  
The following sections provide an overview of program strengths, areas identified for 
improvement, program recommendations, and limitations of this evaluation. 
Program Strengths 
 Many areas of strength were identified during the program evaluation. Indeed, the value 
and worth of Patient Support Services was clearly demonstrated from the perspective of program 
utilization as well as program satisfaction. Program strengths provide insight into services that 
were well utilized and most valued; areas of strength should continue to receive attention from 
PSS staff as program recommendations are considered.   
Utilization of services. An analysis of program services was conducted to better 
understand how program services were utilized and by whom, identifying program services that 
were well utilized or well represented by patients. In general, an analysis of utilization of 
services demonstrated alignment with the overall mission of PSS: To reach a broad patient 
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population and provide services to some of PRCP’s patients in greatest need. Three areas of 
strength were identified:  
• While this evaluation was not an exhaustive analysis of services utilized by all 
patients but a snapshot of services provided during a specific timeframe, it did 
demonstrate that more than 17% of all new patients at PRCP participated in 
program services beyond Distress Assessments. While all patients are assessed for 
low, moderate, and high levels of distress based on NCCN (2016b) guidelines, 330 
of 1,904 all new patients participated in at least one program service beyond 
Distress Assessment. Further, 83% of patients who utilized program services (n = 
330 of 400) interacted with PSS beyond Distress Assessment. These findings 
suggest that PSS reaches an expansive population of patients beyond screening 
requirements as outlined by NCCN.  
• Participation in program services appeared to be reflective of patients’ needs and 
presumed financial resources according to primary payer information. In general, 
patients presumed to have the fewest financial resources participated in program 
services more frequently and diversely, compared to patients presumed to have 
better access to financial resources and support opportunities. Medicaid patients 
were more likely to participate in nearly all program services, despite comprising 
only 16% of program participants and 7.5% of all new cancer cases. Medicare 
patients represented the largest portion of all patients (52.6%) and were most likely 
to request follow up on Distress Assessment questionnaires, likely because 
Medicare patients represent an older patient population or medically disabled 
persons with complex needs and, therefore, requests for follow up on psychosocial 
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questionnaires can be expected. Alternately, patients with commercial insurance 
presumably represent younger or actively employed persons with greater access to 
financial resources and support. Patients with commercial insurance were twice as 
likely to participate in support groups, taking advantage of peer support 
opportunities more so than other program resources suggesting a greater interest in 
building a supportive, peer community.  
• Patients with advanced stage cancer were shown to use program services more 
frequently and diversely. While patients with Stage IV cancer represented 19.7% of 
all new cancer cases at PRCP, they represented 53% of multiuse participants. 
Assuming patients with advanced stage cancer face greater emotional distress and 
more complex psychosocial needs than patients with earlier stage cancer, advanced 
cancer patients’ vast participation in program services affirms the mission of PSS to 
meet the needs of patients in distress.  
Patient perspective. Patient surveys sought to elicit areas of program strength based on 
patients’ understanding of services or experience participating in services. Patient feedback 
revealed many encouraging areas of program services and, in general, patients were likely to 
express satisfaction and gratitude for the program. What follows is a summary of areas of patient 
satisfaction based on 152 returned surveys.  
• Eighty-two percent of patients reported being informed of program services.  
• Emotional support was identified as the program’s greatest strength and most helpful 
service provided by staff, with support groups being ranked second and resources and 
financial support ranked third.   
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• The vast majority of patients reported high satisfaction with the quality (82.6%) and 
variety (77.6%) of program services currently offered.  
• Eighty percent of patients reported satisfaction with staff access and responsiveness  
• Psychosocial services were perceived as a valuable part of cancer care treatment by 
76.3% of patients.  
• Patients who had used program services were highly likely to continue using services 
and to refer others to program services.  
Staff perspective. Staff surveys aimed to understand how program services were used by 
staff, what services were considered most valuable, and if the inclusion of psychosocial services 
had an affect on staff as well as the larger cancer treatment program at PRCP. Forty-one staff 
completed the survey identifying the strengths and value of program services from staff 
perspective.  
• Sixty-eight percent of staff reported familiarity with program services.  
• The majority of staff regarded psychosocial services as being a valuable part of 
cancer care treatment (92.7%) and having positive effects on patient outcomes 
(85.4%). 
• Similar to patient feedback, staff also identified emotional support as the program’s 
greatest strength. 
• All program services were recommended with high consistency among staff. Social 
work was the most referred resource followed by counseling.   
• Staff reported being most likely to refer patients to program services under three 
circumstances which support the goals and mission of PSS: When patient is upset, 
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when family members have concerns or need support, and when a patient presents 
with complex medical or psychosocial needs.  
• Staff were in high agreement of the perceived benefits of PSS. When psychosocial 
services are offered in tandem with medical procedures to treat cancer, staff were 
likely to endorse the beliefs that (a) patients are better able to cope with emotional 
distress, (b) patients are less likely to develop severe emotional disorders, and (c) 
patients are more likely to be satisfied with their cancer care. Additionally, staff 
thought participation in program services was likely to increase compliance with 
treatment recommendations and improve patients’ overall health and functioning.  
Program Limitations and Recommendations  
Program limitations were identified based on underutilized or underrepresented program 
services as well as areas of dissatisfaction reported by patients and staff. Program 
recommendations are offered with input from stakeholders to further benefit program services 
based on identified areas of concern. In general, program recommendations may assist 
stakeholders and staff delivering services in staying accountable to the program goals, mission, 
and values, understanding program issues, examining areas of concern, refining program 
planning, and making program decisions (Fitzpatrick et al., 2004).  
In many instances, proposed recommendations affect more than one area of 
improvement. For example, making improvements to staff and patient education, enhancing 
outreach efforts, and modifying marketing materials may each have an aggregate affect on 
program utilization and satisfaction of services. The proposed recommendations are offered as 
considerations, not as prescriptive or required program changes.   
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Utilization of services. While program strengths were identified based on areas well 
utilized and well represented by patients, trends in program services that were underutilized or 
underrepresented by patients were identified as areas in need of improvement. Feedback is 
offered to diversify program services and reach patients who appear to be underserved by PSS 
currently. Contextualized recommendations are proposed to improve services available as well as 
program marketing and recruiting.  
Diversity of services (gender). Although new cancer cases were represented by men and 
women nearly equally at PRCP, PSS saw a significantly higher portion of women (68%) than 
men (32%) participate in program services. Indeed, men represented less than a third of program 
participants despite comprising 44% of all new cancer cases at PRCP. Of those men who 
participated in program services, 15% represented group users and 36% represented multiuse 
participants. In general, it appeared that men were much less likely than women to seek services 
beyond an initial screening with PSS staff. It should be noted, however, that men diagnosed with 
prostate cancer represent 5.5% of all new cancer cases at PRCP, but may never access PSS 
because their treatment may be limited to surgical oncology or surveillance only, rather than 
ongoing oncology care typical of other cancer diagnoses. Regardless, women demonstrated 
much higher rates of utilization than expected compared to general demographics of PRCP 
patients.  
Proposed recommendations. Given the low frequency of men among program services 
despite being near equally represented among new cancer cases, PSS is encouraged to modify 
current marketing materials to recruit men with cancer more explicitly and encourage their 
participation in program services. Further exploration is also recommended to better understand 
		
 
111 
what program services men may be most interested in receiving as current program services may 
not accurately reflect the needs of men with cancer.  
Diversity of services (cancer). Breast cancer patients were superiorly represented among 
all other program participants and, consequently, across all program services. While national 
prevalence rates estimate that breast cancer comprises 14.6% of all new cancer cases (NCI, 
2016), patients with breast cancer represented 19.4% of all new cases at PRCP and 34.8% of all 
program participants in this evaluation. Breast cancer patients were represented at much higher 
rates than expected, nearly one and half times the frequency of all other single and multiuse 
participants and nearly ten times the frequency of all other group participants. Participation rates 
of patients with other cancer diagnoses paled in comparison to the frequency of breast cancer 
patients, despite similarly high national prevalence rates.  
Proposed recommendations. The NCI (2016) projects breast, lung, prostate, colorectal, 
bladder, melanoma, renal, leukemia and lymphoma, endometrial, and pancreatic cancers to be 
the most common cancers among new cases diagnosed in 2016. PSS should make a concerted 
effect to market program services to be inclusive and representative of the most commonly 
occurring cancer diagnoses. Considerations should be made during program planning to recruit a 
more diverse group of patients that parallels national prevalence rates and PRCP demographics. 
A follow up analysis may evaluate why frequently observed cancer diagnoses are 
underrepresented among PRCP cases and/or program participants. For example, male 
reproductive cancers represent high national prevalence rates comparable to breast cancer 
(11.2%), and yet represent only 6.5% of all new cases at PRCP and, as such, are significantly 
underrepresented among program users as well.  
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Support groups. Data from utilization of services indicated several considerations 
regarding how support groups are currently structured and valued. Despite the ability of support 
groups to capture a large and diverse audience, current support groups appear to be dominated by 
a fairly homogeneous group, namely patients with early stage cancer and women with breast 
cancer. In general, support groups were utilized less frequently than office visits and ranked 
lower than emotional support and counseling services by patients and staff alike. Indeed, 
evidence of the underutilization of support has been present as far back as 2005, when 
psychosocial services were offered as ambulatory services prior to PRCP being built (PRCP, 
2005b). Anecdotally, past and present PSS staff reported low weekly attendance among support 
groups with few new patients returning beyond an initial support group meeting. Although 
support groups have received mixed feedback from patients and staff, they have the potential to 
provide substantial support to a large audience and deserve more attention to ensure their 
usefulness.  
Proposed recommendations. Given the mixed feedback support groups received from 
patients and staff alike, it is worth evaluating how support groups are currently utilized, 
including the diversity of attendees and the ratio between new and returning attendees. 
Utilization data indicated that support groups are currently dominated by a fairly homogenous 
patient population; because of the advantages support groups have in reaching a broad 
community, attention should be paid to how support groups can recruit a more diverse audience 
that encompasses commonly occurring cancers at PRCP. 
PSS is encouraged to consider how support groups are currently structured to evaluate 
how many support groups may be necessary to meet the emotional needs of patients, caregivers, 
and family members. Future program planning may investigate whether current support groups 
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should be consolidated to reach a higher volume of patients rather than a specialized population, 
for example support groups for all men or all women with cancer rather than focusing on prostate 
or breast cancers. Additionally, the structure of support groups should be evaluated to consider 
the benefit of offering open verses closed groups requiring preregistration or groups held for a 
specified length of time rather than ongoing. An appraisal of support groups may also consider 
what areas of interest tend to attract a higher volume of attendees to improve support group 
content and recruiting efforts. For example, in the past, guest speakers have attracted a high 
volume of attendees and it may be worth allocating funds toward speakers to increase the overall 
value of support groups. 
Satisfaction of services. Using surveys, patients and PRCP staff were invited to submit 
feedback and ideas to improve PSS services. In total, 48 responses were received, 16 from 
patients and 32 from staff members. Responses were organized based on shared themes and 
categorized into three identified areas for improvement: (a) education and outreach, (b) services 
and access, and (c) PSS staffing.  
 Education and outreach. Results from patient and staff surveys indicated education and 
outreach as an area in need of improvement. Patients requested staff members place greater 
emphasis on utilizing “integrative services,” or services available beyond standard medical 
treatments. PRCP offers several ancillary support services under the umbrella of integrative 
health, including acupuncture provided by practitioners of Bastyr University, naturopathic 
medicine, nutrition classes with a registered dietician, and behavioral health and counseling 
services provided by PSS. In addition, the Cancer Resource Center, staffed by the knowledgeable 
Patient Navigator and volunteers from the American Cancer Society, offers a plethora of 
literature on cancer and treatments as well as resources such as hats, wigs, port pillows, and 
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camisoles to support breast prostheses. Palliative Care clinicians help manage treatment-related 
symptoms and pain control, focusing on preserving patients’ quality of living and chaplains 
employed through Providence Medical Center are available for spiritual care and emotional 
support. For the purpose of this evaluation, data was collected primarily on behavioral health and 
departments that worked most closely with PSS including nutrition and the Cancer Resource 
Center; acupuncture, naturopathic medicine, Palliative Care, and Spiritual Care were not 
explicitly evaluated. 
Staff education. According to staff surveys, only 37% of PRCP staff made referrals to 
PSS “often” and 39% of staff referred “sometimes.” While the vast majority of staff  (92.7%) 
agreed that psychosocial services are a valuable part of cancer care treatment, 32% of staff 
reported being unfamiliar with PSS. Furthermore, patients felt their treatment providers did not 
actively encourage PSS services as part of their treatment. Better staff education is necessary to 
help PSS to retain its importance and value within the cancer treatment center. After all, a robust 
integrative health department is only as valuable as the use it receives from patients. Staff 
education and encouragement to use supportive services can breathe new life into ancillary 
services and provide the recognition integrative health deserves.  
PSS staff is encouraged to create a quarterly newsletter to advertise program services and 
introduce PSS staff members and areas of specialty or interest. Because a majority of PSS is 
comprised of psychology interns, the department sees a fair deal of staff turnover annually; in 
essence, the department changes with each new cohort of interns and PRCP at large needs a 
better way to acclimate to program and staffing changes. Newsletters are a great way to 
familiarize PRCP with the most accurate department information, including program services, 
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referral information, and current staff members. It would follow that greater familiarity with PSS 
staff and program services would generate more frequent referrals from treatment providers.  
The more visible PSS staff are throughout the cancer program, the more familiar PRCP 
staff will be with staff members, program services, and procedural policies. As such, PSS is 
encouraged to have a department representative attend quarterly all staff service meetings and 
daily cancer specialty conferences. Greater involvement from PSS staff within the Cancer 
Partnership reinforces the mission of PRCP to provide comprehensive cancer care. To that effect, 
PSS should be represented among the other disciplines as often as possible. Similarly, PRCP 
staff should also be more involved in understanding PSS services to help bridge the gap between 
disciplines and departments. During new employee orientation, new staff hires should meet with 
PSS staff and shadow their position to learn about the department first hand, as they do with 
providers in other departments.  
Patient education and outreach. While staff education can help increase referrals to PSS 
and strengthen multidisciplinary, integrative cancer care, patient education and outreach is 
needed to ensure program services are reaching their intended audience. Although all patients to 
receive a paper-and-pencil screening for psychosocial distress meant to identify patients in need 
of outreach and support services, not all patients meet PSS staff or understand the full breadth of 
services available to them and their family members.  
Patients expressed the need for more information on available program resources, both in 
print and in person. Similarly, PRCP staff requested program services be explained to patients 
more thoroughly or explicitly at the beginning of treatment. Because patients are initially focused 
on understanding their diagnosis and treatment options, information they receive upfront is 
heavily focused on treatment education and less on ancillary services. The general census of PSS 
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staff is to provide PSS outreach shortly after patients have had a chance to acclimate to their 
treatment schedule, presumably when they are better able to absorb additional information and 
consider adjacent services to support their cancer care. PSS is encouraged to consider delivering 
patient education in-person on a regular basis. A monthly “meet and greet” table can be set up in 
high traffic areas such as infusion or waiting rooms to increase PSS visibility and provide in-
person education. Printed program materials can be easily advertised and distributed, and 
patients and staff alike can also become more familiar with PSS staff in a personable, informal 
manner. A meet and greet table also brings awareness and education directly to patients, quite 
literally meeting patients where they are rather than relying on them to seek out program services 
on their own.  
Because patients receive oncology services on the second and third floor of the Cancer 
Partnership, services located on the first floor do not regularly receive foot traffic from patients. 
Additionally, many services aren’t easily noticeable as they occur behind locked doors, a part of 
the building not accessible to patients unless accompanied by staff. A team of receptionists and 
schedulers were previously staffed on the first floor, which drew greater attention to first floor 
services in general and also helped direct patients to services as needed. Reinstating staffing on 
the first floor of the building where ancillary services are housed may also increase visibility and 
awareness of program services and create a more engaging atmosphere on the first floor. 
Marketing and advertising. The more marketing materials are made easily and readily 
accessible, the more patients and staff can be accurately informed of program services, eligibility 
(when appropriate), and how to reach PSS. In general, better marketing and up-to-date 
advertising may reduce confusion and inaccuracies in program services that have potentially led 
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to areas of dissatisfaction in the first place. Clearer and more accessible program information 
may improve patient education and help patients better utilize program services.   
Marketing materials should be frequently monitored to ensure the most accurate 
information is being advertised. In addition to marketing materials being placed in highly visible 
locations throughout the Cancer Partnership, fact sheets answering frequently asked questions 
can be created and stored at nursing stations in infusion. Oncology nurses spend a great deal of 
time interacting with patients as they deliver chemotherapy and other treatments and, as such, 
nurses often screen patients for distress and serve as a primary point of contact for patients to 
learn about ancillary services. Nurses could easily distribute fact sheets with up-to-date 
information on frequently requested resources such as transportation services, Washington 
Medicaid Programs such as Community Options Program Entry System (COPES), and Social 
Security Disability Insurance Program (SSDI). Fact sheets would also serve to educate PRCP 
staff on resources that receive a great deal of attention within the Cancer Partnership and 
improve the working relationship between PSS and other departments creating a more cohesive 
experience for patients.  
In addition to traditional marketing materials (i.e., business cards, flyers, printed 
brochures), PRCP should consider investing in television monitors that digitally display 
information about PRCP at large. Television monitors have the advantage of displaying a variety 
of information to a large audience rather than printed brochures that patients have to seek out on 
their own. Additionally, digital information can be easily updated or edited without having to 
reprint materials. Television monitors can be positioned in waiting areas or infusion where 
patients are gathered for long periods of time. Advertised information could include PRCP staff 
biographies and specialties, clinical research trials, upcoming events, and program services. 
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Program services can also be advertised while callers are placed on hold during telephone calls 
to PRCP.  
 Services and access. In general, patients expressed high satisfaction regarding the 
quality and variety of program services. However, transportation, hospice care, and family 
services were identified as areas in need of improvement. 
Transportation. Satisfaction surveys demonstrated transportation services were a highly 
valued service and appeared to be well utilized by patients. In many instances, transportation 
services were rated as a program strength. Additionally, 63% of staff reported making referrals to 
PSS for patient transportation needs, indicating a highly visible service within the department. 
PSS is advised to create handouts advertising available transportation services to clarify 
rider eligibility requirements and inform staff and patients how services can be utilized and 
arranged. Brief, fact-based handouts should be placed in high traffic areas such as infusion, 
waiting areas, and nursing stations for easy access and reference to available services. Because 
available transportation services are limited based on rider eligibility requirements, PSS is urged 
to consider allocating funds toward alternate transportation options to assist patients with 
transportation hardships. Funds could be put towards purchasing ferry tickets, bus fare, taxicab 
vouchers, or additional gas gift cards.  
Concerns regarding transportation services may have more to do with available 
transportation services and rider eligibility requirements than deficits in how PSS utilize 
services. Further evaluation is recommended to determine specific areas of dissatisfaction within 
transportation services.  
Hospice care. Patients receiving hospice care were marginally represented throughout 
this evaluation, despite Palliative Care having a strong presence at PRCP. Indeed, of the 152 
		
 
119 
patient surveys, only one respondent indicated receiving hospice care and two respondents 
reported involvement with Palliative Care. Nevertheless, providing compassionate end-of-life 
care is an essential component treating progressive illness and requires more attention than this 
evaluation could provide.  
While advanced stage cancer represents a high percentage of all cancer cases at PRCP 
(19.7%) and, therefore, many patients who eventually face the final stages of their illness, it is 
unclear how well hospice care is utilized within the Cancer Partnership and what role PSS could 
provide in helping patients transition onto hospice. Further evaluation is recommended to better 
understand how and when referrals to hospice are made and how PSS might provide assistance.  
Family services. Both patients and staff surveyed requested more support opportunities 
for family members and caregivers. Interestingly, the inclusion of family members in program 
services occurred quite frequently and organically. Indeed, 17% of single-use participants, 42% 
of multiuse participants, and 37% of group users involved family members in their care and PSS. 
However, data from the current evaluation did not distinguish family members who participated 
in program services for their own needs from those who participated in program services for the 
primary purpose of supporting the person affected by cancer. Effects of cancer on caregivers and 
family members are well documented (see IOM, 2008 for a review of relevant research), and as 
such, a strong argument can be made to ensure program services are offered explicitly for 
caregiver support. 
Currently, PSS does not offer any resources explicitly for caregivers, though family 
members are welcome to participate in most program services including counseling and the 
majority of PSS support groups. A Caregiver Support Group previously existed, but has since 
been consolidated into a general support group due to low attendance numbers. Family members 
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do appear to be present among a variety of program services as indicated by utilization of 
services results, however, how family members utilize services and for what purpose remains 
unknown. PSS is encouraged to consider how family members and caregivers can be better 
supported through program services, both for their own benefit and to support loved ones going 
though cancer. Marketing materials should be modified to inform and encourage caregivers of 
support opportunities geared specifically towards them.  
PSS staffing. Staffing concerns were the most frequently critiqued area within the 
department. Patients and staff identified PSS staffing concerns including staff training and 
consistency in care provided, staff access, and staff response time on urgent needs. Proposed 
recommendations focus on understanding staffing concerns based on the current model of care.  
Staff training and consistency. Patients reported dissatisfaction with PSS staff training 
and education as well as inconsistencies receiving care from PSS staff. Training and consistency 
concerns may be related to the annual turnover rate of PSS staff given the department’s reliance 
on psychology and social work interns to supplement PSS staffing. Current PSS staffing consists 
of a half-time psychologist who also serves as the medical director of program services and a 
social worker who is employed 32 hours per week. On average, one or two psychology interns 
join the department for a twelve-month contractual learning agreement to complete clinical 
training requirements. Modifications to PSS’s internship training curriculum may address 
concerns regarding staff education and inconsistencies and in care provided.   
The Medical Director of Psychosocial Services is encouraged to create a standard training 
program with specific learning modules based on department needs to improve consistency and 
education among staff and interns. Procedural flow charts should be created to help staff identify 
available resources and program services based on the level of patient care needed. Examples 
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could include procedural diagrams on when and how to complete applications for Washington 
Medicaid Programs (i.e., Community Options Program Entry System, COPES), Social Security 
Disability Insurance Program (SSDI), and PRCP’s Patient Assistance Fund for patients 
experiencing financial hardship.  
Staff access. PRCP staff expressed critical feedback regarding PSS staffing access 
including staff availability, visibility throughout the Cancer Partnership, and lack of full-time 
staffing. Recommendations are proposed to improve accessibility and consider overall staffing 
conditions. Visibility concerns may be improved secondarily by addressing staff access as well 
as proposed recommendations to improve PRCP staff education, patient outreach, and program 
marketing, as previously discussed (see education and outreach section above).  
PRCP staff indicated difficulty reaching PSS by phone during regular business hours and 
a request was made for PSS staff to be more available for referrals and immediate concerns. A 
centralized phone number is recommended to reach all PSS staff and, thereby, improve staff 
accessibility. Currently, two phone numbers exist for the department based on office staffing—
one number reaches the designated social worker, while another number reaches interns and the 
Director of program services. A separate number is also utilized to reach staff by pager, for 
example when staff are outside the office visiting patients in infusion or patients hospitalized in 
an adjacent building. All PSS staff generally provide the same services and work in close 
proximity to one another, eliminating the need for two distinct phone numbers; a centralized 
phone number would likely improve accessibility and reduce confusion among staff trying to 
promptly reach PSS.  
Again, it is worth noting that a good portion of PSS staffing is comprised of psychology 
interns, generally constituting at least half the department’s staff. Specific requests were made by 
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PRCP staff to expand current PSS staffing conditions including first floor reception staff, a full-
time social worker, and a full-time nutritionist or dietician. Because current staffing conditions 
affect available program services, satisfaction of services, consistency and quality of services 
provided, and department accessibility or visibility, the current staffing model should be further 
evaluated. More specifically, the long-term sustainability of PSS should be evaluated based on 
PSS’s current staffing conditions and reliance on qualified psychology interns. Furthermore, the 
ratio of full-time PSS staff to all PRCP patients should be evaluated and compared to other 
cancer treatment programs to determine if PSS’s current staffing model is similar and/or 
sufficient. It should be noted that since 2010, the Medical Director of Psychosocial Services has 
sought to identify ways to rely less heavily on students/interns and increase hiring practices for 
permanent staffing (K. Johnson, personal communication, 2013; PSS, 2010), recognizing the 
sustainability of quality, consistent staffing as an area of concern the past several years. 
Response time. In addition to difficulty reaching PSS staff, PRCP staff indicated 
dissatisfaction with PSS response time on urgent matters such as calls, pages, and Distress 
Assessment questionnaires with marked levels of high distress. Additionally, results from the 
staff survey rated PSS staff’s ability to triage patients with high acuity as a relatively low 
department strength, indicating a consistent concern from staff about how PSS attends to patients 
in high or immediate need. Interestingly, patient surveys indicated high satisfaction concerning 
both PSS staff access and responsiveness, reflecting differences among patient and staff 
perceptions.  
Concerns regarding the immediacy of PSS staff responding to perceived urgent needs is 
an area that requires further evaluation. Poor response time on urgent matters may reflect a 
variety of concerns, for example understaffing, poor staff accessibility, or insufficient education 
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about how PRCP staff can use and access PSS resources. The fact that staff reported low 
satisfaction with PSS response time but patients did not indicate an interesting discrepancy 
between staff and patient perceptions, which is worth investigating. To better understand 
concerns, PRCP staff should be interviewed to identify specific areas of concern and how 
concerns may be addressed. Additionally, quality assurance measures should be reviewed to 
monitor response time on urgent referrals made by staff and Distress Assessment questionnaires 
to corroborate concerns. It is possible that recommended improvements regarding PSS staff 
accessibility and PRCP staff education may secondarily address response time concerns. 
Stakeholder Feedback Sessions  
Three feedback sessions were held to present evaluation findings and invite stakeholders 
to participate in how findings can be used to improve and advance program services. The 
intended audience of this evaluation was PSS staff who deliver program services as well as 
program administrators who have input in making overall program changes. Feedback sessions 
were tailored to the audience of each meeting and delivered in multiple formats to make 
information easily accessible and engaging (Fitzpatrick et al., 2004). In alignment with the 
collaborative methodology of program evaluations, stakeholders were intentionally and 
continuously involved in the entirety of this evaluation (Preskill & Jones, 2009) which 
undoubtedly shaped the usefulness and credibility of program findings and recommendations.  
The first stakeholder feedback session was held during the quarterly Psychosocial 
Steering Committee, the same meeting where areas of evaluation interest were first generated the 
prior year. Nine staff members were present during the feedback session, including members of 
the management team (Executive Director of PRCP and administrative executive) as well as 
supporting specialists (Medical Director of Psychosocial Services, American Cancer Society 
		
 
124 
representative, and Patient Support Services clinical staff). A PowerPoint presentation outlined 
evaluation findings and identified areas for improvement. An informal follow up meeting was 
held during the weekly PSS meeting to further discuss areas of feedback and generate program 
recommendations. Six staff attended the follow up meeting representing the current PSS team 
entirely and a representative from ACS.  
 A final feedback session was held during the quarterly Cancer Executive Committee 
meeting, the forum for discussing organizational recommendations for strategic and business 
development. Program findings and proposed recommendations based on stakeholder input were 
presented to leadership as part of the dialogue on the growth and development of PRCP at large. 
Fourteen members were present including the Vice President and Chief Medical Officer of 
PRCP among physicians and administration representative of medical oncology, radiation 
oncology, diagnostic radiology, and surgery.  
Evaluation Limitations  
Several limitations of this evaluation and its methodology are noted. First, utilization of 
services data did not represent an exhaustive review of all patients who participated in program 
services nor all staff members who provided services. Patient names were selected for auditing 
based on staff charting records, July 2014–June 2015 for group participation and January–June 
2015 for individual or family interaction. Four hundred chart audits were decidedly selected to 
allow for comparisons between groups—single-use participants, multiuse, and group users—
though more chart audits could have easily occurred. Selecting electronic health records for 
review in this manner was somewhat arbitrary and neglected many people may have participated 
in program services. For example, data did not include men who attended the prostate cancer 
support group since it was not facilitated by PSS staff. Data also did not accurately capture 
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family members who received support services since there was no way to verify information or 
collect data using electronic health records unless family members were also oncology patients. 
In other instances, PSS may have provided services to persons with cancer who were treated 
outside PRCP; for example, support groups were open to all persons with cancer and attracted 
people who have/had received treatment elsewhere, but live near PRCP and chose to participate 
in program services. Again, unless an electronic health record was available for review, these 
persons were not included in the analysis. Data was also not available for patients who received 
services from the Medical Director of Psychosocial Services or the social work intern who began 
working with the department midway through this evaluation. It would seem there were many 
exceptions to how data was collected for chart review and, thus, results did not wholly 
encompass program participants. Had utilization of services represented all patients who used 
program services during a one-year span, more inferences could have been made generalizing 
how services were utilized and by whom. For example, it may have been useful to know how 
many patients were served by PSS compared to all new cancer cases at PRCP. Instead of a 
comprehensive and exhaustive analysis of program utilization, observed trends were noted and 
recommendations made for further evaluation as indicated.  
The methodology used to collect survey data also contained shortcomings. For the most 
part, patient and staff surveys consisted of forced choice, Likert scales to easily capture 
respondents’ attitudes and opinions and to identify trends based on positive or negative feedback. 
A substantial limitation to forced choice responses on surveys was the dearth of specificity 
captured in responses. While forced choice surveys may have encouraged a high response rate 
given the relative ease of completing surveys, they lacked specificity and detail in their 
responses. In this evaluation, it would have been helpful to have more information when patients 
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or staff indicated areas of concern. Specific examples or scenarios illustrating areas of concern or 
criticism may have helped better inform treatment recommendation and ensure future changes 
address areas of concern based on feedback. Interviews were not conducted to limit the scope of 
this evaluation, though future interviews could explore areas of feedback more thoroughly to 
provide a more in-depth analysis of perceived areas of strength and weakness.  
While this evaluation focused specifically on services provided by Patient Support 
Services, other departments within integrative services were included in the data as well. 
Information about nutrition services, the Cancer Resource Center, and financial assistance were 
included given the proximity of those departments working with PSS. However, combining 
integrative services with PSS made it difficult to delineate which services were utilized and 
criticized at times. For example, some survey respondents indicated attending a support group, 
but listed the Look Good Feel Better class offered through the Cancer Resource Center, which is 
not facilitated by PSS staff. Additionally, financial assistance could refer to PSS staff helping 
patients apply for SSDI, completing an application for the Susan G. Komen breast cancer fund, 
or PRCP’s financial assistance fund, or, alternately, could refer to assistance provided by PRCP’s 
financial advisors who oversee insurance coverage and billing questions. Small distinctions in 
language may have also produced skewed results on survey questions. For example, the phrase 
“social work” was used to imply working with a PSS staff member to gather resources or help 
with financial assistance; however, respondents may have assumed that meeting with a social 
worker (verses psychologist or intern) for any reason (i.e., emotional support, family counseling) 
was “social work,” thus misrepresenting the services actually used. Respondents may have also 
struggled to differentiate between “emotional support during treatment” (meant to convey 
services received during infusion, radiation, or hospitalization) from “counseling” (meant to 
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convey individual or family psychotherapy or counseling generally received in the office). 
Again, a clear limitation of using surveys to collect data was that respondents were unable to ask 
for clarification and the evaluator was unable to ask respondents any follow up questions.  
 A final limitation of this evaluation was its intended scope. From the beginning, this 
formative evaluation sought to evaluate a part of PSS, not the summation of program services. 
Therefore, limitations of this evaluation were inherent given the finite scope of services reviewed 
for feedback. In the future, a summative evaluation may be conducted to further assess PSS’s 
value and to help program personnel make decisions concerning the program’s continuation or 
expansion (Fitzpatrick et al., 2004). Lastly, while this evaluation identified program strengths 
and recommendations to address areas of improvement, the organization is responsible for 
deciding whether to implement recommendations and to use evaluation findings as one tool in 
understanding and enhancing program services. 
Conclusion 
This program evaluation provided an overview of psychosocial services as they are 
utilized and valued by patients and staff. Nine years since the inception of Providence Regional 
Cancer Partnership, this evaluation took a first look at how Patient Support program services 
were utilized and by whom. Results identified program strengths indicated by areas well 
represented by patients. Patients with advanced stage cancer were highly represented among 
program participants as well as patients with presumed financial distress. Program 
recommendations were provided to improve areas underutilized and underrepresented by 
patients, in particular identifying the need to diversify program services to more closely reflect 
expected gender and cancer demographics compared to national prevalence rates (NCI, 2016) 
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and PRCP population statistics. Additionally, a proposal was made to further evaluate support 
groups based on utilization trends and mixed feedback. 
In addition to program utilization data, satisfaction surveys were distributed for the first 
time since 2009 providing feedback concerning areas of satisfaction and dissatisfaction.  Survey 
data revealed many program areas of strength and satisfaction including the department’s ability 
to provide emotional support, high quality and variety of program services, and the program’s 
overall value as part of a larger cancer treatment center. Areas for improvement were categorized 
into three themes reflecting shared concerns: patient education and outreach, program services 
and access, and PSS staffing. Thoughtful and informed recommendations were presented with 
collaboration from stakeholders to improve program services and further benefit PRCP’s patient 
population. Upon implementing recommendations, PSS may see remarkable differences in more 
than one area identified as a concern. For example, concerns regarding staff access and visibility 
may be resolved secondarily by improvements made to PRCP staff education, patient outreach, 
and program marketing. 
In general, this evaluation clarified areas of strength and areas recommended for 
improvement. During multiple stakeholder meetings, feedback was provided about the general 
efficacy of program services and the merit of Patient Support Services within the larger Cancer 
Partnership. Subsequently, results of this evaluation validated staff efforts to enact the mission of 
PSS: To provide psychosocial services to some of PRCP’s patients in greatest need. Results from 
this evaluation can be referred to throughout the program’s existence to monitor PSS’s adherence 
to the program’s goals and mission and to continue assessing its efficacy in providing program 
services that are well utilized and valued.  
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Appendix A 
NCCN Standards of Care for Distress Management  
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• Distress should be recognized, monitored, documented, and treated promptly at all stages 
of disease and in all settings.  
• Screening should identify the level and nature of the distress.  
• Ideally, patients should be screened for distress at every medical visit as a hallmark of 
patient-centered care. At a minimum, patients should be screened for distress at their 
initial visit, at appropriate intervals, and as clinically indicated, especially with changes in 
disease status (i.e., remission, recurrence, progression, treatment-related complications).  
• Distress should be assessed and managed according to clinical practice guidelines.  
• Interdisciplinary institutional committees should be formed to implement standards for 
distress management.  
• Educational and training programs should be developed to ensure that health care 
professionals and certified chaplains have knowledge and skills in the assessment and 
management of distress.  
• Licensed mental health professionals and certified chaplains experienced in psychosocial 
aspects of cancer should be readily available as staff members or by referral.  
• Medical care contracts should include reimbursement for services provided by mental 
health professionals.  
• Clinical health outcomes should include assessment of the psychosocial domain (e.g., 
quality of life and patient and family satisfaction).  
• Patients, families, and treatment teams should be informed that distress management is an 
integral part of total medical care and provided with appropriate information about 
psychosocial services in the treatment center and the community.  
• Quality of distress management programs/services should be included in institutional 
continuous quality improvement (CQI) projects.  
  (NCCN, 2016b, p. DIS-3) 
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Appendix B 
Providence Regional Cancer Partnership Organizational Chart  
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Appendix C 
 
Providence Regional Cancer Partnership Services Provided  
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Diagnostic Imaging 
Angiography 
Bronchoscopy  
Computerized Axial Tomography Scan  
Digital Radiography for Mammography 
Echocardiography 
Electromagnetic Navigational Bronchoscopy 
Low-dose CT Screening 
Magnetic Resonance Imaging 
Magnetic Resonance Mammography 
Mammography 
Mediastinoscopy  
Nuclear Medicine 
Positron Emission Tomography Scan 
Stereotactic Guided Biopsy 
Ultrasound  
 
Clinical Research 
Prevention 
Quality of Life 
Screening 
Treatment 
 
Medical Oncology 
Biotherapy 
Chemoembolization  
Hormone Therapy 
Immunotherapy 
Infusion Center with Chemotherapy 
Plasmapheresis  
 
Surgery 
Cryosurgery 
da Vinci Robotic Assisted Procedures 
DIEP Flap Breast Reconstruction  
Laparoscopic Surgery 
Limb Infusion 
Mammosite 
Microwave Ablation 
Sentinel Lymph Node Biopsy 
Ultrasonic Surgical Aspiration  
Video Assisted Thoracic Surgery  
 
Radiation Oncology  
3D Conformal Radiation Therapy  
Brachytherapy (High Dose Rate) 
Brachytherapy (Low Dose Rate) 
Computerized Treatment Planning 
Electron Beam 
External Beam Radiation Therapy 
Extracranial Radiosurgery 
MammoSite Radiation Therapy 
Image-Guided Radiation Therapy 
Intensity Modulated Radiation Therapy 
Linear Accelerator  
Prostate Seed Implant 
Respiratory Gating 
Stereotactic Radiosurgery 
Systemic Radioisotopes  
 
Support Services 
Acupuncture 
Advanced Care Planning  
Art Therapy  
Breast Pain Clinic 
Cancer Resource Center 
Caregiver and Family Counseling 
Classes and Support Groups 
Distress Assessment 
Integrative Medicine Services 
Fertility Counseling 
Financial Counseling 
Genetic Counseling and Testing 
Healing Spirit Boutique 
Home Care Program 
Hospice 
Lodging Assistance 
Mastectomy Education 
Mind-Body Medicine 
Naturopathic Medicine  
Nutrition Counseling 
Pain and Symptom Management 
Palliative Care Services 
Pastoral Care 
Patient Navigator Program 
Prosthetic Services  
Rehabilitation Therapy 
Smoking Cessation Program 
Survivorship Program 
Transportation Assistance 
Wellness Program  
Wound Care Clinic
(PRCP, 2014) 
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Appendix D 
Providence Regional Cancer Partnership Incidence of Cancer by Site and Gender 
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Primary Site # of Cases Male Female 
Brain 33 21 12 
Cranial nerves & nervous system 47 16 31 
Oral cavity & pharynx 40 35 5 
Esophagus  26 20 6 
Larynx 9 7 2 
Thyroid 44 19 25 
Other endocrine 20 9 11 
Lung 275 142 133 
Mesothelioma 4 4 0 
Breast 370 2 368 
Liver & intrahaptic bile duct 25 16 9 
Stomach  20 13 7 
Pancreas 36 15 21 
Kidney & renal pelvis 56 39 17 
Small intestine 4 4 0 
Colon 89 47 42 
Bladder 92 71 21 
Rectum & rectosigmoid 58 36 22 
Anus, anal canal, anorectum 9 1 8 
Cervix uteri 21 -- 21 
Corpus uteri 94 -- 94 
Ovary 35 -- 35 
Vulva 13 -- 13 
Prostate 105 105 -- 
Testis 17 17 -- 
Leukemias 47 15 7 
Lymphomas 82 50 42 
Multiple myeloma 24 17 7 
Melanoma 64 28 36 
Soft tissue 6 4 2 
Other  139 84 70 
TOTAL 1,904 837 1,067 
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Appendix E 
Providence Regional Cancer Partnership Incidence of Cancer by Site and Stage 
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Primary Site Stage I Stage II Stage III Stage IV 
Oral cavity & pharynx 2 1 4 32 
Esophagus  9 2 6 9 
Larynx 3 2 1 3 
Thyroid 24 3 9 7 
Lung 71 29 40 134 
Mesothelioma 1 1 0 1 
Breast 160 112 31 12 
Liver & intrahaptic bile duct 6 4 4 10 
Stomach  5 3 4 8 
Pancreas 3 7 2 23 
Kidney & renal pelvis 30 6 8 9 
Small intestine 0 0 2 2 
Colon 20 24 20 22 
Bladder 19 10 4 9 
Rectum & rectosigmoid 12 17 13 13 
Anus, anal canal, anorectum 5 2 1 0 
Cervix uteri 10 3 4 3 
Corpus uteri 74 3 9 7 
Ovary 5 7 16 6 
Vulva 7 0 0 2 
Prostate 16 53 20 16 
Testis 17 0 0 0 
Lymphomas 23 19 16 34 
Melanoma 32 12 7 3 
Soft tissue 3 1 1 1 
Other  4 5 12 9 
TOTAL 561 326 234 375 
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Appendix F 
Providence Regional Cancer Partnership Incidence of Cancer by Site and Primary Payer Report 
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Primary Site Private Medicaid Medicare 
Brain 19 3 11 
Cranial nerves & nervous system 18 3 23 
Oral cavity & pharynx 24 1 12 
Esophagus  11 0 15 
Larynx 4 2 3 
Thyroid 31 2 11 
Other endocrine 9 3 7 
Lung 68 19 185 
Mesothelioma 1 0 3 
Breast 189 34 147 
Liver & intrahaptic bile duct 4 3 18 
Stomach  11 0 9 
Pancreas 10 3 23 
Kidney & renal pelvis 17 3 35 
Small intestine 1 1 2 
Colon 37 5 47 
Bladder 26 5 60 
Rectum & rectosigmoid 27 2 27 
Anus, anal canal, anorectum 2 1 6 
Cervix uteri 13 3 5 
Corpus uteri 29 10 52 
Ovary 13 3 18 
Vulva 0 1 12 
Prostate 37 8 57 
Testis 11 2 0 
Leukemias 16 3 27 
Lymphomas 30 9 52 
Multiple myeloma 4 2 18 
Melanoma 28 4 31 
Soft tissue 4 0 2 
Other  31 7 84 
TOTAL 725 142 1,002 
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Appendix G 
 
Psychosocial Services Policy and Procedures: Access to Psychosocial Services  
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PURPOSE 
The purpose is to ensure that all patients, family members, and caregivers have access to 
psychosocial services. Psychosocial services are essential components of comprehensive cancer 
care and are provided to patients with cancer and their caregivers throughout the continuum of 
care. These services address physical, psychological, social, spiritual, and financial support needs 
that result from a cancer diagnosis and help ensure the best possible outcome.  
 
PSYCHOSOCIAL SERVICE PROVIDERS 
A variety of psychosocial services are available on-site, most at no cost, to all patients and their 
caregivers. These services are provided by the following disciplines:  
• Chaplain 
• Psychologist 
• Clinical social worker 
• Registered dietician 
• Interns in the fields of clinical psychology and social work 
• Financial counselors 
• Clinical nurse specialist 
• American Cancer Society volunteers 
 
POLICY 
• All patients, family members, and caregivers have access to the full range of 
psychosocial services 
• Individuals who are not receiving treatment at PRCP are also welcome to attend the 
support groups and classes at PRCP 
• Patients may be referred for services by their physician, nurse, or any staff member  
• Patients and caregivers may self-refer for all groups, classes, and individual services 
• If the needed service is not available on-site, Patient Support staff will provide 
appropriate community referrals 
• Both on-site and community resources are available on the PRCP website. Brochures and 
flyers outlining the available services are available and displayed on each floor of the 
Cancer Partnership, as well as in the Cancer Resource Center  
• Each patient’s needs for services are routinely monitored through the use of the distress 
assessment tool 
• Once a need is identified, the patient will be informed of available services either by 
phone, in person, or by mail  
 
DOCUMENTATION  
• Support group attendance is reported monthly to the Cancer Partnership administration 
• Individual services are documented as notes in the patient’s electronic health record  
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AVAILABLE GROUPS AND RESOURCES 
The following is a list of services typically available on-site. Specific groups are subject to 
change based on the current needs and requests of patients at any given time.  
• Supportive counseling 
• Support groups  
• Assistance with resources 
• Spiritual support 
• Assistance with Advanced Directive, Living Will, and Durable Power of Attorney for 
Health Care 
• Nutritional counseling 
• Financial counseling and assistance for uninsured and underinsured patients 
(PRCP, 2012c) 
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Appendix H 
 
Providence Regional Cancer Partnership Support Resources  
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Support resources add an extra dimension of care to fight your cancer and promote your health 
on every level—body, mind and spirit. You can count on the attention and knowledge of leading 
practitioners in their fields who are devoted to helping you feel better and get better.   
 
Cancer Resource Center 
The Cancer Resource Center is a quiet, comfortable place for patients, families and caregivers to 
find information on cancer, log on to the internet, or talk with a Patient Navigator or volunteer. 
It’s also a convenient source for the latest information on cancer tests, treatments, clinical trials, 
and local resources for support groups and transportation services. A wide variety of literature on 
cancer and treatment is here for you, free of charge. 
 
Patient Navigator  
At the Cancer Partnership, you’ll have a Patient Navigator who is dedicated to answering 
questions, providing resources and suggesting support services throughout your treatment 
and beyond. This highly-trained cancer expert is part of the American Cancer Society 
Patient Navigator Program, a respected network that follows national standards, offers 
extensive training, and serves patients at more than 60 sites around the country. 
The Patient Navigator is here to listen, care and help, so you never have to wonder where 
to turn. You can count on your Patient Navigator to: 
• Provide information on what to expect during chemotherapy and radiation, and on 
dealing with any side effects of treatment. 
• Share resources with you for financial assistance, medication needs, home health 
care, insurance, transportation and other concerns. 
• Refer you to groups, classes and support programs. 
• Connect you with helpful resources in your community. 
• Suggest activities that can help ensure a better quality of life both during and after 
treatment. 
 
Healing Spirit Boutique 
The Healing Spirit Boutique is a special place in the hearts of many cancer patients. It is 
here to provide free hats, wigs and understanding to patients experiencing appearance-
related changes during cancer treatment. The boutique is staffed by volunteers who are 
experienced in finding and fitting the right style and hair color of wig, along with 
complementary cosmetics.  
 
Classes 
Classes at the Cancer Partnership are open to all patients, family members, friends and 
caregivers. They’re a great way to build your support network and engage in the healing process 
with others who understand. Classes are also open to the general public and to cancer patients 
who are not patients of the Cancer Partnership. 
 
Art therapy 
Art therapy increases your awareness of yourself and others and is a great therapeutic tool 
for cancer patients. It is fun and life-affirming, and enhances cognitive abilities.  This 
class offers a supportive, non-judgmental environment, and no artistic ability is 
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required.  Our art therapists, trained in both art and therapy, offer guidance and support, 
as well the opportunity to explore a variety of art materials.  
 
Gentle yoga 
Reconnect with your body and learn how to be gentle with yourself in a fun, 
noncompetitive environment. Wear comfortable clothes, and bring a mat and water 
bottle. This non-aerobic form of exercise concentrates on movements and deep breathing. 
It can help reduce stress and fatigue, as well as improve sleep. Exercise promotes healing 
and well-being during cancer treatment and can help accelerate your long-term recovery 
process. 
 
Look good. Feel better. 
The name of this unique program says it all. Sponsored by American Cancer Society, it’s 
designed for women going through the effects of cancer treatment. Classes focus on skin 
and hair care, cosmetics, wigs and head wraps, dealing with hair loss, and getting healthy 
nutrition. Cosmetic samples and makeovers are available. All cosmetic products for your 
makeover are complimentary and provided for you to enjoy and take home with you. 
 
Nutrition 
Learn about the foods that can strengthen your immune system, improve your energy, 
and maintain a healthy weight. Our free monthly nutrition class is dedicated to helping 
patients, survivors, family members and other caregivers improve their health through 
better eating. 
 
Counseling Services 
When you receive a cancer diagnosis, it’s natural to have questions and concerns. You may also 
need some extra support for yourself and your loved ones. After all, a cancer diagnosis affects 
everyone in the family in many ways. 
 
Our Patient Support Services Team is available by appointment to provide one-to-one counseling 
and help you address any of the following concerns: 
• Coping with a new diagnosis, treatment or recurrence 
• Creating a care team at home 
• Family communication 
• Support in making difficult treatment decisions 
• Self-care for patients and caregivers 
• Stress management 
• Identifying resources 
• Anxiety and depression 
• Grief and loss 
• Survivorship concerns 
• End of life concerns 
 
Individual, group, and family counseling services are also available at no cost to Cancer 
Partnership patients and family members. Counseling services are provided by Masters-level 
trained clinicians working closely with cancer patients and their families. They’re good listeners 
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and problem-solvers who are here to address the psychological, social, cultural, financial and 
continuing care needs of you and your family.  
 
Financial Counseling 
We believe everyone should have access to quality healthcare. If the financial side of cancer 
treatment is a worry for you, we encourage you to talk with our financial counselors. Financial 
counselors verify benefits, help develop a payment plan for treatment, and obtain outside 
assistance if necessary. 
 
Patient Assistance Fund  
The Linda Baltzell Patient Assistance Fund (PAF) was established in 1978 for patients 
who needed financial support, particularly paying their medical bills while they were 
receiving radiation treatments. The PAF today supports Cancer Partnership patients who 
are receiving chemotherapy and/or radiation and need financial assistance with rent, gas, 
groceries, medication, clothing, etc. (PRCP, 2015a). 
 
Integrative Medicine  
Integrative medicine offers a unique approach to healing. Services include a variety of 
complementary treatment options so patients are able to achieve maximum benefit and symptom 
relief. Care is coordinated with patient’s chemotherapy and radiation treatment (PRCP, 2014).  
 
Naturopathic Medicine 
Naturopathic medicine is based on the knowledge that the human body has a natural healing 
ability, and that much can be done to enlist it in your care. Naturopathic doctors work with their 
patients to use diet, exercise, lifestyle changes and leading-edge natural therapies to improve 
their bodies’ ability to combat disease and decrease side effects of treatment. Naturopathic 
services include: 
• Nutrition 
• Natural medicines (vitamins, minerals, botanicals) 
• Acupuncture / Acupressure 
• Risk reduction for cancer recurrence 
• Re-establishing health 
• Counseling 
 
Nutrition Counseling 
Nutrition counseling is provided for specific disease and symptoms to decrease the side 
effects of treatment. Vitamins and supplements are also addressed.  
 
Acupuncture 
Of all the support services we offer, acupuncture is one of the most often requested. For 
many of our patients and their referring oncologists, it plays a valuable role in addressing 
cancer from every angle. Studies show that acupuncture can help relieve cancer’s 
symptoms and the side effects of treatment, including nausea, vomiting, fatigue and 
stress. 
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We make the best acupuncture available to you through our collaboration with Bastyr 
University, a national leader in natural health arts and sciences education and research. If 
you’re interested in making acupuncture part of your personal treatment plan, please talk 
with your doctor or nurse. 
 
Mindy-Body Medicine 
Mindy-Body medicine is a field of medicine that uses the powers of the mind to enhance 
physical and emotional health. Patients learn to use the mind’s healing abilities to relieve 
stress, manage symptoms, help with sleep, and restore mind, body, and spirit. Hypnosis, 
biofeedback, and relaxation techniques are taught.  
 
Wellness Consults 
Wellness consults are provided through the naturopathic medicine provider. Learn what 
steps to take after you are finished with treatment to return to wellness.  
 
Language Support 
For patients and their families who speak little or no English, we offer a toll-free telephone 
interpreter service. We invite patients to use this service to make appointments and related phone 
calls. Family members may use the service to call a loved one who is a patient in the hospital. 
 
Palliative Care 
Palliative care is dedicated to managing disease and treatment-related symptoms that help 
preserve quality of life for patients during all stages of serious illness. Our Palliative Care team 
includes nursing support through Partners in Palliative Care, together with medical care from our 
Palliative Care physician and Advance Registered Nurse Practitioner. These clinicians work 
together with your oncologist and the Patient Support Services Team to provide comprehensive 
care for the physical, emotional and spiritual needs of you and your family—always with your 
permission and your input. Palliative care is here to help in many ways, including: 
• Managing pain and other symptoms 
• Improving communication with your health care team, if needed 
• Identifying goals of care 
• Providing information about Advanced Directives 
• Addressing home care needs 
• Maintaining quality of life 
 
Spiritual Care 
Spirituality means different things to each of us—but for many people, it’s an essential part of 
getting through a difficult time in life. 
 
The chaplains at the adjacent Providence Regional Medical Center are available to help you 
through any emotional or spiritual aspects of your treatment. Professionally trained and board-
certified, they are great listeners who do everything possible to support you and your family 
regardless of your religious beliefs. We strongly believe in respecting the cultural and spiritual 
diversity of those we serve. 
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Support Groups  
Studies show what cancer patients know from their own personal experience: A support group 
can often play a valuable role in helping you feel better and get better. A good support group can 
be a powerful source of information, help, encouragement and understanding throughout your 
cancer treatment—for you and your loved ones. We offer a number of free, ongoing support 
groups here. 
Retrieved from http://www.cancerpartnership.org/Support-Resources.aspx 
(PRCP, n.d.) 
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Appendix I 
 
Patient Support Services: Classes and Support Groups  
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Art Therapy Group 
Art therapy increases your awareness of yourself and others and is a great therapeutic tool for 
cancer patients. It is fun and life-affirming, and enhances cognitive abilities. This class offers a 
supportive, non-judgmental environment, and no artistic ability is required. Our art therapists, 
trained in both art and therapy, offer guidance and support, as well the opportunity to explore a 
variety of art materials. 
 
Women with Cancer Support Group 
Previously the Breast Cancer Support Group 
A support group for women who have or have had cancer. Connect with other women to 
maintain a positive focus and self-image and to build a support network. Topics include coping 
and relaxation strategies, breast cancer education, adjusting to change and guest speakers on a 
variety of topics.  
 
Breast Cancer Support Group 
For breast cancer patients and survivors to connect with each other and to maintain a 
positive focus and self-image, building a support network, and learn coping and 
relaxation strategies.  
 
Young Breast Cancer Support Group 
A support group for women who have or have had breast cancer. This group is target at women 
who are in their 20’s, 20’s, and 40’s. Facilitated by an Oncology Social Worker. 
 
Gentle Yoga 
Reconnect with your body and learn how to be gentle with yourself in a fun, noncompetitive 
environment. This non-aerobic form of exercise concentrates on movements and deep breathing. 
It can help reduce stress and fatigue, as well as improve sleep. Exercise promotes healing and 
well-being during cancer treatment and can help accelerate your long-term recovery process. 
Facilitated by oncology yoga instructors. First five sessions are free.  
 
Look Good… Feel Better 
Sponsored by the American Cancer Society, this class is designed for women going through the 
effects of cancer treatment. The class focuses on skin and hair care, cosmetics, wigs and head 
wraps, dealing with hair loss, and getting healthy nutrition. Cosmetic samples and makeovers are 
available. All cosmetic products for your makeover are complimentary and provided for you to 
enjoy and take home with you. Registration required.  
 
Nutrition Class 
Learn about the foods that can strengthen your immune system, improve your energy, and 
maintain a healthy weight. Our free nutrition class is dedicated to helping patients, survivors, 
family members and other caregivers improve their health through better eating. Facilitated by a 
registered dietician.  
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Man-to Man Prostate Cancer Support Group 
This group offers education and information sharing exclusively for men who have been 
diagnosed with, or who have had, prostate cancer. Facilitated by a cancer survivor contracted by 
Providence Regional Medical Center.  
 
Support Group for Cancer Patients and Survivors 
Combines two previous support groups: Caregiver Support Group and Support Group for 
Patients with Metastatic Disease  
This support group is open to all cancer patients and survivors who have been diagnosed with 
any type of cancer. Members offer each other comfort, support, information, and suggestions for 
coping with potential challenges during and after treatment. Discussions may include developing 
a resiliency plan, work issues, designing a holistic health plan, finding hope and meaning, 
adjusting to effects of treatment, and building a support network.  
 
Caregiver Support Group 
This group teaches caregivers how to support someone with cancer while still taking care 
of themselves. Make time for yourself, maintain a positive focus, build a support network, 
learn coping and relaxation strategies, and more.  
 
Support Group for Patients with Metastatic Disease (Advanced Cancer) 
This group focuses on living with cancer and what it means to have metastatic disease. 
The discussion includes topics such addressing pain and other symptoms, increasing 
quality of life, managing treatment’s late effects, talking to your family, getting the help 
you need, and interpreting medical information.  
 
Tai Chi Self-Cultivation  
Re-experience your mind and body through the practice of relaxing meditative movements. 
Participants will also receive information and learn how to promote self-care through positive 
psychology.  
 
Survivorship Series Program  
This eight-week services will give you ideas on maximizing your resources and strengths to help 
you adjust to life after treatment. As part of your own health care team, you will be given the 
opportunity to identify a wellness plan that is best for you. Registration required.  
(PRCP, 2015b) 
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Appendix J 
Psychosocial Services Policy and Procedures: Psychosocial Distress Screening  
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PURPOSE 
To comply with Standard 3.2, American College of Surgeons, Commission on Cancer. The 
importance of screening patients for distress and psychosocial health is a critical step in 
providing high-quality cancer care. The purpose of this policy is to assure that distress is 
recognized, monitored, documented and treated promptly at all stages of the disease. A standard 
process is in place to incorporate distress screening into the standard of care for oncology 
patients and provide patients identified with distress with appropriate resources or referrals.  
 
The Medical Director of Psychosocial Services oversees this activity and reports to the cancer 
committee annually.  
 
PROCESS 
Timing of Screening and Method  
All patients diagnosed with cancer who seek treatment at PRCP are screened for distress a 
minimum of one time per treatment episode, although multiple screenings are scheduled for each 
patient. Due to the differential nature of radiation and chemotherapy treatment protocols, a 
distress screening protocol was developed for each. A standard patient questionnaire is used with 
all patients. If a patient is unable to read or use the paper form for any reason, clinical staff will 
verbally administer the screening.  
 
Radiation Oncology patients receive the distress assessment the day of their intake appointment 
with the nurse. This is completed with the nurse intake. The front desk receptionist gives the 
form to the nurse who reviews it and incorporates it into the nurse intake. The nurse then initials 
the distress assessment and puts it in the patient support box at the front desk. Patient Support 
staff review the distress assessment forms daily, take necessary action, then take the forms to 
medial records to be scanned into the patient’s chart.  
 
Medical Oncology patients receive a distress assessment each time they are scheduled for both 
an office visit with a provider (MD, ARNP, or PA) and infusion treatment. The front desk 
receptionist gives the form to the patient to fill out in the reception area. The patient gives the 
completed distress assessment form to the medical assistant who documents the level of distress 
in the medial record and leaves the completed form for the provider to incorporate into their 
visit. The form is then put into the patient support box at the nursing station. Patient Support staff 
review the distress assessment forms daily, take action, then take the forms to be scanned into the 
patient’s chart.  
 
Tools  
A distress measure was developed based on the NCCN Screening Tool for Measuring Distress. 
Patients who meet the following criteria using this measure receive further evaluation for follow-
up care:  
• Distress rated at or above 5 on a 1–10 scale (unless the box marked “No follow-up is 
needed at this time” is checked) 
• Emotional, spiritual, family, or other concerns checked (unless the box marked “No 
follow-up is needed at this time” is checked) 
• Any level of distress if the patient checks the box stating “I wish to be contacted 
regarding my concerns” 
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Assessment and Referral 
If there is evidence of moderate or severe distress, as determined by the distress assessment 
questionnaire or by a member of the oncology team, further assessment will be done by a 
member of the Patient Support team within 72 hours. Assessment is done to determine if there 
are any psychological, behavioral, social, practical, financial, or spiritual problems that might 
interfere with the patient’s ability to participate fully in their healthcare and adequately manage 
their illness.  
 
Distress assessment questionnaires are collected each day and patients identified as needing 
follow-up are contacted either in person or by phone. In some instances patients are not 
contacted directly but are mailed information if they identify low levels of distress but indicate a 
desire for more information about specific supportive services such as available classes or 
support groups.  
 
If the patient is in severe distress and needs to see someone immediately, any staff member may 
call the patient support pager. A patient support staff member will respond and assess the need 
for service.  
 
Documentation  
Distress screening and follow-up is documented in the patient’s medical record. The distress 
assessment form is scanned into the record. All contact with patients, whether in person or by 
phone, are documented as clinical notes.  
 
COMPLIANCE 
A quality measure has been established to assure that patients are screened for distress. Each 
month a sample of at least 30 new treatment patients are identified. Each patient’s medical record 
is reviewed for documentation of a distress screening within 30 days of the start of a treatment 
episode. The standard is that 95% of new treatment patients will have a documented distress 
screening within 30 days.  
(PRCP, 2012b) 
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Appendix K 
 
Providence Regional Cancer Partnership Distress Assessment Tool 
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Please circle the number that best describes how much distress you have been 
experiencing in the past week including today.  
 
No 
Distress 
          Extreme 
Distress           
   
                         0        1        2       3        4        5       6       7        8        9       10 
 
 
  
  I wish to be contacted regarding my concerns 
  No follow up needed at this time 
 
 
 
Practical Concerns 
 Insurance 
 Unable to pay bills 
 Legal (POA, living wills, etc) 
 School/Work 
 Transportation 
 Housing 
 Child care 
 Chores 
 Bathing/dressing 
 Sleep 
 Respite care 
 
Family Problems 
 Dealing with children 
 Dealing with partner 
 Intimacy/Sexuality 
 
Spirituality 
 Spiritual support 
 Questions of faith 
 
 
 
 
Emotional Problems 
 Depression 
 Fears/Worry 
 Nervousness 
 Sadness 
 Loss of interest in usual 
activities 
 
Other problems or concerns   
     
  
 
 
I would like information about: 
 Social Security benefits 
 Medicaid benefits 
 Medicare benefits 
 Nutrition 
 Exercise & movement 
 Hospice 
 Support groups 
 Other     
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Appendix L 
 
Providence Regional Cancer Partnership Committees Supporting Goals  
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Multidisciplinary Cancer Committee (MDCC) 
Chair: Elie Saikaly, MD 
Meets quarterly and is charged with ensuring compliance with ACoS standards for all the Cancer 
Programs. 
 
Multidisciplinary Cancer Committee Quality Assurance (MDCC QA) 
Chair: Elie Saikaly, MD 
Meets quarterly and is charged with ensuring, tracking, and reporting of all quality assurance and 
improvement activities for all the Cancer Programs.  
 
Cancer Executive Committee 
Chair: Elie Saikaly, MD 
Meets monthly as the strategic and business development forum for the Cancer Program.  
 
Integrative Medicine Committee 
Chair: Cheryl Beighle, MD 
Meets quarterly to educate and develop programs for patients.  
 
Lung Task Force 
Chair: Kimberly Costas, MD 
Meets monthly to identify and implement multidisciplinary best practices for lung cancer 
patients to reduce time from diagnosis to treatment. 
 
Medical Directors Meeting 
Chair: Elie Saikaly, MD 
Meets quarterly to oversee the operational management of the Cancer Partnership. 
 
Psychosocial Committee 
Chair: Kathryn Johnson, PhD 
Meets quarterly to plan and implement program and service development to meet cancer 
patients’ psychosocial needs. 
 
Survivorship Steering Committee 
Chair: Dawn Dickson, MSW, LICSW 
Meets quarterly to plan and implement a Survivorship Program offered at Providence Regional 
Cancer Partnership 
(PRCP Annual Report, 2012a) 		 	
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Appendix M 
Proposed Program Evaluation of Patient Support Services Stakeholder Brainstorming Meeting 
 
  
		
 
165 
The following summary information was generated during an initial brainstorming meeting with 
identified stakeholders during PRCP’s fall quarterly Psychosocial Steering Committee meeting.  
 
ATTENDEES  
Kathryn Johnson, PhD, Julie MacDougall, Kelly Mardesich, RN, Kathy Reiff, Elie Saikaly, MD, 
Margaret Salmassy, Gerald Vasquez, Justine Colombo, MSW, Mary Jo Sarver, RN, Carrie 
Pilger, and Kristoffer Rouse 
 
PRCP VISION 
 “A comprehensive, regional, state-of-the-art, single destination designed exclusively for the 
cancer patient and family with integrated and seamless clinical, operational and business 
processes.”   
 
PROGRAM EVALUATION 
Definition  
Program Evaluation addresses professional issues through the use of evaluation design, problem 
formation, methodology, analysis of relevant quantitative and/or qualitative data, and report of 
findings in a constructive fashion. It may include questions pertaining to program utilization, 
implementation, fine-tuning, and effectiveness.  
 
Purpose  
To judge the merit or worth of a program and provide information for program improvement. 
Audience is generally people delivering the program or people who are in a position to make 
changes in the program and its day-to-day operations.  Questions typically asked: What is 
working? What needs to be improved? How can it be improved? 
 
BRAINSTORMING PHASE 
What aspects of the program should be evaluated? From a patient perspective, what should be 
evaluated? 
• Elie: What is the purpose and value of PSS? Can a new intervention be added to PSS? 
• Justine: What is the current patient experience?  How do program services affect staff 
members? What is the cost and/or time savings on providers and the institution as a result 
of PSS? 
• Mary Jo: What is the utilization of services among different types of cancer? 
• Margaret: How does PRCP compare to other Providence cancer programs? 
• Kathryn: How effective is the model of care based on current staffing? How does our 
model of care compare to other cancer programs? What is the difference between people 
who receive program services and those who do not? Is our mission still accurate? Are 
we doing what we said we would and are we doing it well? 
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Appendix N 
Logic Model: If…Then Assumptions  
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Note. From “Logic Model Development Guide” by W. K. Kellogg Foundation, 2004b, p. 3. 
Reprinted with permission.   
Input  
• If you have 
access to 
certain 
resources, 
then you 
can use 
them to 
accomplish 
your 
planned 
activities 
Output 
• If you 
accomplish 
your 
planned 
activities, 
then you 
can deliver 
the product 
or service 
you intend 
Outcome 
• If you 
accopmlish 
your 
planned 
activites, 
then your 
participants 
will benefit 
in specific 
ways 
Impact 
• If benefits to 
partipants are 
achieved, 
then changes 
in systems 
might occur 
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Appendix O 
Outcomes Approach Logic Model  
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Program Rationale: Persons affected by cancer experience psychosocial distress 
  
 
Planned Work      Intended Results 
Note. Adopted from W. K. Kellogg Foundation (2004b, p. 54). 
 
Input/Activities: Describes the activities conducted in the program. May include 
products, services, and infrastructure.  
Outputs: Refers to the direct results produced by a program activity. Usually quantified 
in terms of size and/or scope of the services delivered or products produced.  
Outcomes: Refers to short-term and long-term outcomes expected as a result of each 
activity implemented. May include individual changes in attitude, behavior, knowledge, 
skills, status, or level of functioning.  
Impacts: Refers to the results expected 7–10 years after an activity has been 
implemented. Reflects the impact activities and subsequent results have on an 
organizational, community, or systems level. May include improved program conditions, 
expanded services, or changes in policy and procedures. (W. K. Kellogg Foundation, 
2004b, p. 8) 
 
 
 
Input 
Patient Support 
Services 
• Individual, 
couples, & family 
counseling 
• Support groups 
• Crisis intervention 
& safety 
assessment 
• Formal/informal 
assessment  
• Psychoeducation  
• Consultation 
• Community 
resourcing & 
outside referrals 
Output 
• Number (#) of 
patients served 
annually 
• Number (#) of 
annual ER visits 
•  Utilization (%) of 
PSS services 
• Distress 
Assessment 
questionnaires 
• Satisfaction 
interviews 
Outcomes 
Short-term (1-3 
years) 
• Manage & triage 
psychosocial 
distress  
• Decrease annual 
ER visits  
• Increase treatment 
compliance  
• Increase staff and 
patient satisfaction 
Outcomes 
Long-term (4-6 
years) 
• Increase cost & 
time savings 
• Increase 
department 
referrals 
Impact 
(7-10 years) 
• Increase annual 
number (#) of 
patients served 
• Increase program 
services & 
utilization of 
services 
• Increase funding 
opportunities 
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Appendix P 
Patient Support Services Patient Satisfaction Survey 
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We are interested in your feedback about our services.  Please take a moment to complete this 
survey and return it to any reception desk or suggestion box.  Thank you! 
 
Are you a patient receiving treatment or a friend/family member? o Patient 
        o Friend or family  
 
Have you heard about the services available through the Patient Support Services Department? 
(counseling, social work, nutrition, support groups, etc.)    Please check one: 
o I am well informed 
o I have some limited knowledge and know where to go if I need to 
o I could use more information 
o I have never heard about Patient Support  
 
Gender: o Male o Female 
 
Age: o 18–25 o 26–34 o 35–44 
 o 45–54 o 55–64 o 65–74 o 75+ 
 
Marital Status: o Single  o Married or Domestic Partner   
 o Separated o Divorced  o Widowed 
 
Race/Ethnicity: o Caucasian/White  o Hispanic/Latino  
 o African American/Black o Asian/Pacific Islander 
 o American Indian/Alaska Native o Other _______________ 
 
What year did you start treatment at Providence Regional Cancer Partnership? _______ 
 
What type of cancer is being treated?  Please select all that apply: 
 
o Aids-related Cancer o Gestational  o Non-Hodgkin's     
o Bladder Cancer      Trophoblastic Cancer      Lymphoma 
o Bone Cancer o Head and Neck Cancer o Ovarian Cancer 
o Brain Tumor o Hodgkin's Lymphoma o Pancreatic Cancer 
o Breast Cancer o Kidney Cancer o Prostate Cancer 
o Cervical Cancer o Leukemia o Skin Cancer 
o Colorectal Cancer o Liver Cancer o Soft Tissue Sarcoma 
o Endometrial Cancer o Lung Cancer o Uterine Cancer 
o Esophageal Cancer o Malignant Mesothelioma o Other: ______________ 
o Gallbladder Cancer o Melanoma ______________________ 
o Gastrointestinal Tumor o Multiple Myeloma  
 
Stage of cancer:  o 0     o I     o II     o III     o IV     o  Unknown  o N/A 
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What treatment(s) have been received during the past 12 months? Select all that apply: 
o Biopsy   o Palliative Care 
o Hormone Treatment  o Hospice 
o Radiation    o Clinical Research Trial 
o Surgery   o Calmare Pain Therapy Treatment 
o Chemotherapy   o Observation Only 
o Other       
 
Have you used Patient Support Services at any point during treatment at Providence 
Regional Cancer Partnership?   Please check one: oYes o No  
If so, which services have you used? Please check all that apply:  
o emotional support during treatment (infusion, radiation, hospitalization) 
o counseling with a PSS staff member (psychologist, social worker, intern) 
o attending a support group: which group(s)?      
o social work, resources, or financial assistance 
o other          
 
How likely are you to use or continue using Patient Support Services during your 
treatment at Providence Regional Cancer Partnership? 
oVery Likely     oSomewhat Likely     oMaybe      oSomewhat Unlikely     oVery Unlikely  
 
How satisfied have you been with the quality of services provided by Patient Support? 
o Satisfied  oSomewhat Satisfied     oNeutral  oSomewhat Dissatisfied oDissatisfied  
 
How satisfied have you been the variety of services provided by Patient Support? 
o Satisfied  oSomewhat Satisfied     oNeutral  oSomewhat Dissatisfied oDissatisfied  
 
How satisfied have you been with Patient Support Services staff access and responsiveness? 
o Satisfied  oSomewhat Satisfied     oNeutral  oSomewhat Dissatisfied oDissatisfied  
 
Do you consider Patient Support Services a valuable part of your cancer treatment at 
Providence Regional Cancer Partnership? 
oStrongly Agree   oAgree oNeutral  oDisagree oStrongly Disagree 
 
How likely are you to recommend Patient Support Services to other patients or family 
members? 
oVery Likely     oSomewhat Likely     oMaybe      oSomewhat Unlikely     oVery Unlikely  
 
In your experience, which Patient Support Services have been most helpful?  
Please select one: 
o Emotional support provided in the office or during treatment 
o Support group opportunities 
o Access to resources and financial support  
o Other: ______________________ 
 
What else could Patient Support Services do to improve services?  
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Appendix Q 
Patient Support Services Staff Satisfaction Survey 
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Number of years employed at PRCP: 
□< 1   □1–2  □3–4  □ 5–6  □ 8–9 
 
Position: □MD  □ACP  □RN   □MA   
□Other Clinical Staff □ Support Staff  □ Administration  
 
1. How familiar are you with the services offered by Patient Support? 
□  □  □  □  □ 
5   4  3  2  1 
Very   Somewhat   Not At All 
 
2. How often do you refer patients or family members to Patient Support Services? 
□  □  □  □  □ 
5  4  3  2  1 
Very Often   Sometimes   Not At All 
 
3. In what types of situations do you typically refer patients to PSS? Please select all that apply:  
□ Not applicable: I don’t refer patients in my position  
□ When a patient appears upset or distraught  
□ When a patient receives upsetting news  
□ When a family member has concerns or needs support 
□ When a patient has difficulty understanding diagnosis, prognosis, or treatment options 
□ When a patient appears cognitively impaired or has difficulty comprehending 
information  
□ When a patient’s health begins to decline  
□ When a patient has complex medical and/or psychosocial needs 
□ When a patient appears at risk of self-harm or injury (i.e., intoxication, suicidality, 
domestic violence, vulnerable adult abuse) 
□ When a patient has upset staff or other patients  
□ When a patient has financial concerns   
□ When a patient has transportation concerns  
□ When a patient would benefit from a nutrition consultation  
□ When a patient would benefit from additional time or attention from staff 
□ Other: ___________________________________________ 
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4. What PSS resources do you usually recommend to patients? Please select all that apply:  
□ Financial/resources   □ Support groups 
□ Counseling   □ Social Work    
□ Cognitive testing   □ Cancer Resource Center  
□ Nutrition    □ Not applicable 
□ Other: ____________________ 
 
5. Do you consider Patient Support Services a valuable part of PRCP’s cancer treatment 
program?  
□  □  □  □  □ 
5  4  3  2  1 
Very Much   Somewhat   Not Really 
   
6. Do you think Patient Support Services positively affects treatment outcomes for patients?  
□  □  □  □  □ 
5   4  3  2  1 
Very Much   Somewhat   Not Really 
 
7. Research suggests several benefits when psychosocial services are offered along side cancer 
treatment. In your opinion, what outcomes might be likely to happen, in part because a 
patient has participated in Patient Support Services? Please select all that apply:  
□ Reduced risk of developing more severe emotional distress or disorders 
□ Improved ability to cope with expected distress throughout cancer treatment  
□ Improved overall health and level of functioning 
□ Improved satisfaction with the services available for cancer care  
□ Increased treatment compliance and follow up care  
□ Reduced workload for treatment providers or support staff  
□ Lower use of unnecessary medical or emergency services 
□ Reduced financial costs of our larger medical system 
 
8. What do you think the Patient Support Services team does particularly well? Please select all 
that apply:  
□ Assesses psychosocial needs  
□ Facilitates support groups 
□ Provides emotional support to patients and family members  
□ Provides crisis intervention or urgent risk assessment 
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□ Helps manage or triage patients with high acuity or psychosocial distress  
□ Other __________________________________ 
 
9. What can Patient Support Services do to improve its services? Please select all that apply:  
□ Increase staff access during business hours  
□ Improve staff response time for urgent needs  
□ Offer support groups more frequently  
□ Offer more support service options  
□ Generate revenue or funding opportunities for the cancer center  
□ Offer publicity or marketing within our community to recruit patients  
□ Nothing! Keep doing what you’re doing! 
□ I’m not sure  
□ Other: ______________________________________________ 
 
If you would be willing to be contacted for a brief, informal interview to say more about your 
experience utilizing Patient Support Services, please provide your name for follow up:  
 
 
____________________________________________________________________________ 
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Providence Regional Cancer Partnership Executive Summary 
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EXECUTIVE SUMMARY 
PROGRAM EVALUATION OF PSYCHOSOCIAL SUPPORT SERVICES AT PROVIDENCE 
REGIONAL CANCER PARTNERSHIP- MAY 2016  
NICOLA B. MUCCI, MA, LMHC  
 
EVALUATION PURPOSE AND EVALUATION QUESTIONS 
The purpose of this program evaluation was to better understand (a) how patients utilize Patient Support 
Services and (b) what patients and staff value about program services. This evaluation sought to provide 
an overview of program services as they are currently utilized and to offer informed program 
recommendations based on identified areas of satisfaction and dissatisfaction.  
 
EVALUATION DESIGN AND METHODS  
UTILIZATION OF SERVICES  
• EHR audits: 300 single-use and multiuse participants; 100 group users 
• Inclusion criteria: PSS participation July 2014–June 2015  
• Data collected: Patient demographics (age, gender, insurance), diagnostic information (cancer 
origin, stage), treatment modalities (surgery, chemotherapy, radiation), PSS services (CRC, NT, 
FA, OV, INF, SG, family services) 
• Utilization of services was compared among four sets of data: 1) all new cancer cases at PRCP, 2) 
single-use participants, 3) multiuse participants, and 4) group participants 
 
SATISFACTION OF SERVICES  
• STAFF SURVEY: Survey Monkey, forced-choice Likert scale 
o Inclusion criteria: Direct/indirect patient interaction  
o Response rate: 41 of 110 staff invited  (37%) 
• PATIENT SURVEY: Paper copies, forced-choice Likert scale  
o Inclusion criteria: Patients available during INF or SG July–October 2015 (n = 150); 
mailed to patients who attended new patient OV July–October 2014 (n = 440) 
o Response rate: 152 of 590 surveys distributed (26%) 
 
EVALUATION FINDINGS  
PROGRAM STRENGTHS 
 
UTILIZATION OF SERVICES 
In general, utilization of services data appears to align with the mission of PSS 
• While this evaluation is not an exhaustive analysis of utilization of services, it did demonstrate 
that more than 17.3% of all new patients at PRCP interacted with PSS beyond DA; services 
provided by one 0.8 MSW, 2 FT interns   
• Participation in program services was highly reflective of patients’ needs and presumed financial 
resources. Medicaid patients were more likely to participate in nearly all program services, 
despite comprising only 16% of participants and 7.5% of all new cancer cases. Medicare patients 
were more likely to request follow up on DAs, while commercial users were twice as likely to 
participate in SGs 
• Advanced cancer patients used services more frequently and diversely. Stage IV patients 
represented 19.7% of all new cancer cases at PRCP, but represented 53% of multiuse participants 
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PATIENT PERSPECTIVE 
• Eighty-two percent of patients are informed of program services 
• Greatest program strength is emotional support  
• High satisfaction of quality and variety of program services 
• High satisfaction of staff access and responsiveness  
• Psychosocial services perceived as having high value as part of cancer treatment 
• Likelihood of using services or referring others to program services highly dependent upon prior 
use of services  
 
STAFF PERSPECTIVE  
• Sixty-eight percent of staff report familiarity of program services  
• Highly regarded as being valuable and having positive effects on patient outcomes 
• All program services recommended with high consistency  
• Greatest program strength is emotional support 
• Most perceived benefits of PSS: Increased ability to cope with distress, reduction in severe 
emotional disorders, higher satisfaction with cancer care treatment, increased treatment 
compliance, and increased overall health and functioning  
 
PROGRAM LIMITATIONS AND RECOMMENDATIONS  
Proposed recommendations are offered with input form PSS staff and other stakeholders 
 
UTILIZATION OF SERVICES  
• Women comprised 56% of all new cancer cases, but represented 68% of all program participants  
• Breast cancer patients were superiorly overrepresented among all program participants and across 
all program services. Despite high national prevalence rates, male reproductive cancer patients 
were underrepresented across all new cancer cases as well as program services 
 
PROPOSED RECOMMENDATIONS  
• Diversity of services (gender): Market program services for men with cancer: Men 
represent 44% of all new cancer cases, but only 32% of program participants (15% group users 
and 36% of multiuse participants)  
• Diversity of services (cancer): Based on projected prevalence rates of common cancer 
diagnoses reported by NCI, focus recruiting a more diverse group of patients to participate in 
program services  
o Program services should aim to target commonly diagnosed cancers that are similarly 
represented among all new cancer cases at PRCP. According to the NCI, the most 
commonly diagnosed cancers include bladder, breast, colorectal, endometrial, kidney, 
leukemia, lung, melanoma, non-Hodgkin lymphoma, pancreatic, prostate, and thyroid 
cancer  
• Support groups: While SGs tend to be a well known aspect of cancer support services and 
have the potential to reach a large and diverse group of people, it is worth further evaluating how 
SGs are currently utilized at PRCP  
o Evaluate use of staff resources compared to attendance numbers, diversity of participants, 
and the ability to reach a large and broad audience  
o Evaluate how many SGs are needed to meet the emotional needs of patients and 
caregivers. Can current SGs be consolidated to reach a higher volume of patients (i.e., all 
men or all women with cancer) vs specialized SGs (i.e., women with breast cancer)? 
What is the advantage of offering open vs. closed groups that require registration or are 
held for a limited time (i.e., eight weeks) vs. ongoing?  
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o Evaluate what attracts the most attendees to SGs.  For example, should funds be allocated 
to inviting guest speakers? 
 
EDUCATION AND OUTREACH 
IDENTIFIED CONCERNS  
• Staff education and encouragement to use services; limited emphasis on “integrative services” 
• Patient education and outreach  
• Advertisement of program services  
 
PROPOSED RECOMMENDATIONS  
• Staff education: Only 37% of staff refer to PSS “often” and 39% refer “sometimes”  
o Create a quarterly PSS newsletter that includes staff biographies and specialties, patient 
narratives describing frequent scenarios or illustrating program resources and utilization 
of services. Distribute the newsletter via email and place hard copies in the staff lounge  
o Have a PSS representative attend quarterly all staff service meetings; have a PSS 
representative attend PRCP cancer conferences  
o During NEO job training, have new staff shadow a PSS staff member  
• Patient education and outreach: Once a month, set up a “meet and greet” table in INF to 
distribute program information, answer questions, and increase staff visibility  
o Consider placing a support staff person in the first floor reception area to help direct 
patients and increase visibility of first floor services  
• Marketing and advertising: Advertise PSS services in prominent locations such as INF 
and nursing stations; create quick fact sheets with PSS contact information, program services, and 
commonly requested resources (i.e., COPES, SSDI, transportation) 
o Consider investing in television monitors that can be mounted in common areas such as 
the waiting room. Screensavers can advertise program services, PSS biographies and 
contact information along with other PRCP information. Update the phone message to 
advertise PSS services while callers are on hold 
o Monitor the accuracy of current marketing materials and update information frequently 
(i.e., printed brochures, website information) 
 
SERVICES AND ACCESS 
IDENTIFIED CONCERNS  
• Transportation services   
• Transitioning onto hospice care 
• Support for family members and caregivers (endorsed by patients + staff) 
 
PROPOSED RECOMMENDATIONS  
• Transportation: Provide handouts that advertise available transportation services and 
eligibility. Evaluate whether dissatisfaction reflects problems with transportation services and 
eligibility, or a deficit in how PRCP uses services.  
o Consider allocating PAF towards alternate transportation options (i.e., ferry tickets, bus 
fare) and additional gas cards  
• Hospice care: Evaluate how and when referrals are made to hospice to better understand 
concerns and areas for improvement  
• Family services: There is already a high inclusion of family involvement in services occurring 
naturally (17% single-use, 42% multiuse, 37% group). Market services for family members and 
caregivers more explicitly; create a brochure that markets services toward caregivers and include 
a list of outside resources available for caregivers  
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STAFFING 
IDENTIFIED CONCERNS  
• Training and education of PSS staff; inconsistency providing care (patient criticism)  
• Staffing access—availability, visibility, and lack of full-time staffing (staff criticism) 
• Response time on urgent needs—difficulty reaching staff and less than desirable response time on 
calls, pages, and DAs; ability to triage patients with high acuity ranked low as a department 
strength  
 
PROPOSED RECOMMENDATIONS  
• Staff training and consistency: Create a standard training program with learning modules 
on department needs for interns. Create procedural flow charts that illustrate level of patient care, 
available resources, and program services (i.e., COPES, SSDI, PAF)  
• Staff access: Create one centralized phone number to contact all PSS staff  
o FT staffing: Evaluate the ratio of full-time PSS staff to patients compared to other cancer 
treatment programs to determine if PRCP staffing is similar and/or sufficient  
o Evaluate the sustainability of the internship program. What is the long-term sustainability 
of PSS services based on current staffing conditions?  
o Visibility concerns may also be addressed via improvements made to staff education, 
patient outreach, and program marketing (as indicated above)  
• Response time: Evaluate QA measures to assess timely follow up on urgent referrals and DA 
response time  
 
ACRONYMS & ABBREVIATIONS 
 
COPES  Community Options Program Entry System (WA Medicaid program)  
CRC  Cancer Resource Center 
DA  Distress Assessment  
EHR  Electronic health record  
FA  Financial support (i.e., Patient Assistance Fund, SSDI applications)  
INF  Infusion  
MSW  Master of social work  
NCI  National Cancer Institute  
NEO  New Employee Orientation  
NT  Nutrition  
OV  Office visit  
PAF  Patient Assistance Fund  
PSS  Patient Support Services  
QA  Quality assurance  
SG  Support group 
SSDI  Social Security Disability Insurance program    
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Appendix S 
 
Permissions 
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National Academies Press hereby granted permission at no charge for the following materials to 
be reused in the present dissertation manuscript.  
• Figure 1. Model for the delivery of psychosocial health services  
• Table 1. Psychosocial needs and formal services to address them  
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Providence Regional Cancer Partnership hereby granted permission at no charge for the 
following material to be reused in the present dissertation manuscript.  
• Appendix K: Distress Assessment tool  
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W. K. Kellogg Foundation hereby granted permission at no charge for the following materials to 
be reused in the present dissertation manuscript.  
• Appendix N. Logic Model: If…Then Assumptions  
• Appendix O. Outcomes Approach Logic Model  
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